
<html lang="en"     class="pb-page"  data-request-id="beeabba4-6bcd-4182-b614-20eff07f6c28"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01635;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple Sclerosis" /></meta><meta name="dc.Creator" content="Qinjie  Weng" /></meta><meta name="dc.Creator" content="Jinxin  Che" /></meta><meta name="dc.Creator" content="Zhikang  Zhang" /></meta><meta name="dc.Creator" content="Jiahuan  Zheng" /></meta><meta name="dc.Creator" content="Wenhu  Zhan" /></meta><meta name="dc.Creator" content="Sendong  Lin" /></meta><meta name="dc.Creator" content="Tian  Tian" /></meta><meta name="dc.Creator" content="Jincheng  Wang" /></meta><meta name="dc.Creator" content="Renhua  Gai" /></meta><meta name="dc.Creator" content="Yongzhou  Hu" /></meta><meta name="dc.Creator" content="Bo  Yang" /></meta><meta name="dc.Creator" content="Qiaojun  He" /></meta><meta name="dc.Creator" content="Xiaowu  Dong" /></meta><meta name="dc.Description" content="Multiple sclerosis (MS) is a disease of the autoimmune-mediated disorder in the central nervous system, for which no effective therapeutic agent is currently available. The regulation of macrophage..." /></meta><meta name="Description" content="Multiple sclerosis (MS) is a disease of the autoimmune-mediated disorder in the central nervous system, for which no effective therapeutic agent is currently available. The regulation of macrophage..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 11, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01635" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01635" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01635" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01635" /></link>
        
    
    

<title>Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple Sclerosis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01635" /></meta><meta property="og:title" content="Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple Sclerosis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0018.jpeg" /></meta><meta property="og:description" content="Multiple sclerosis (MS) is a disease of the autoimmune-mediated disorder in the central nervous system, for which no effective therapeutic agent is currently available. The regulation of macrophage polarization toward M2 is a general benefit for treating MS. The gene biomarker-based phenotypic screening approach was developed, and 3,4-disubstituted piperidine derivative S-28 was identified as a lead compound modulating macrophage M2 polarization. Further SAR studies resulted in the discovery of the most potent modulator D11 that showed good oral bioavailability and significant in vivo therapeutic effects. Mechanistic studies demonstrated that the M2 polarization macrophages modulated by D11 mainly functioned through inhibiting the proliferation of T-cells and activating the phosphorylation of Stat3 and Akt. Therefore, the gene biomarker-based phenotypic screening was demonstrated as a promising tool for the discovery of novel macrophage M2 polarization modulators. Compound D11 may serve as a promising starting point for the development of therapeutics to treat MS." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Multiple sclerosis (MS) is a disease of the autoimmune-mediated disorder in the central nervous system, for which no effective therapeutic agent is currently available. The regulation of macrophage polarization toward M2 is a general benefit for treating MS. The gene biomarker-based phenotypic screening approach was developed, and 3,4-disubstituted piperidine derivative S-28 was identified as a lead compound modulating macrophage M2 polarization. Further SAR studies resulted in the discovery of the most potent modulator D11 that showed good oral bioavailability and significant in vivo therapeutic effects. Mechanistic studies demonstrated that the M2 polarization macrophages modulated by D11 mainly functioned through inhibiting the proliferation of T-cells and activating the phosphorylation of Stat3 and Akt. Therefore, the gene biomarker-based phenotypic screening was demonstrated as a promising tool for the discovery of novel macrophage M2 polarization modulators. Compound D11 may serve as a promising starting point for the development of therapeutics to treat MS." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0018.jpeg" /></meta><meta name="twitter:title" content="Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple Sclerosis" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01635"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01635">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01635&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01635&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01635&amp;href=/doi/10.1021/acs.jmedchem.8b01635" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3268-3285</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01719" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01642" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple Sclerosis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Qinjie Weng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qinjie Weng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qinjie++Weng">Qinjie Weng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jinxin Che</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jinxin Che</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ZJU-ENS Joint Laboratory of Medicinal Chemistry, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jinxin++Che">Jinxin Che</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhikang Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhikang Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhikang++Zhang">Zhikang Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiahuan Zheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiahuan Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiahuan++Zheng">Jiahuan Zheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenhu Zhan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenhu Zhan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ZJU-ENS Joint Laboratory of Medicinal Chemistry, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenhu++Zhan">Wenhu Zhan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sendong Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sendong Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ZJU-ENS Joint Laboratory of Medicinal Chemistry, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sendong++Lin">Sendong Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tian Tian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tian Tian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ZJU-ENS Joint Laboratory of Medicinal Chemistry, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tian++Tian">Tian Tian</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jincheng Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jincheng Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jincheng++Wang">Jincheng Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Renhua Gai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Renhua Gai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Renhua++Gai">Renhua Gai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yongzhou Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yongzhou Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ZJU-ENS Joint Laboratory of Medicinal Chemistry, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yongzhou++Hu">Yongzhou Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bo Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bo Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Yang">Bo Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiaojun He</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiaojun He</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiaojun++He">Qiaojun He</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiaowu Dong</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaowu Dong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">ZJU-ENS Joint Laboratory of Medicinal Chemistry, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#debab1b0b9a6a99ea4b4abf0bbbaabf0bdb0"><span class="__cf_email__" data-cfemail="15717a7b726d62556f7f603b7071603b767b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaowu++Dong">Xiaowu Dong</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2178-4372" title="Orcid link">http://orcid.org/0000-0002-2178-4372</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01635&amp;href=/doi/10.1021%2Facs.jmedchem.8b01635" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3268–3285</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 11, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 October 2018</li><li><span class="item_label"><b>Published</b> online</span>11 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01635" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01635</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3268%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DQinjie%2BWeng%252C%2BJinxin%2BChe%252C%2BZhikang%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b01635%26title%3DPhenotypic%2BScreening-Based%2BIdentification%2Bof%2B3%252C4-Disubstituted%2BPiperidine%2BDerivatives%2Bas%2BMacrophage%2BM2%2BPolarization%2BModulators%253A%2BAn%2BOpportunity%2Bfor%2BTreating%2BMultiple%2BSclerosis%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3285%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01635"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2122</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01635" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple Sclerosis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Qinjie&quot;,&quot;last_name&quot;:&quot;Weng&quot;},{&quot;first_name&quot;:&quot;Jinxin&quot;,&quot;last_name&quot;:&quot;Che&quot;},{&quot;first_name&quot;:&quot;Zhikang&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jiahuan&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Wenhu&quot;,&quot;last_name&quot;:&quot;Zhan&quot;},{&quot;first_name&quot;:&quot;Sendong&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Tian&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Jincheng&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Renhua&quot;,&quot;last_name&quot;:&quot;Gai&quot;},{&quot;first_name&quot;:&quot;Yongzhou&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Qiaojun&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Xiaowu&quot;,&quot;last_name&quot;:&quot;Dong&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3268-3285&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01635&quot;},&quot;abstract&quot;:&quot;Multiple sclerosis (MS) is a disease of the autoimmune-mediated disorder in the central nervous system, for which no effective therapeutic agent is currently available. The regulation of macrophage polarization toward M2 is a general benefit for treating MS. The gene biomarker-based phenotypic screening approach was developed, and 3,4-disubstituted piperidine derivative S-28 was identified as a lead compound modulating macrophage M2 polarization. Further SAR studies resulted in the discovery of the most potent modulator D11 that showed good oral bioavailability and significant in vivo therapeutic effects. Mechanistic studies demonstrated that the M2 polarization macrophages modulated by D11 mainly functioned through inhibiting the proliferation of T-cells and activating the phosphorylation of Stat3 and Akt. Therefore, the gene biomarker-based phenotypic screening was demonstrated as a promising tool for the discovery of novel macrophage M2 polarization modulators. Compound D11 may serve as a promising startin&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01635&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01635" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01635&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01635" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01635&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01635" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01635&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01635&amp;href=/doi/10.1021/acs.jmedchem.8b01635" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01635" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01635" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01635%26sid%3Dliteratum%253Aachs%26pmid%3D30856328%26genre%3Darticle%26aulast%3DWeng%26date%3D2019%26atitle%3DPhenotypic%2BScreening-Based%2BIdentification%2Bof%2B3%252C4-Disubstituted%2BPiperidine%2BDerivatives%2Bas%2BMacrophage%2BM2%2BPolarization%2BModulators%253A%2BAn%2BOpportunity%2Bfor%2BTreating%2BMultiple%2BSclerosis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3268%26epage%3D3285%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=290648" title="Polarization">Polarization</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Volume 62, Issue 7"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Volume 62, Issue 7"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Multiple sclerosis (MS) is a disease of the autoimmune-mediated disorder in the central nervous system, for which no effective therapeutic agent is currently available. The regulation of macrophage polarization toward M2 is a general benefit for treating MS. The gene biomarker-based phenotypic screening approach was developed, and 3,4-disubstituted piperidine derivative <b>S-28</b> was identified as a lead compound modulating macrophage M2 polarization. Further SAR studies resulted in the discovery of the most potent modulator <b>D11</b> that showed good oral bioavailability and significant in vivo therapeutic effects. Mechanistic studies demonstrated that the M2 polarization macrophages modulated by <b>D11</b> mainly functioned through inhibiting the proliferation of T-cells and activating the phosphorylation of Stat3 and Akt. Therefore, the gene biomarker-based phenotypic screening was demonstrated as a promising tool for the discovery of novel macrophage M2 polarization modulators. Compound <b>D11</b> may serve as a promising starting point for the development of therapeutics to treat MS.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16547" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16547" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Multiple sclerosis (MS) represents an immune-mediated chronic and demyelinating disease of the central nervous system (CNS),<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> featuring perivascular leukocyte infiltrates, astrogliosis, axonal damage, and loss of function.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> In particular, MS is the most common cause of neurological disability among young adults, affecting approximately one in 1000 individuals in both Europe and North America.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Clinically, there are various MS treatment approaches available that have been shown to decrease the frequency of relapses and delay disease progression. Examples include β-interferons, glatiramer acetate, fingolimod, teriflunomide, dimethyl fumarate, natalizumab, and ocrelizumab.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, there is no effective therapeutic agent that cures MS is currently available. Most of the above-mentioned anti-MS drugs only relief the development of MS progression. Moreover, the application of developed anti-MS drugs is often limited by frequently occurring side effects, including flu-like symptoms and the development of other autoimmune disorders by interferon-β or fingolimod.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Hence, it is of particular importance to identify more effective compounds with new mechanisms of action. Therefore, the development of more effective compounds as alternative approaches for the treatment of MS remains a critical, albeit unmet, scientific goal in MS research.</div><div class="NLM_p">Macrophages exhibit a dynamic role in host defense and the maintenance of tissue homoeostasis. This necessitates a delicate balance between the proinflammatory and immunomodulatory functions to ensure appropriate responses to environmental stimuli. In general, macrophages can be broadly classified as M1 (classical) and M2 (alternative) subtypes based on the function.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> M1 macrophages are activated by LPS and/or IFN-γ to elaborate proinflammatory cytokine production and tissue inflammation.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Conversely, M2 macrophages can be characterized by high expression of arginase 1 (Arg1), mannose receptor C-type 1 (Mrc1), resistin-like molecule alpha1 (Fizz1) on cell surface marker CD206, stimulated by Th2 cytokines IL-4 or IL-13 to promote helminthic immunity, fibrosis, allergy, and immunomodulation.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a></div><div class="NLM_p">The encephalomyelitis (EAE) model is a standard model for MS.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Recently, macrophages have been shown to actively participate in the pathogenesis of EAE progression.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> In particular, during the induction phase of EAE, it was found that the M1 macrophages’ proportion increases in the spleen, resulting in the draining of lymph nodes (dLNs) in C57BL/6 mice with early EAE.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In this state, M1-polarized macrophages were found to exhibit the ability to induce neuronal destruction,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> with symptoms of ongoing EAE worsening.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, M2-polarized macrophages have been demonstrated to produce pro-repair molecules, including the brain-derived neurotropic factor, IL-10, and ferritin.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20−23)</a> After administration of M2-activated macrophages, the development of an EAE model could be significantly suppressed.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Importantly, pro-repair molecules secreted by M2 macrophages favor the restoration of myelin and axons, which indicates particularly beneficial characteristics for the potential cure of MS.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> Therefore, the inflammatory phenotype of macrophage cells is crucial for the EAE progression, revealing that the regulatory control of macrophage polarization may be a promising strategy for the treatment of MS. However, the molecular mechanism of regulating macrophages M2-polarization is still not very clear. To the best of our knowledge, there is no specific effective regulator to treat or control MS using this strategy. Therefore, it would be of particular interest to explore small molecular compounds that could induce the M2-polarization of macrophages for MS therapy.</div><div class="NLM_p last">In recent years, interest in phenotypic screening as a means for small-molecule drug discovery has continued to increase as an alternative to target-based screening.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> However, there is an ever-growing curiosity to elucidate potential benefits of combining phenotypic and genomic data, in an effort to advance small-molecule drug discovery. Accordingly, the distinct biomarkers of two inflammatory phenotypes (M1 and M2) of macrophage cells described herein render phenotypic screening suitable to find small molecular regulators for macrophages M2-polarization. In the previous work, we have established an effective evaluation system of macrophage polarization based on gene biomarkers such as <i>Arg1</i> and <i>Mcp1</i>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> As a continued study for identifying novel macrophage M2 polarization modulators, we wonder whether this evaluation system can be used for the discovery of novel macrophage M2 polarization modulators for the treatment of MS. Thus, similarity search and SAR studies involving different structural moieties of different lead compounds were carried out based on in-house database screening. This led to the identification of the most potent (both in vitro and in vivo) compound <b>D11</b> (14-fold upregulation of M2 marker <i>Arg1</i>). Further mechanism studies of compound <b>D11</b> demonstrated that <b>D11</b> mainly functioned through inhibiting the proliferation of T-cells in the EAE mouse model, and Stat3 and Akt proteins may be important nodes for its regulation of macrophage M2 polarization.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Phenotypic Screening of a Structurally Diverse Compound Library</h3><div class="NLM_p">A structurally diverse compound library containing approximately 20 000 compounds was established in-house for phenotypic screening, assisted by cluster analysis. A total of 28 compounds with significantly different structural skeletons were selected (for corresponding compound structures, see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Figure S1</a>). The murine macrophage cell line RAW264.7 was treated with different compounds for 24 h. Then, the relative expression of macrophage M1 polarization biomarker <i>Mcp1</i> and M2 polarization biomarker <i>Arg1</i> was tested. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, several compounds demonstrated a good M2 polarization-inducing activity such as compounds <b>S-2</b>, <b>S-7</b>, <b>S-9</b>, <b>S-11</b>, <b>S-13</b>, and <b>S-28</b> (for corresponding data, see <a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Table S1</a>). Specifically, treatment with compound <b>S-28</b> (also termed as PZ8 in our database) was accompanied by the most remarkable elevation of the M2 marker <i>Arg1</i> mRNA expression and the least upregulation of M1 marker <i>Mcp1</i> mRNA expression among all studied compounds.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>S-28</b> promoted macrophage M2 polarization most effectively; (blue) quantitative real-time polymerase chain reaction (qRT-PCR) analysis for expression of macrophage M2 phenotype gene <i>Arg1</i> in RAW264.7 cells treated with 28 compounds (300 nM) for a total 24 h. IL-4 (20 ng/mL) was used as a positive control; (purple) qRT-PCR analysis for expression of macrophage M1 phenotype gene <i>Mcp1</i> in RAW264.7 cells treated with 28 compounds (300 nM) for 24 h. LPS (50 ng/mL) was used as a positive control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>S-28</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) was composed of four rings, <b>a</b>, <b>c</b>, and <b>d</b> rings represented aryl rings, and the <b>b</b> ring represented a saturated (3<i>S</i>,4<i>S</i>)-piperidine ring. In order to explore the structure–activity relationship of compound <b>S-28</b> and in an effort to identify more potent M2 polarization modulators, three strategies were applied: (A) a structure similarity search was performed using a MolPort database for the purpose of extending the structural diversity based on the skeleton of compound <b>S-28</b>; (B) it was also found that two chiral centers were present in the <b>b</b> ring; therefore, the influences on M2 polarization modulation activity of the chiral centers were also evaluated; and (C) in order to explore SAR at the initial stage, the four different ring systems and two rings in compound <b>S-28</b> were retained such as the <b>a–b</b> and <b>c–d</b> ring systems. Substituted phenyl, heterocycles, or saturated chains were selected as substituents of the <b>a–b</b> or <b>c–d</b> ring systems.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Different strategies of structure modification for SAR study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  Synthetic Route of Compounds <b>B1</b>, <b>C1–C11</b>, and <b>D1–D21</b></h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6">2.2.1.  Synthesis of Biaryl Carboxylic Acid <b>3a–c</b>, <b>6a–c</b>, and <b>9a–j</b></h4><div class="NLM_p">The synthetic route for the production of the acid fragments is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Different esters (<b>1a–b</b>, <b>4</b>, and <b>7a–d</b>) were used as starting materials. The coupling reaction with 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole provided compounds <b>2a–b</b>, <b>5</b>, and <b>8a–d</b>. After electrophilic reaction with <i>N</i>-bromosuccinimide (NBS) or <i>N</i>-chlorosuccinimide (NCS) and hydrolysis, the biaryl carboxylic acids <b>3a–c</b>, <b>6a–c</b>, and <b>9a–j</b> were obtained.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, DMF; (b) NBS or NCS, Dichloromethane; (c) NaOH, H<sub>2</sub>O/EtOH</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">2.2.2.  Synthesis of 3-Amino-4-aryl Piperidine <b>14a–d</b></h4><div class="NLM_p">The synthetic route to obtain a series of 3,4-disubstituted piperidine compounds is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compounds <b>10a–c</b> underwent R or S Jorgensen-Hayashi reagent-catalyzed cyclization with compound <b>10</b> to provide the (3<i>S</i>,4<i>S</i>) compounds <b>12a–c</b> and (3<i>R</i>,4<i>R</i>) compound <b>12d</b>. Treatment of compounds <b>12a–d</b> with EtSiH and following in the presence of Fe/NH<sub>4</sub>Cl provided 3-amino-4-aryl piperidine.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. (a) (<i>S</i>)-2-(Diphenyl((trimethylsilyl)oxy)methyl)pyrrolidine, Dichloromethane; (i) TFA, Dichloromethane; (b) (<i>R</i>)-2-(Diphenyl((trimethylsilyl)oxy)methyl)pyrrolidine, Dichloromethane; (ii) TFA, Dichloromethane; (c) (i) EtSiH, TFA; (ii) Boc<sub>2</sub>O, TEA, Dichloromethane; and (d) Fe, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">2.2.3.  Synthesis of Target Compounds <b>B1</b>, <b>C1–C11</b>, and <b>D1–D21</b></h4><div class="NLM_p">The synthetic route for the production of the target compounds is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Treatment of aryl acids with aliphatic amines in the presence of EDCI and HOBt provided the condensed intermediates. Then, deprotection with HCl in ethyl acetate yielded the target compounds <b>B1</b>, <b>C1–C11</b>, and <b>D1–D19</b>. For compounds <b>D20</b> and <b>D21</b>, <span class="smallcaps smallerCapital">l</span>-tartrate was introduced to replace hydrochloride as a counteranion. In doing so, the target compounds could be obtained as white solids as opposed to colorless oils in the case of hydrochloride as a counteranion. The purities of all synthesized compounds were over 95%.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. (a) EDCI, HOBt, and DIPEA; (b) EA and HCl; and (c) <span class="smallcaps smallerCapital">l</span>-Tartaric Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.3.  In Vitro Evaluation of Macrophage Polarization Gene Biomarker Expression Fold Change</h3><div class="NLM_p">Ten different structures were selected from the MolPort database based on similarity search results (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Unfortunately, among these structures, we could not identify any other more potent skeletons. The bioactivity test results (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) indicated that most of the study compounds exhibited low macrophage M2 or M1 polarization-induced activity. Specifically, compounds <b>A2</b> and <b>A9</b> displayed about fourfold upregulation of <i>Arg1</i> expression; however, the activity was significantly lower than that of compound <b>S-28</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Macrophage Polarization Gene Biomarker Expression Fold Change of Compounds <b>A1–A10</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0014.gif" alt="" id="GRAPHIC-d7e721-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">M2 marker Arg1</th><th class="rowsep1 colsep0" colspan="2" align="center">M1 marker Mcp1</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">fold<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">SEM</th><th class="colsep0 rowsep0" align="center">fold<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">SEM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ctr</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A1</b></td><td class="colsep0 rowsep0" align="left">2.35</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="left">1.14</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A2</b></td><td class="colsep0 rowsep0" align="left">4.85</td><td class="colsep0 rowsep0" align="char" char=".">1.04</td><td class="colsep0 rowsep0" align="left">1.24</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A3</b></td><td class="colsep0 rowsep0" align="left">0.80</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="left">2.14</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A4</b></td><td class="colsep0 rowsep0" align="left">1.48</td><td class="colsep0 rowsep0" align="char" char=".">0.97</td><td class="colsep0 rowsep0" align="left">1.52</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A5</b></td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="left">1.40</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A6</b></td><td class="colsep0 rowsep0" align="left">1.09</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="left">1.34</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A7</b></td><td class="colsep0 rowsep0" align="left">2.22</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="left">1.95</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A8</b></td><td class="colsep0 rowsep0" align="left">2.22</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="left">1.86</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A9</b></td><td class="colsep0 rowsep0" align="left">3.92</td><td class="colsep0 rowsep0" align="char" char=".">2.22</td><td class="colsep0 rowsep0" align="left">2.14</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>A10</b></td><td class="colsep0 rowsep0" align="left">1.33</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="left">1.53</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Gene expression was determined by qRT-PCR, the fold change was calculated as follows: gene expression level of dosing group/gene expression level of the control group.</p></div></div></div><div class="NLM_p">A further study of compound <b>S-28</b> focused on chirality and the exploration of other ring systems. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, compound <b>B1</b> bearing a (3<i>R</i>,4<i>R</i>)-disubstituted piperidine ring showed a dramatical loss of M2 polarization-induced activity (0.31-fold upregulation of <i>Arg1</i>), whereas the expression of M1 marker <i>Mcp1</i> could still be retained (1.76-fold upregulation of <i>Mcp1</i>), indicating that the (3<i>S</i>,4<i>S</i>)-disubstituted piperidine ring was indeed essential in maintaining compound activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Macrophage Polarization Gene Biomarker Expression Fold Change of Compounds <b>B1</b> and <b>C1–C11</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0015.gif" alt="" id="GRAPHIC-d7e933-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0016.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Gene expression was determined by qRT-PCR; the fold change was calculated as follows: gene expression level of dosing group/gene expression level of the control group.</p></div></div><div></div></div><div class="NLM_p">When the <b>c–d</b> ring system was replaced by substituted phenyl or heteroaromatic rings such as compounds <b>C1–C6</b>, both exhibited no obvious influences on <i>Mcp1</i> expression or upregulation of <i>Arg1</i> expression. As for the <b>a–b</b> ring system that was replaced by other substituents (compounds <b>C7–C11</b>), the results were performed in the same manner as the lack of the <b>c–d</b> ring system. The ablation of only the <b>a</b> ring (compound <b>C11</b>) or the <b>d</b> ring (compound <b>C1</b>) caused the loss of induced potency. Therefore, we speculated that <b>a</b>, <b>b</b>, <b>c</b>, and <b>d</b> rings were both essential for keeping the induce activity of compound <b>S-28</b>.</div><div class="NLM_p">The subsequent adjustment of the skeleton was mainly carried out on the substituents of the four rings. When the pyridine ring was substituted for the <b>b</b> ring, compounds <b>D1–D7</b> showed no improvements in induced activity (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). On the basis of the above SAR study, we deemed the skeleton highly conserved and fine-adjustment of compound <b>S-28</b> may lead to the identification of an even more potent compound. Compounds <b>D8–D21</b> were synthesized and tested, and the corresponding results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Compounds <b>D8</b>, <b>D11</b>, <b>D12</b>, and <b>D15</b> demonstrated an over 10-fold upregulation of the M2 marker <i>Arg1</i>. As expected, most of the compounds showed less potency in elevating the M1 marker <i>Mcp1</i>, except for compounds <b>D14–D16</b>. Here, R<sub>3</sub> was substituted with 3-CF<sub>3</sub>-4-Cl. However, compound <b>D11</b> showed the strongest ability to promote expression of the M2 marker <i>Arg1</i> in RAW264.7 and much lower upregulation of M1 marker <i>Mcp1</i> mRNA expression (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Furthermore, RAW264.7 cells were treated with LPS, accompanied by administration of the potent M2 polarization modulators <b>D8</b>, <b>D11</b>, <b>D12</b>, and <b>D15</b>. It was found that compound <b>D11</b> could also reverse the upregulation of M1 marker <i>Mcp1</i> expression induced by LPS (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Thus, compound <b>D11</b> was selected for the following pharmacokinetic and pharmacodynamic studies.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) (Blue) qRT-PCR analysis to determine the expression of macrophage M2 phenotype gene <i>Arg1</i> in RAW264.7 cells treated with compounds (300 nM) for 24 h. IL-4 (20 ng/mL) was used as a positive control. (Purple) qRT-PCR analysis for the determination of macrophage M1 phenotype gene <i>Mcp1</i> expression in RAW264.7 cells treated with compounds (300 nM) for 24 h. LPS (50 ng/mL) was used as a positive control; (B) qRT-PCR analysis for the determination of macrophage M1 phenotype gene <i>Mcp1</i> expression. RAW264.7 cells were pretreated with LPS (50 ng/mL) for 24 h and subsequently treated with compounds (300 nM) for 24 h. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Macrophage Polarization Gene Biomarker Expression Fold Change of Compounds <b>D1–D21</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0017.gif" alt="" id="GRAPHIC-d7e1111-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">M2 marker Arg1</th><th class="rowsep1 colsep0" colspan="2" align="center">M1 marker Mcp1</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">fold<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">SEM</th><th class="colsep0 rowsep0" align="center">fold<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">SEM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ctr</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D1</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">0.71</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="left">1.63</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D2</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="left">1.99</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-4-Cl</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="left">1.37</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D4</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="left">1.14</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D5</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="left">1.23</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D6</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left">1.01</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D7</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="left">1.32</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D8</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">10.12</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="left">2.05</td><td class="colsep0 rowsep0" align="char" char=".">0.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D9</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">8.35</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="left">2.44</td><td class="colsep0 rowsep0" align="char" char=".">0.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D10</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">6.54</td><td class="colsep0 rowsep0" align="char" char=".">1.71</td><td class="colsep0 rowsep0" align="left">1.89</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D11</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">13.97</td><td class="colsep0 rowsep0" align="char" char=".">3.18</td><td class="colsep0 rowsep0" align="left">1.47</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D12</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">10.05</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D13</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-4-Cl</td><td class="colsep0 rowsep0" align="left">5.08</td><td class="colsep0 rowsep0" align="char" char=".">1.60</td><td class="colsep0 rowsep0" align="left">1.49</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D14</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-4-Cl</td><td class="colsep0 rowsep0" align="left">1.82</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="left">4.85</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D15</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-4-Cl</td><td class="colsep0 rowsep0" align="left">10.33</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="left">3.54</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D16</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-4-Cl</td><td class="colsep0 rowsep0" align="left">2.82</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="left">5.08</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D17</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">3,4-diF</td><td class="colsep0 rowsep0" align="left">1.72</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D18</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3,4-diF</td><td class="colsep0 rowsep0" align="left">1.97</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="left">1.50</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D19</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3,4-diF</td><td class="colsep0 rowsep0" align="left">3.99</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3,4-diF</td><td class="colsep0 rowsep0" align="left">3.42</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D21</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3,4-diF</td><td class="colsep0 rowsep0" align="left">2.27</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="left">1.77</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Gene expression was determined by qRT-PCR; the fold change was calculated as follows: gene expression level of dosing group/gene expression level of the control group.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">2.4.  In Vivo Pharmacokinetic Evaluation</h3><div class="NLM_p">Definitive single-dose pharmacokinetic studies were conducted in rats (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compound <b>D11</b> demonstrated excellent absolute oral bioavailability in rats with an F value of 50.63%. In addition, the compound showed good clearance and oral absorption (<i>t</i><sub>1/2</sub> = 3.3 h, <i>C</i><sub>max</sub> = 313 ng/mL, AUC<sub>0–<i>t</i></sub> = 4669 μg/L·h) characteristics. These data suggested that compound <b>D11</b> constitutes a reasonable starting point for further drug development studies.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters of <b>D11</b> in Sprague-Dawley (SD) Rat</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">compound <b>D11</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">50 mg/kg</th><th class="colsep0 rowsep0" align="center">10 mg/kg</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameters</th><th class="colsep0 rowsep0" align="center">oral</th><th class="colsep0 rowsep0" align="center">intravenous</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">3.25 ± 0.5</td><td class="colsep0 rowsep0" align="left">0.083 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">7.77 ± 1.52</td><td class="colsep0 rowsep0" align="left">6.30 ± 1.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/L)</td><td class="colsep0 rowsep0" align="left">313.23 ± 87.45</td><td class="colsep0 rowsep0" align="left">1001.40 ± 423.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–<i>t</i></sub> (μg/L·h)</td><td class="colsep0 rowsep0" align="left">4669.27 ± 1165.37</td><td class="colsep0 rowsep0" align="left">1844.42 ± 568.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (μg/L·h)</td><td class="colsep0 rowsep0" align="left">4743.69 ± 1166.54</td><td class="colsep0 rowsep0" align="left">1869.93 ± 585.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R_AUC<sub>(<i>t</i>/∞)%</sub></td><td class="colsep0 rowsep0" align="left">98.425 ± 1.32</td><td class="colsep0 rowsep0" align="left">98.75 ± 1.287</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" colspan="2" align="left">50.63%</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">2.5.  Compound <b>D11</b> Changes Macrophage Polarization Balance toward M2</h3><div class="NLM_p">In <b>D11</b>-treated RAW264.7 cells, the microarray analysis result indicated that <b>D11</b> activated M2 macrophage marker genes but suppressed M1 marker genes (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B). Compared to the passage cell line RAW264.7, bone marrow-derived macrophages (BMDMs) present a more ideal in vitro model to understand the mechanisms controlling polarization of activated macrophages.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> It was further demonstrated that the M2 macrophages marker CD206 expression was elevated (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A) and M1 macrophages marker CD86 expression was suppressed dose-dependently after treatment with <b>D11</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B) on BMDMs.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>D11</b> promotes the polarization of M2 macrophages in combination with inhibiting M1 polarization ex vivo. (A) Numbers of altered genes after the RAW264.7 cells were treated with <b>D11</b>; (B) fold change of macrophage polarization gene markers; (C) BMDM cells were treated with 300 nM of <b>D11</b> for 24 h. qRT-PCR was performed to investigate the macrophages M2 polarization-associated genes <i>Arg1</i>, <i>Mrc1</i>, and <i>Fizz1</i> mRNA expression levels. (D) BMDM cells were pretreated with LPS (50 ng/mL) for 24 h and then treated with 300 nM of <b>D11</b> for 24 h. qRT-PCR was performed to investigate the macrophages M1 polarization-associated gene <i>Mcp1</i>, <i>Inos</i>, and <i>Cd86</i> mRNA expression levels. (E) BMDM cells were treated with 300 nM of <b>D11</b> for 24 h. The percentage of M2 macrophages (CD206<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow-cytometry. (F) BMDM cells were pretreated with LPS (50 ng/mL) for 24 h and then treated with 300 nM of <b>D11</b> for 24 h. The percentage of M1 macrophages (CD86<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow cytometry. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, ***<i>P</i> < 0.01 versus control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>D11</b> promotes macrophages M2 polarization and inhibits M1 polarization dose-dependently. (A) BMDM cells were treated with indicated concentration of <b>D11</b> for 24 h. The percentage of M2 macrophages (CD206<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow-cytometry. (B) BMDM cells were pretreated with LPS (50 ng/mL) for 24 h and then treated with indicated concentration of <b>D11</b> for 24 h. The percentage of M1 macrophages (CD86<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow cytometry. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, ***<i>P</i> < 0.01 vs control group. <sup>#</sup><i>P</i> < 0.05 versus LPS group. n.s. <i>P</i> > 0.05 vs control or LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Hence, the BMDM cell line was used for further biomechanistic studies of compound <b>D11</b>. Treatment of BMDMs with 300 nM <b>D11</b> resulted in an increase of mRNA levels of the M2 markers <i>Arg1</i>, <i>Mrc1</i>, and <i>Fizz1</i> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Furthermore, compound <b>D11</b> at a concentration of 300 nM reversed the elevation of mRNA levels of the M1 markers <i>Mcp1</i>, <i>Inos</i>, and <i>Cd86</i> stimulated by LPS (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). Meanwhile, the western blot analysis also showed that the expression level of macrophage M2 polarization marker Arg1 and Ym1 proteins increased, whereas the M1 polarization marker Tnf-α protein was still remained (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Figure S2</a>). Furthermore, treatment of BMDM cells with 300 nM of <b>D11</b> increased the expression of the M2 macrophages marker CD206 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E) and suppressed the expression of the M1 macrophages marker CD86 stimulated by LPS (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F) as measured by flow cytometry.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">2.6.  Therapeutic Effect of Compound <b>D11</b> in the EAE Model</h3><div class="NLM_p">Because the myelin oligodendrocyte glycoprotein (MOG) has emerged as one of the most important target antigens in MS,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> the in vivo therapeutic effect of compound <b>D11</b> was evaluated in a MOG<sub>35–55</sub>-induced mouse EAE model. Further safety evaluation of <b>D11</b> on healthy mice indicated that no other obvious side effects were observed except for immunosuppressive activity (which is beneficial in EAE and MS) at 400 mg/kg (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Figure S3</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Table S2 and S3</a>). To avoid the potential side effects caused by excessive immunosuppression and maintain the exposure of <b>D11</b> being above 300 nM, the doses of 100 and 200 mg/kg were chosen as the therapeutic doses in animal EAE study. The therapeutic administration of the drug (<b>D11</b>, 100 and 200 mg/kg, ig, qd) was performed after day 8, right after the appearance of clinical symptoms of EAE (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Dexamethasone (DXM), which is the first choice for the treatment of acute relapses of MS,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was also observed therapeutic effect in the EAE model when treating with DXM as reported,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> so it was chosen as a positive control. The data indicated that when administered at 200 mg/kg, compound <b>D11</b> clearly reduced disease progression, as observed by a significantly lower average clinical score in EAE mice administrated with 200 mg/kg of compound <b>D11</b> compared to vehicle-treated EAE mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Accordingly, H&E and Luxol fast blue (LFB) histological analysis of the affected spinal cord indicted that treatment with 200 mg/kg of <b>D11</b> attenuated demyelination and inflammation in EAE mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D). To study the effect of treatment with compound <b>D11</b> on the pro-inflammatory cells Th1 and Th17 infiltration into the CNS, we isolated mononuclear cells (MNCs) from the CNS (spinal cords and brains) of EAE mice. Then, we performed flow-cytometry analysis and detected a remarkable percentage reduction of both Th1 and Th17 in CD4<sup>+</sup> T-cells of <b>D11</b>-treated EAE mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E,F).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>D11</b> ameliorated clinical severity and limited CNS autoimmunity of EAE mice. (A) Schematic representation of the EAE model. (B) In vivo effect of compound <b>D11</b> on EAE mice. EAE mice were treated with <b>D11</b> (100, 200 mg/kg, i.g.), DXM (10 mg/kg, i.g.), or vehicle (saline, i.g.). Mean clinical scores are shown (<i>n</i> = 5). (C,D) H&E and LFB staining of spinal cords from vehicle- and <b>D11</b>-treated EAE mice on day 14 after induction of EAE. The shown arrows indicate infiltration of inflammatory cells and demyelination in the spinal cord. Scale bars: 100 μm (upper) and 50 μm (bottom). (E,F) Flow cytometry analysis of Th1 and Th17 (IFN-γ<sup>+</sup> and IL-17<sup>+</sup>) on the range of CD4<sup>+</sup> cells isolated from the CNS of vehicle-treated and 200 mg/kg <b>D11</b>-treated EAE mice (<i>n</i> = 4 mice per group), detected between day 13 to day 19 after induction of EAE. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.01 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">2.7.  Compound <b>D11</b> Distorts Macrophages Polarization toward M2 in Vivo</h3><div class="NLM_p">To evaluate the in vivo effect of compound <b>D11</b> on modulating the polarization of macrophages, flow cytometry was used to assess the polarization of macrophages in EAE mice between day 13 and day 19 after induction of EAE. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, the proportion of M2 macrophages (F4/80<sup>+</sup>CD206<sup>+</sup>) in total macrophage populations (F4/80<sup>+</sup>) from both peripheral immune organs (spleen and draining lymph nodes) and the CNS (spinal cord and brain) was found to be significantly elevated in 200 mg/kg <b>D11</b>-treated mice compared to vehicle-treated EAE mice. Conversely, the percentage of M1 macrophages (F4/80<sup>+</sup>CD86<sup>+</sup>) in total macrophage populations (F4/80<sup>+</sup>) was found to be declined in 200 mg/kg <b>D11</b>-treated mice compared with vehicle-treated EAE mice (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). In addition, the influence on dendritic cells and <i>T</i><sub>reg</sub> cells was not observed in <b>D11</b>-treated EAE mice (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Figure S4</a>).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>D11</b> promotes polarization of M2 macrophages and inhibits M1 polarization in EAE mice. (A,B) Spleen, DLN, and CNS were isolated from vehicle-treated and <b>D11</b>-treated (200 mg/kg) EAE mice (<i>n</i> = 4 mice per group) between day 13 and day 19 after induction of EAE. (A) Flow cytometry analysis of M2 marker CD206 in the range of macrophage marker F4/80<sup>+</sup> cells. (B) Flow cytometry analysis of M1 marker CD86 in the range of macrophage marker F4/80<sup>+</sup> cells. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">2.8.  Studies of Compound <b>D11</b> on Crosstalk between Macrophages and CD4<sup>+</sup> T Cells</h3><div class="NLM_p">Our data indicated that treatment with compound <b>D11</b> altered the polarization of macrophages toward an anti-inflammatory phenotype. We then addressed the issue of functionality of <b>D11</b>-treated macrophages. As a potent member of the myeloid lineage, during the induction phase of EAE, M1 macrophages adapt an antigen presenting cell-like capacity to active CD4<sup>+</sup> T cells proliferation and differentiation.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Importantly, compound <b>D11</b> suppressed M1 macrophage-driven T-cell proliferation (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,B). Furthermore, <b>D11</b> treatment decreased the production of the Th1 and Th17 cell signature cytokines IFN-γ and IL-17A (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C,D).</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>D11</b>-treated macrophages inhibited the proliferation of CD4<sup>+</sup> T cells. (A,B) BMDM cells were treated with 50 ng/mL LPS or with 300 nM compound <b>D11</b> for 48 h. Then, BMDM cells were cocultured with CD4<sup>+</sup> T cells, and proliferation was determined after 72 h. Histograms display proliferation profiles of CD4<sup>+</sup> T-cells. Graphs display mean fluorescence intensity of the proliferation dye carboxyfluorescein succinimidyl ester (CFSE) and proliferation percentages of CD4<sup>+</sup> T-cells. (C,D) Coculture supernatant was collected for ELISA analysis of IFN-γ and IL-17 secretion. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, **<i>P</i> < 0.01, n.s. <i>P</i> > 0.05 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">2.9.  Compound <b>D11</b> Promotes Macrophages Polarization via Activating Akt/Stat3 Pathways</h3><div class="NLM_p">In order to fully comprehend the mechanisms involved in the processes described above, microarray analysis was performed using a gene chip technology. RAW264.7 cells were treated in the absence or presence of 300 nM compound <b>D11</b> for 24 h. Among the altered genes (2729 upregulated versus 2769 downregulated, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A), the potential target genes in response to <b>D11</b> treatment are listed in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B, which could well explain the mechanism of macrophages M2 polarization. A number of TLR ligands and cytokines such as TLR4 and IL-6 are potent macrophages M1 polarization promoters, which lead to activation of pro-inflammatory transcription factor STAT1 and NF-κB.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Cytokine IL-4 activated Stat6 and IL-10 activated Stat3, which in turn activated transcription of genes typical of M2 polarization, for example, mannose receptor (Mrc1), resistin-like α (Retnla, Fizz1), chitinase 3-like 3 (Chi3l3,Ym1), IL-10, and TGF-β.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Among all altered genes, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway classification analysis<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> showed that the genes of the immune system and signal transduction were the most altered (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C). On the basis of the microarray analysis results, we further found that the significantly differentially expressed genes such as IKK, Pim-1, AMLI-ETC, and PML-RARα proteins mainly belonged to the Jak-Stat and PI3K-Akt signaling pathways (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Figure S5</a>). Subsequently, western blot analysis was performed, as shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>D. Compound <b>D11</b> was demonstrated to promote phosphorylation of Akt at both sites of 308 and 473, and phosphorylation of Stat3, but did not influence phosphorylation of Stat6. This finding is believed to be due to Stat3 and Akt protein representing an important node in modulating macrophage M2 polarization after treatment with compound <b>D11</b>.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Volcano plot of differentially expressed genes by microarray analysis on <b>D11</b>-treated macrophages RAW264.7. (B) Heatmap of differentially expressed genes by microarray analysis on <b>D11</b>-treated macrophages RAW264.7. (C) Changes of gene expression in the KEGG pathway analysis. (D) Western blotting shows the expression level of Akt/p-Akt(473)/p-Akt(308), Stat3/p-Stat3(Y705), and Stat6/p-Stat6 protein; GAPDH was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">3.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Macrophages exhibit important roles in the development of MS. M1 polarization macrophages exert pathogenic effects, whereas M2 polarization macrophages present an anti-inflammatory phenotype. Thus, molecular intervention to alter macrophage polarization toward M2 poses as a potential therapeutic approach for the treatment of MS. Compound <b>S-28</b> bearing a 3,4-disubstituted piperidine skeleton was identified from an in-house compound library by using phenotypic screening. Following medicinal chemistry optimization and SAR studies revealed compound <b>D11</b> as the most potent derivative in this series that altered macrophages M2 polarization, together with excellent oral bioavailability and therapeutic effects in a mural EAE model. It was also found that compound <b>D11</b> was able to distort the polarization of macrophages toward M2 in vivo and M2 polarization macrophages functioned through inhibiting T-cell proliferation. According to gene chip and western blot studies, Stat3 and Akt proteins were identified to be the main targets that contributed to the biological effects induced by the treatment of compound <b>D11</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). As previously reported, the PI3K/Akt signaling pathway plays a vital role in mediating the macrophages polarization<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> and p-STAT3 is a strong transcription factor of many M2-related genes.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Whereas we only proved that Akt and Stat3 phosphorylation are involved in <b>D11</b> promoting macrophage M2 polarization, further study is needed to investigate the synergistic role of Akt and Stat3 in macrophages M2 polarization. Our study not only demonstrated a promising approach for the discovery of novel macrophage M2 modulators for the treatment of MS but also provided a new strategy for phenotypic screening of modulators that could alter cells in different states. Compound <b>D11</b> identified in this study may be taken as a promising starting point for the development of small-molecule therapeutics to treat MS.</div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Schematic Representation of <b>D11</b>-Mediated M2 Polarization and Neuroprotective Effect; <b>D11</b> is Uptaken by Macrophages and Promotes Macrophages M2 Polarization by Activating Akt and Stat3; Phosphorylated Stat3 Translocated into the Nucleus Encoding M2 Macrophages Related Genes Such as <i>Mrc1</i>(CD206), <i>Arg1</i>, and <i>Fizz1</i>; <b>D11</b>-Treated Macrophages Inhibit CD4<sup>+</sup> T Cells Proliferation, Therefore, Reduce the Inflammatory Reaction Generated by Autoreactive Th1 and Th17 Cells, Finally Inhibits Demyelination and Prevents EAE</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">4.1.  Chemistry</h3><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded at 500 MHz using a Bruker AVANCE III spectrometer in CDCl<sub>3</sub>, or DMSO-<i>d</i><sub>6</sub> solution, with tetramethylsilane serving as the internal standard. Chemical shift values (δ) were reported in ppm. Multiplicities are recorded by the following abbreviations: s, singlet; d, double; t, triplet; q, quartet; m, multiplet; and <i>J</i>, coupling constant (Hz). High-resolution mass spectra (HRMS) were obtained from Agilent Technologies 6224 TOF LC/MS. The purities of compounds for biological testing were assessed by NMR and HPLC, and the purities were ≥95%. The analytical HPLC was performed on an Agilent 1260 Infinity II (LC03) machine and a C18 reversed-phase column (Agilent Eclipse XDB-C18, 4.6 × 250 mm, 5 μm), with a flow rate of 1.0 mL/min, the detection by UV absorbance at a wavelength of 254 nm, the column temperature was 25 °C, eluting with water (0.1% trifluoroacetic acid) as A phase and methanol as B phase (0 min, A phase: 90%, B phase: 10%; 8 min, A phase: 10%, B phase: 90%; 13 min, A phase: 10%, B phase: 90%; 15 min, A phase: 90%, B phase: 10%; 20 min, A phase: 90%, B phase: 10%). Unless otherwise noted, reagents and solvents were obtained from commercial suppliers and without further purification.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">4.2.  General Procedure A: (for the Synthesis of Compounds <b>2a</b>, <b>2b</b>, <b>5</b>, and <b>8a–d</b>)</h3><div class="NLM_p last">Tetrakistriphenylphosphine Pd(0) (3.45 g, 3 mmol) was added to a stirred suspension of 4-halogen-substituted aromatic ester (30 mmol), 1-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1<i>H</i>-pyrazole (7.5 g, 36 mmol), and potassium phosphate (12g, 45 mmol) in dimethylformamide (DMF, 100 mL) at 0 °C under nitrogen protection. The reaction mixture was heated at 100 °C for 10 h, then poured into H<sub>2</sub>O (300 mL), and extracted with ethyl acetate (100 mL × 3). The combined organic layers were washed with saturated brine (200 mL × 3), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum to afford an off-white semisolid. The crude product was purified by column chromatography.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">4.3.  General Procedure B: (for the Synthesis of Compounds <b>3a</b>, <b>3c</b>, <b>6b</b>, <b>6c</b>, <b>9a–d</b>, <b>9g</b>, <b>9h</b>, and <b>9j</b>)</h3><div class="NLM_p">To a solution of biaryl ester (10 mmol) in dry THF/DMF (v/v, 10: 1) at 0 °C was added NCS (1.46 g, 11 mmol) in one portion. The reaction mixture was stirred at r.t. for 5 h. After it was fully reacted, the mixture was poured into H<sub>2</sub>O (50 mL) and extracted with ethyl acetate (30 mL × 3). The combined organic layers were washed with saturated brine (50 mL × 2), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum. The residue was purified by column chromatography.</div><div class="NLM_p last">To a solution of the above intermediate products (8.8 mmol) in dry THF/EtOH (v/v, 4:1) was slowly added aqueous NaOH (3 N, 10 mL, 30 mmol), and the mixture was stirred at r.t. for 5 h. After it was fully reacted, the solvent was removed under vacuum and the resulting crude mixture was dissolved in H<sub>2</sub>O (30 mL) and acidified with 1 N hydrochloric acid until pH 2–3 and extracted with ethyl acetate (30 mL × 3). The combined organic layers were washed with saturated brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and then concentrated to dryness under vacuum to provide the white solid.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29">4.4.  General Procedure C: (for the Synthesis of Compounds <b>3b</b>, <b>6a</b>, <b>9e</b>, <b>9f</b>, and <b>9i</b>)</h3><div class="NLM_p last">To a solution of biaryl ester (2.2 g, 8.8 mmol) in the mixture of tetrahydrofuran and ethanol (v/v = 4:1, 30 mL), aqueous NaOH (3 N, 10 mL, 30 mmol) was slowly added. The mixture was stirred at r.t. for 5 h. The mixture was then concentrated under reduced pressure; the residue was resolved in water (30 mL) and acidified with 1 N hydrochloric acid until pH 2–3 and extracted with ethyl acetate (30 mL × 3). The combined organic layers were washed with saturated brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and dried under vacuum to afford the white solid.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30">4.5.  General Procedure D: (for the Synthesis of Compounds <b>12a–d</b>)</h3><div class="NLM_p last">To a solution of compound <b>11</b> (<i>tert</i>-butyl-(2-nitroethyl) carbamate, 285 mg, 1.5 mmol), (2<i>S</i>) or (2<i>R</i>)-2-(diphenyl((trimethylsilyl)oxy)methyl) pyrrolidine (33 mg, 0.1 mmol) and benzoicacid (25 mg, 0.2 mmol) in dry dichloromethane (2 mL) was slowly added substituted cinnamyl aldehyde (1 mmol) at 0 °C. After the addition was complete, the reaction was warmed up to room temperature and stirred overnight. The stirring was continued until aldehyde was consumed (monitored by TLC). The solution was diluted to 10 mL with dichloromethane, and trifluoroacetic acid (148 μL, 2 mmol) was added dropwise; then, the reaction mixture was stirred for another 5 h. The reaction was quenched by the adding dropwise of 1 N aqueous sodium bicarbonate solution (10 mL) and stirred for another 10 min. Water phase was extracted with ethyl acetate (10 mL × 3), and the combined organic layers were washed with saturated brine (20 mL × 2), dried over anhydrous sodium sulfate, and concentrated. Purification by flash column chromatography afforded yellow solid.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">4.6.  General Procedure E: (for the Synthesis of Compounds <b>13a–d</b>)</h3><div class="NLM_p last">To a solution of 3,4-disubstituted piperidine compound (5.4 mmol), triethylsilane (1.8 mL, 11 mmol) in dichloromethane (25 mL) was added dropwise trifluoroacetic acid (3.7 mL, 50 mmol) at 0 °C. After the addition was complete, the reaction was warmed up to room temperature and stirred overnight. Then, the reaction was quenched by the adding dropwise of saturated aqueous sodium bicarbonate (50 mL) and stirred for another 10 min. Water phase was extracted with dichloromethane (20 mL × 3), and the combined organic layers were washed with saturated brine (20 mL × 2), dried over anhydrous sodium sulfate, and concentrated in vacuo to give an oil. To a suspension of the residue and triethylamine (1.4 mL, 10 mmol) in tetrahydrofuran (45 mL), di-<i>tert</i>-butyl dicarbonate (3.7 mL, 50 mmol) was added in batches at 0 °C. After the addition was complete, the reaction was warmed up to room temperature and stirred for 5 h. After solvent removal, the residue was dissolved in ethyl acetate (50 mL), washed by 0.5 N hydrochloric acid (20 mL × 2) and saturated brine (20 mL × 2), and dried over anhydrous sodium sulfate. After solvent removal, the residue was purified by column chromatography to afford the product as a white solid.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32">4.7.  General Procedure F: (for the Synthesis of Compounds <b>14a–d</b>)</h3><div class="NLM_p last">To a suspension of 3,4-disubstituted piperidine compound (4.2 mmol) in ethyl alcohol–water (v/v, 3:1, 40 mL) was added iron powder (2.82 g, 50.4 mmol) and ammonium chloride (1.0 g, 16.8 mmol), then the mixture was refluxed for 5 h with mechanical stirring. After it is fully reacted, the mixture was filtered and the filtrate was concentrated under vacuum. The residue was dissolved in ethyl acetate (50 mL), washed by saturated aqueous sodium bicarbonate (20 mL × 2) and saturated brine (20 mL × 2), and dried over anhydrous sodium sulfate. After solvent removal, the residue was dried in vacuum to give a gray solid.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33">4.8.  General Procedure G</h3><div class="NLM_p">To a suspension of the acid (0.2 mmol), EDCI (69 mg, 0.36 mmol), HOBT (49 mg, 0.36 mmol), and DIPEA (87 μL, 0.5 mmol) in dichloromethane was added the amine (58.8 mg, 0.2 mmol); then, the mixture was reacted for 5 h at room temperature with mechanical stirring. After it was fully reacted, the mixture was concentrated under vacuum. The residue was dissolved in ethyl acetate (50 mL), washed by 1 N HCl (20 mL × 2) and saturated brine (20 mL × 2), and dried over anhydrous sodium sulfate. After solvent removal, the residue was purified by column chromatography to afford the product as a light-yellow solid (for the synthesis of compounds <b>C7–C10</b>).</div><div class="NLM_p">To a solution of the above yellow solid in ethyl acetate was added HCl saturated ethyl acetate, stirred at room temperature for 6 h. After it was fully reacted, the mixture was filtered and the resulted solid was washed with diethyl ether. The solid was dried in vacuum to afford target product as a white solid (for the synthesis of compounds <b>B1</b>, <b>C1–C6</b>, <b>C11</b>, and <b>D1–D19</b>).</div><div class="NLM_p">To a solution of above-resulted hydrochloride product in MeOH was added <span class="smallcaps smallerCapital">l</span>-tartaric acid, stirred in room temperature for 2 h. After the solvent removal, the residue was washed with diethyl ether and dried in vacuum to afford white solid (for the synthesis of compounds <b>D20</b> and <b>D21</b>).</div><div class="NLM_p">After the SAR study, 33 compounds were obtained in total, the compound information of the target compounds and the intermediates can be found in the following part.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.8.1.  Methyl 3-Methyl-5-(1-methyl-1<i>H</i>-pyrazol-5-yl)picolinate (<b>2a</b>)</h4><div class="NLM_p last">General procedure A, yield: 94%; ESI-MS <i>m</i>/<i>z</i>: 232 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.8.2.  Methyl 5-(1-Methyl-1<i>H</i>-pyrazol-5-yl)picolinate (<b>2b</b>)</h4><div class="NLM_p last">General procedure A, yield: 66%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.83 (dd, <i>J</i> = 2.2, 0.7 Hz, 1H), 8.23 (dd, <i>J</i> = 8.1, 0.7 Hz, 1H), 7.91 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.56 (d, <i>J</i> = 2.2 Hz, 1H), 6.45 (d, <i>J</i> = 2.2 Hz, 1H), 4.04 (s, 3H), 3.94 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 218 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.8.3.  5-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-methylpicolinic Acid (<b>3a</b>)</h4><div class="NLM_p last">General procedure B, yield: 87%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.56 (s, 1H), 7.94 (s, 1H), 7.73 (s, 1H), 3.82 (s, 3H), 2.51 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 294 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">4.8.4.  3-Methyl-5-(1-methyl-1<i>H</i>-pyrazol-5-yl)picolinic Acid (<b>3b</b>)</h4><div class="NLM_p last">General procedure C, yield: 85%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.16 (s, 1H), 8.64 (d, <i>J</i> = 1.7 Hz, 1H), 7.98 (d, <i>J</i> = 1.7 Hz, 1H), 7.54 (d, <i>J</i> = 1.9 Hz, 1H), 6.60 (d, <i>J</i> = 1.9 Hz, 1H), 3.92 (s, 3H), 2.53 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 216 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">4.8.5.  5-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)picolinic Acid (<b>3c</b>)</h4><div class="NLM_p last">General procedure B, yield: 67%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.46 (s, 1H), 8.85 (dd, <i>J</i> = 2.0, 1.0 Hz, 1H), 8.21–8.15 (m, 2H), 7.76 (s, 1H), 3.84 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 280 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">4.8.6.  Methyl 6-(1-Methyl-1<i>H</i>-pyrazol-5-yl)nicotinate (<b>5</b>)</h4><div class="NLM_p last">General procedure A, yield: 72%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.25 (d, <i>J</i> = 2.2 Hz, 1H), 8.31 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.65 (d, <i>J</i> = 8.3 Hz, 1H), 7.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.68 (d, <i>J</i> = 1.9 Hz, 1H), 4.27 (s, 3H), 3.97 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 218 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">4.8.7.  6-(1-Methyl-1<i>H</i>-pyrazol-5-yl)nicotinic Acid (<b>6a</b>)</h4><div class="NLM_p last">General procedure C, yield: 91%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.12 (d, <i>J</i> = 2.1 Hz, 1H), 8.31 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.92 (d, <i>J</i> = 8.3 Hz, 1H), 7.52 (d, <i>J</i> = 1.9 Hz, 1H), 6.92 (d, <i>J</i> = 1.9 Hz, 1H), 4.17 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 202 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.8.8.  6-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)nicotinic Acid (<b>6b</b>)</h4><div class="NLM_p last">General procedure B, yield: 88%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (d, <i>J</i> = 2.2 Hz, 1H), 8.43 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 7.89 (d, <i>J</i> = 8.2, 1H), 7.72 (s, 1H), 3.97 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 236 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">4.8.9.  6-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)nicotinic Acid (<b>6c</b>)</h4><div class="NLM_p last">General procedure B, yield: 94%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (d, <i>J</i> = 2.2, 0.7 Hz, 1H), 8.43 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 7.89 (dd, <i>J</i> = 8.2, 0.7 Hz, 1H), 7.71 (s, 1H), 3.95 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 280 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">4.8.10.  Methyl 3-Chloro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzoate (<b>8a</b>)</h4><div class="NLM_p last">General procedure A, yield: 44%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.99 (d, <i>J</i> = 8.7 Hz, 1H), 7.52 (d, <i>J</i> = 1.9 Hz, 1H), 7.38–7.23 (m, 2H), 6.34 (d, <i>J</i> = 1.9 Hz, 1H), 3.91 (s, 3H), 3.90 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 251 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">4.8.11.  Methyl 3-Methyl-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzoate (<b>8b</b>)</h4><div class="NLM_p last">General procedure A, yield: 97%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.99 (s, 1H), 7.92 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.58 (d, <i>J</i> = 1.9 Hz, 1H), 7.29 (d, <i>J</i> = 7.9 Hz, 1H), 6.25 (d, <i>J</i> = 1.9 Hz, 1H), 3.95 (s, 3H), 3.68 (s, 3H), 2.23 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 231 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">4.8.12.  Methyl 4-(1-Methyl-1<i>H</i>-pyrazol-5-yl)benzoate (<b>8c</b>)</h4><div class="NLM_p last">General procedure A, yield: 89%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.12 (d, <i>J</i> = 8.3 Hz, 2H), 7.54 (d, <i>J</i> = 1.9 Hz, 1H), 7.51 (d, <i>J</i> = 8.3 Hz, 2H), 6.38 (d, <i>J</i> = 1.9 Hz, 1H), 3.95 (s, 3H), 3.93 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 217 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">4.8.13.  Methyl 2-Fluoro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzoate (<b>8d</b>)</h4><div class="NLM_p last">General procedure A, yield: 74%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.09–7.99 (m, 1H), 7.55 (d, <i>J</i> = 1.9 Hz, 1H), 7.29 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.23 (dd, <i>J</i> = 11.3, 1.6 Hz, 1H), 6.40 (d, <i>J</i> = 1.9 Hz, 1H), 3.97 (s, 3H), 3.95 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 235 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.8.14.  4-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-chlorobenzoic Acid (<b>9a</b>)</h4><div class="NLM_p last">General procedure B, yield: 53%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.62 (s, 1H), 8.12 (d, <i>J</i> = 1.6 Hz, 1H), 8.03 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H), 7.73 (s, 1H), 7.63 (d, <i>J</i> = 7.9 Hz, 1H), 3.65 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 313 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4.8.15.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-methylbenzoic Acid (<b>9b</b>)</h4><div class="NLM_p last">General procedure B, yield: 76%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.09 (s, 1H), 7.98 (d, <i>J</i> = 6.6 Hz, 1H), 7.93–7.83 (m, 1H), 7.69 (s, 1H), 7.44 (d, 7.9 Hz, 1H), 3.58 (s, 3H), 2.18 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 249 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">4.8.16.  4-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-methylbenzoic Acid (<b>9c</b>)</h4><div class="NLM_p last">General procedure B, yield: 56%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.99 (s, 1H), 7.97 (s, 1H), 7.88 (dd, <i>J</i> = 7.9, 1.2 Hz, 1H), 7.69 (s, 1H), 7.39 (d, <i>J</i> = 7.9 Hz, 1H), 3.59 (s, 3H), 2.15 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 293 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">4.8.17.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)benzoic Acid (<b>9d</b>)</h4><div class="NLM_p last">General procedure B, yield: 94%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.11–8.08 (m, 2H), 7.70 (s, 1H), 7.68–7.64 (m, 2H), 3.80 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 235 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">4.8.18.  2-Fluoro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzoic Acid (<b>9e</b>)</h4><div class="NLM_p last">General procedure C, yield: 83%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.46 (s, 1H), 8.03–7.87 (m, 1H), 7.55 (d, <i>J</i> = 11.8 Hz, 1H), 7.51 (d, <i>J</i> = 1.5 Hz, 1H), 7.49 (d, <i>J</i> = 8.1 Hz, 1H), 6.58 (d, <i>J</i> = 1.5 Hz, 1H), 3.92 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 219 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">4.8.19.  3-Chloro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzoic Acid (<b>9f</b>)</h4><div class="NLM_p last">General procedure C, yield: 46%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.54 (s, 1H), 8.07 (d, <i>J</i> = 1.7 Hz, 1H), 7.97 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.62 (d, <i>J</i> = 7.9 Hz, 1H), 7.54 (d, <i>J</i> = 1.9 Hz, 1H), 6.42 (d, <i>J</i> = 1.9 Hz, 1H), 3.66 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 235 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">4.8.20.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-2-fluorobenzoic Acid (<b>9g</b>)</h4><div class="NLM_p last">General procedure B, yield: 77%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.50 (s, 1H), 8.07–7.95 (m, 1H), 7.72 (s, 1H), 7.56 (dd, <i>J</i> = 11.5, 1.5 Hz, 1H), 7.47 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 3.82 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 253 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">4.8.21.  3-Chloro-4-(4-chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)benzoic Acid (<b>9h</b>)</h4><div class="NLM_p last">General procedure B, yield: 46%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.63 (s, 1H), 8.13 (d, <i>J</i> = 1.6 Hz, 1H), 8.04 (dd, <i>J</i> = 7.9, 1.6 Hz, 1H), 7.73 (s, 1H), 7.67 (d, <i>J</i> = 7.9 Hz, 1H), 3.65 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 269 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">4.8.22.  4-(1-Methyl-1<i>H</i>-pyrazol-5-yl)benzoic Acid (<b>9i</b>)</h4><div class="NLM_p last">General procedure C, yield: 99%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.19 (d, <i>J</i> = 8.2 Hz, 2H), 7.61 (d, <i>J</i> = 1.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 6.44 (d, <i>J</i> = 1.8 Hz, 1H), 3.99 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 201 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">4.8.23.  4-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)benzoic Acid (<b>9j</b>)</h4><div class="NLM_p last">General procedure B, yield: 94%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.26 (d, <i>J</i> = 8.3 Hz, 2H), 7.59 (s, 1H), 7.56 (d, <i>J</i> = 8.3 Hz, 2H), 3.87 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 279 [M – H]<sup>−</sup>.</div></div><div id="sec4_8_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">4.8.24.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-4-(3-Fluorophenyl)-3-nitro-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>12a</b>)</h4><div class="NLM_p last">General procedure D, yield: 47%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.35–7.28 (m, 1H), 7.19–6.93 (m, 4H), 4.93 and 4.82 (d, <i>J</i> = 4.3 Hz, and d, <i>J</i> = 5.3 Hz, 1H, 1:1.3 ratio due to amide rotamers), 4.69–4.59 (m, 1H), 4.26–4.22 (m, 1H), 4.17–4.06 (m, 1H), 3.92 and 3.99 (d, <i>J</i> = 12.5 Hz, and d, <i>J</i> = 12.2 Hz, 1H, 1:1.3 ratio due to amide rotamers), 1.52 (s, 9H). ESI-MS <i>m</i>/<i>z</i>: 345 [M + Na]<sup>+</sup>.</div></div><div id="sec4_8_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">4.8.25.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-4-(4-Chloro-3-(trifluoromethyl)phenyl)-3-nitro-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>12b</b>)</h4><div class="NLM_p last">General procedure D, yield: 72%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.56 (d, <i>J</i> = 1.9 Hz, 1H), 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.36 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.18 and 7.03 (d, <i>J</i> = 7.9 Hz, and d, <i>J</i> = 7.8 Hz, 1H, 1:1.2 ratio due to amide rotamers), 4.89 and 4.78 (d, <i>J</i> = 6.0 Hz, and d, <i>J</i> = 6.0 Hz, 1H, 1:1.2 ratio due to amide rotamers), 4.66–4.58 (m, 1H), 4.29–4.26 (m, 1H), 4.11–3.97 (m, 2H), 1.53 (s, 9H). ESI-MS <i>m</i>/<i>z</i>: 429 [M + Na]<sup>+</sup>.</div></div><div id="sec4_8_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">4.8.26.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-4-(3,4-Difluorophenyl)-3-nitro-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>12c</b>)</h4><div class="NLM_p last">General procedure D, yield: 53%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.19–6.95 (m, 4H), 4.90 and 4.79 (d, <i>J</i> = 6.0 Hz, and d, <i>J</i> = 5.6 Hz, 1H, 1:1.3 ratio due to amide rotamers), 4.66–4.55 (m, 1H), 4.22–4.17 (m, 1H), 4.12–3.93 (m, 2H), 1.52 (s, 9H). ESI-MS <i>m</i>/<i>z</i>: 363 [M + Na]<sup>+</sup>.</div></div><div id="sec4_8_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">4.8.27.  <i>tert</i>-Butyl (3<i>R</i>,4<i>R</i>)-4-(3-Fluorophenyl)-3-nitro-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (<b>12d</b>)</h4><div class="NLM_p last">General procedure D, yield: 58%. ESI-MS <i>m</i>/<i>z</i>: 345 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">4.8.28.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-4-(3-Fluorophenyl)-3-nitropiperidine-1-carboxylate (<b>13a</b>)</h4><div class="NLM_p last">General procedure E, yield: 85%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.32–7.26 (m, 1H), 7.00–6.95 (m, 2H), 6.93–6.89 (m, 1H), 4.84–4.55 (m, 2H), 4.27 (m, 1H), 3.30 (td, <i>J</i> = 12.2, 4.1 Hz, 1H), 3.19 (m, 1H), 2.88 (m, 1H), 1.96 (d, <i>J</i> = 13.7 Hz, 1H), 1.79–1.73 (m, 1H), 1.50 (s, 9H).</div></div><div id="sec4_8_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">4.8.29.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-4-(4-Chloro-3-(trifluoromethyl)phenyl)-3-nitropiperidine-1-carboxylate (<b>13b</b>)</h4><div class="NLM_p last">General procedure E, yield: 92%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.51 (d, <i>J</i> = 2.1 Hz, 1H), 7.46 (d, <i>J</i> = 8.3 Hz, 1H), 7.32 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 4.67 (dd, <i>J</i> = 10.6, 7.3 Hz, 1H), 4.31–4.28 (m, 1H), 3.78–3.71 (m, 1H), 3.38–3.31 (m, 1H), 3.29–3.07 (m, 1H), 2.90–2.87 (m, 1H), 1.95 (d, <i>J</i> = 13.5 Hz, 1H), 1.81–1.70 (m, 1H), 1.49 (s, 9H).</div></div><div id="sec4_8_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">4.8.30.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-4-(3,4-Difluorophenyl)-3-nitropiperidine-1-carboxylate (<b>13c</b>)</h4><div class="NLM_p last">General procedure E, yield: 78%; ESI-MS <i>m</i>/<i>z</i>: 327 [M – CH<sub>3</sub>]<sup>+</sup>.</div></div><div id="sec4_8_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">4.8.31.  <i>tert</i>-Butyl (3<i>R</i>,4<i>R</i>)-4-(3-Fluorophenyl)-3-nitropiperidine-1-carboxylate (<b>13d</b>)</h4><div class="NLM_p last">General procedure E, yield: 70%. ESI-MS <i>m</i>/<i>z</i>: 347 [M + Na]<sup>+</sup>.</div></div><div id="sec4_8_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">4.8.32.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-3-Amino-4-(3-fluorophenyl)piperidine-1-carboxylate (<b>14a</b>)</h4><div class="NLM_p last">General procedure F, yield: 81%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.38 (td, <i>J</i> = 7.9, 6.3 Hz, 1H), 7.23 (dd, <i>J</i> = 10.3, 2.0 Hz, 1H), 7.17 (d, <i>J</i> = 7.7 Hz, 1H), 7.10–7.06 (m, 1H), 4.37 (d, <i>J</i> = 10.6 Hz, 1H), 4.04–3.94 (m, 1H), 3.18 (dd, <i>J</i> = 10.4, 6.5 Hz, 1H), 2.90–2.61 (m, 3H), 1.79–1.70 (m, 1H), 1.67–1.57 (m, 1H), 1.43 (s, 9H). ESI-MS <i>m</i>/<i>z</i>: 295 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">4.8.33.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-3-Amino-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidine-1-carboxylate (<b>14b</b>)</h4><div class="NLM_p last">General procedure F, yield: 96%; ESI-MS <i>m</i>/<i>z</i>: 379 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">4.8.34.  <i>tert</i>-Butyl (3<i>S</i>,4<i>S</i>)-3-Amino-4-(3,4-difluorophenyl)piperidine-1-carboxylate (<b>14c</b>)</h4><div class="NLM_p last">General procedure F, yield: 89%; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.15–7.09 (m, 1H), 7.05–7.01 (m, 1H), 6.97–6.93 (m, 1H), 4.45–4.09 (m, 2H), 2.92–2.67 (m, 2H), 2.56–2.43 (m, 1H), 2.38–2.29 (m, 1H), 1.76 (d, <i>J</i> = 12.6 Hz, 1H), 1.71–1.57 (m, 1H), 1.48 (s, 9H). ESI-MS <i>m</i>/<i>z</i>: 313 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">4.8.35.  <i>tert</i>-Butyl (3<i>R</i>,4<i>R</i>)-3-Amino-4-(3-fluorophenyl)piperidine-1-carboxylate (<b>14d</b>)</h4><div class="NLM_p last">General procedure F, yield: 99%. ESI-MS <i>m</i>/<i>z</i>: 295 [M + H]<sup>+</sup>.</div></div><div id="sec4_8_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">4.8.36.  2-Fluoro-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)benzamide Hydrochloride (<b>C1</b>)</h4><div class="NLM_p last">General procedure G, yield: 36%; retention time: 8.931 min, purity: 95.56%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.45 (dd, <i>J</i> = 12.6, 7.0 Hz, 1H), 7.33 (dd, <i>J</i> = 14.1, 6.8 Hz, 2H), 7.15 (t, <i>J</i> = 6.5 Hz, 2H), 7.13–7.05 (m, 2H), 7.01–6.94 (m, 1H), 4.62 (t, <i>J</i> = 9.5 Hz, 1H), 3.63 (d, <i>J</i> = 9.0 Hz, 1H), 3.53 (d, <i>J</i> = 11.2 Hz, 1H), 3.23–3.02 (m, 3H), 2.27–2.05 (m, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 165.35, 163.92, 161.98, 160.57, 158.58, 143.28, 132.80, 130.04, 129.59, 124.10, 122.52, 115.69, 114.26, 48.19, 46.56, 45.09, 43.85, 29.82. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 317.1469 (theor 317.1465).</div></div><div id="sec4_8_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">4.8.37.  4-Fluoro-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)benzamide Hydrochloride (<b>C2</b>)</h4><div class="NLM_p last">General procedure G, yield: 37%; retention time: 9.363, purity: 95.29%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.65 (dd, <i>J</i> = 8.0, 5.3 Hz, 2H), 7.30 (dd, <i>J</i> = 13.8, 7.4 Hz, 1H), 7.17 (d, <i>J</i> = 7.3 Hz, 1H), 7.10 (t, <i>J</i> = 8.5 Hz, 3H), 6.94 (t, <i>J</i> = 7.9 Hz, 1H), 4.62 (s, 1H), 3.64–3.46 (m, 2H), 3.15 (dd, <i>J</i> = 34.0, 23.2 Hz, 3H), 2.15 (dd, <i>J</i> = 46.7, 12.4 Hz, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 167.31, 165.86, 163.90, 163.87, 161.95, 143.53, 130.10, 129.88, 129.55, 123.32, 115.09, 114.15, 113.81, 48.08, 46.75, 45.09, 43.95, 29.91. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 317.1470 (theor 317.1465).</div></div><div id="sec4_8_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">4.8.38.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-Fluorophenyl)piperidin-3-yl)-2-methoxybenzamide Hydrochloride (<b>C3</b>)</h4><div class="NLM_p last">General procedure G, yield: 40%; retention time: 9.161 min, purity: 97.72%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.62 (d, <i>J</i> = 6.3 Hz, 1H), 7.39 (d, <i>J</i> = 36.0 Hz, 2H), 7.14 (t, <i>J</i> = 32.8 Hz, 2H), 7.07–6.86 (m, 3H), 4.66 (s, 1H), 3.80 (s, 3H), 3.72 (s, 1H), 3.54 (s, 1H), 3.18 (d, <i>J</i> = 48.3 Hz, 3H), 2.19 (s, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 166.91, 163.96, 162.01, 157.43, 143.56, 132.92, 130.33, 123.56, 121.26, 120.47, 114.40, 113.73, 111.62, 55.97, 48.44, 47.16, 45.19, 44.63, 30.22. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 329.1670 (theor 329.1665).</div></div><div id="sec4_8_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">4.8.39.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-Fluorophenyl)piperidin-3-yl)-5-methylthiophene-2-carboxamide Hydrochloride (<b>C4</b>)</h4><div class="NLM_p last">General procedure G, yield: 72%; retention time: 9.306 min, purity: 99.17%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.35 (d, <i>J</i> = 3.7 Hz, 1H), 7.32–7.24 (m, 1H), 7.14 (d, <i>J</i> = 7.7 Hz, 1H), 7.09 (d, <i>J</i> = 10.1 Hz, 1H), 6.98–6.90 (m, 1H), 6.75–6.69 (m, 1H), 4.54 (td, <i>J</i> = 11.4, 3.9 Hz, 1H), 3.61–3.47 (m, 2H), 3.19 (dd, <i>J</i> = 15.9, 8.0 Hz, 2H), 3.11 (t, <i>J</i> = 11.9 Hz, 1H), 2.44 (s, 3H), 2.10 (ddd, <i>J</i> = 24.8, 17.5, 9.6 Hz, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 163.75, 162.49, 161.86, 146.13, 143.45, 135.01, 129.99, 129.07, 125.82, 123.06, 113.90, 47.85, 46.74, 44.96, 43.66, 29.90, 14.01. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 319.1278 (theor 319.1280).</div></div><div id="sec4_8_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73">4.8.40.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-Fluorophenyl)piperidin-3-yl)-5-methylfuran-2-carboxamide Hydrochloride (<b>C5</b>)</h4><div class="NLM_p last">General procedure G, yield: 84%; retention time: 8.816 min, purity: 96.42%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.38–7.22 (m, 1H), 7.13 (t, <i>J</i> = 10.2 Hz, 1H), 7.08 (d, <i>J</i> = 10.0 Hz, 1H), 6.96–6.85 (m, 2H), 6.12 (d, <i>J</i> = 2.9 Hz, 1H), 4.69–4.53 (m, 1H), 3.59–3.49 (m, 2H), 3.18 (dd, <i>J</i> = 23.4, 11.5 Hz, 2H), 3.10 (d, <i>J</i> = 11.9 Hz, 1H), 2.29 (s, 3H), 2.10 (dt, <i>J</i> = 23.6, 12.4 Hz, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 163.88, 161.94, 158.75, 155.76, 145.06, 143.40, 129.90, 123.10, 115.93, 113.93, 108.06, 47.05, 46.68, 44.95, 43.75, 30.03, 12.23. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 303.1513 (theor 303.1509).</div></div><div id="sec4_8_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">4.8.41.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-Fluorophenyl)piperidin-3-yl)-1-methyl-1<i>H</i>-pyrazole-5-carboxamide Hydrochloride (<b>C6</b>)</h4><div class="NLM_p last">General procedure G, yield: 43%; retention time: 8.174 min, purity: 98.84%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.49 (s, 1H), 7.30 (dt, <i>J</i> = 14.4, 7.2 Hz, 1H), 7.16 (d, <i>J</i> = 7.2 Hz, 1H), 7.11 (d, <i>J</i> = 9.7 Hz, 1H), 6.95 (t, <i>J</i> = 8.0 Hz, 1H), 6.66 (s, 1H), 4.60 (s, 1H), 3.93 (s, 3H), 3.62–3.52 (m, 2H), 3.24–3.12 (m, 3H), 2.16 (dd, <i>J</i> = 21.5, 9.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 163.89, 161.92, 159.49, 143.37, 136.85, 135.69, 130.09, 123.47, 113.83, 107.20, 47.59, 45.14, 43.91, 37.63, 29.69, 19.17. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 303.1625 (theor 303.1621).</div></div><div id="sec4_8_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">4.8.42.  2-Fluoro-<i>N</i>-(4-fluorophenyl)-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide (<b>C7</b>)</h4><div class="NLM_p last">General procedure G, yield: 60%; retention time: 10.821 min, purity: 100%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.84 (t, <i>J</i> = 7.6 Hz, 1H), 7.70 (dd, <i>J</i> = 7.9, 5.1 Hz, 2H), 7.53 (s, 1H), 7.44 (t, <i>J</i> = 10.3 Hz, 2H), 7.10 (t, <i>J</i> = 8.5 Hz, 2H), 6.49 (s, 1H), 3.92 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 163.24, 160.55, 158.60, 141.84, 138.38, 135.00, 134.30, 130.42, 124.37, 123.58, 122.32, 122.26, 116.19, 115.10, 114.92, 106.56, 36.53. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 314.1108 (theor 314.1105).</div></div><div id="sec4_8_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">4.8.43.  2-Fluoro-<i>N</i>-(4-methoxyphenyl)-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide (<b>C8</b>)</h4><div class="NLM_p last">General procedure G, yield: 66%; retention time: 10.602 min, purity: 98.36%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.84 (t, <i>J</i> = 7.7 Hz, 1H), 7.61–7.56 (m, 2H), 7.52 (t, <i>J</i> = 3.1 Hz, 1H), 7.46–7.40 (m, 2H), 6.95–6.90 (m, 2H), 6.49 (d, <i>J</i> = 2.0 Hz, 1H), 3.93 (s, 3H), 3.79 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 163.07, 160.55, 158.56, 156.99, 141.83, 138.24, 134.84, 131.08, 130.47, 124.52, 124.01, 123.90, 122.13, 116.11, 113.65, 106.47, 54.49, 36.43. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 326.1302 (theor 326.1305).</div></div><div id="sec4_8_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">4.8.44.  <i>N</i>-Ethyl-2-fluoro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide (<b>C9</b>)</h4><div class="NLM_p last">General procedure G, yield: 53%; retention time: 9.208 min, purity: 98.18%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.81 (t, <i>J</i> = 7.8 Hz, 1H), 7.51 (d, <i>J</i> = 2.0 Hz, 1H), 7.39 (ddd, <i>J</i> = 12.9, 9.7, 1.6 Hz, 2H), 6.46 (d, <i>J</i> = 2.0 Hz, 1H), 3.91 (s, 3H), 3.44 (q, <i>J</i> = 7.3 Hz, 2H), 1.24 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 164.56, 160.72, 158.73, 141.85, 138.22, 134.88, 130.47, 124.39, 123.00, 116.07, 106.45, 36.51, 34.55, 13.43. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 248.1195 (theor 248.1199).</div></div><div id="sec4_8_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78">4.8.45.  <i>N</i>,<i>N</i>-Diethyl-2-fluoro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide (<b>C10</b>)</h4><div class="NLM_p last">General procedure G, yield: 52%; retention time: 10.071 min, purity: 96.39%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.51 (d, <i>J</i> = 2.0 Hz, 1H), 7.47 (d, <i>J</i> = 7.1 Hz, 1H), 7.41 (ddd, <i>J</i> = 11.8, 9.1, 1.5 Hz, 2H), 6.46 (d, <i>J</i> = 2.0 Hz, 1H), 3.91 (s, 3H), 3.60 (q, <i>J</i> = 7.1 Hz, 2H), 3.32 (d, <i>J</i> = 7.1 Hz, 1H), 3.29 (d, <i>J</i> = 7.2 Hz, 1H), 1.27 (t, <i>J</i> = 7.1 Hz, 3H), 1.13 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 166.37, 158.91, 156.95, 142.06, 138.06, 133.38, 128.24, 124.75, 115.98, 106.26, 43.38, 39.48, 36.47, 12.84, 11.69. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 276.1517 (theor 276.1512).</div></div><div id="sec4_8_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">4.8.46.  (<i>S</i>)-2-Fluoro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-(piperidin-3-yl)benzamide Hydrochloride (<b>C11</b>)</h4><div class="NLM_p last">General procedure G, yield: 64%; retention time: 7.555 min, purity: 98.18%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 8.05 (d, <i>J</i> = 2.0 Hz, 1H), 7.88 (t, <i>J</i> = 7.3 Hz, 1H), 7.55 (d, <i>J</i> = 9.6 Hz, 2H), 6.81 (d, <i>J</i> = 2.0 Hz, 1H), 4.33 (t, <i>J</i> = 10.3 Hz, 1H), 4.06 (s, 3H), 3.57 (dd, <i>J</i> = 12.6, 3.5 Hz, 1H), 3.37 (d, <i>J</i> = 12.3 Hz, 1H), 3.01 (dd, <i>J</i> = 14.0, 8.1 Hz, 2H), 2.11 (dd, <i>J</i> = 25.7, 13.8 Hz, 2H), 1.81 (ddd, <i>J</i> = 36.6, 25.8, 13.6 Hz, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 172.03, 164.51, 160.65, 158.64, 144.44, 135.89, 132.27, 130.92, 116.68, 107.63, 56.95, 46.31, 44.38, 43.50, 36.47, 27.63. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 303.1626 (theor 303.1621).</div></div><div id="sec4_8_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">4.8.47.  2-Fluoro-<i>N</i>-((3<i>R</i>,4<i>R</i>)-4-(3-fluorophenyl)piperidin-3-yl)-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide Hydrochloride (<b>B1</b>)</h4><div class="NLM_p last">General procedure G, yield: 44%; retention time: 9.159 min, purity: 97.42%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.82 (d, <i>J</i> = 1.7 Hz, 1H), 7.52 (t, <i>J</i> = 7.5 Hz, 1H), 7.41–7.33 (m, 3H), 7.19 (d, <i>J</i> = 7.6 Hz, 1H), 7.13 (d, <i>J</i> = 9.9 Hz, 1H), 6.99 (td, <i>J</i> = 8.5, 2.0 Hz, 1H), 6.63 (d, <i>J</i> = 1.6 Hz, 1H), 4.66 (dd, <i>J</i> = 11.2, 7.7 Hz, 1H), 3.95 (s, 3H), 3.67 (dd, <i>J</i> = 11.9, 3.6 Hz, 1H), 3.55 (d, <i>J</i> = 11.9 Hz, 1H), 3.18 (dt, <i>J</i> = 24.3, 12.4 Hz, 3H), 2.13 (dd, <i>J</i> = 30.0, 17.8 Hz, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 164.44, 163.92, 161.98, 160.41, 158.40, 143.48, 136.70, 133.31, 130.49, 130.07, 124.68, 123.31, 116.34, 114.24, 113.74, 107.32, 48.25, 46.49, 45.09, 43.79, 36.45, 29.80. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 397.1844 (theor 397.1840).</div></div><div id="sec4_8_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">4.8.48.  5-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)-3-methylpicolinamide Hydrochloride (<b>D1</b>)</h4><div class="NLM_p last">General procedure G, yield: 66%; retention time: 9.772 min, purity: 98.80%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.60 (s, 2H), 8.83 (d, <i>J</i> = 9.3 Hz, 1H), 8.50 (d, <i>J</i> = 1.7 Hz, 1H), 7.86 (d, <i>J</i> = 1.5 Hz, 1H), 7.70 (s, 1H), 7.34 (dd, <i>J</i> = 14.3, 7.8 Hz, 1H), 7.11 (d, <i>J</i> = 7.7 Hz, 1H), 7.07 (d, <i>J</i> = 10.2 Hz, 1H), 7.02 (td, <i>J</i> = 8.6, 2.3 Hz, 1H), 4.74–4.64 (m, 1H), 3.78 (s, 3H), 3.38–3.32 (m, 2H), 3.12 (td, <i>J</i> = 11.8, 3.7 Hz, 1H), 3.01–2.87 (m, 2H), 2.24 (s, 3H), 2.12–1.95 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.28, 162.06 (d, <i>J</i> = 241.5 Hz), 149.93, 146.05, 144.84 (d, <i>J</i> = 7.1 Hz), 140.76, 138.74, 136.93, 132.90, 130.28 (d, <i>J</i> = 8.4 Hz), 125.58, 123.78, 114.33 (d, <i>J</i> = 21.0 Hz), 113.59 (d, <i>J</i> = 20.6 Hz), 93.52, 46.47, 46.22, 44.58, 43.15, 38.51, 29.69, 18.40. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 472.1145 (theor 472.1148).</div></div><div id="sec4_8_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">4.8.49.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-Fluorophenyl)piperidin-3-yl)-3-methyl-5-(1-methyl-1<i>H</i>-pyrazol-5-yl)picolinamide Hydrochloride (<b>D2</b>)</h4><div class="NLM_p last">General procedure G, yield: 43%; retention time: 9.028 min, purity: 98.87%; <sup>1</sup>H NMR (500 MHz, DMSO- <i>d</i><sub>6</sub>): δ 9.70 (s, 2H), 8.82 (d, <i>J</i> = 9.3 Hz, 1H), 8.56 (d, <i>J</i> = 1.5 Hz, 1H), 7.91 (d, <i>J</i> = 1.1 Hz, 1H), 7.53 (d, <i>J</i> = 1.7 Hz, 1H), 7.32 (dd, <i>J</i> = 14.3, 7.8 Hz, 1H), 7.10 (d, <i>J</i> = 7.7 Hz, 1H), 7.06 (d, <i>J</i> = 10.2 Hz, 1H), 7.04–6.98 (m, 1H), 6.55 (d, <i>J</i> = 1.7 Hz, 1H), 4.68–4.61 (m, 1H), 3.86 (s, 3H), 3.37–3.30 (m, 2H), 3.17–3.08 (m, 1H), 3.02–2.85 (m, 2H), 2.23 (s, 3H), 2.13–2.05 (m, 1H), 2.01–1.94 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.01, 162.08 (d, <i>J</i> = 241.4 Hz), 148.59, 144.88 (d, <i>J</i> = 7.1 Hz), 144.44, 139.68, 138.78, 138.16, 133.19, 130.29 (d, <i>J</i> = 8.3 Hz), 127.67, 123.83, 114.37 (d, <i>J</i> = 21.1 Hz), 113.60 (d, <i>J</i> = 20.5 Hz), 107.19, 46.57, 46.22, 44.61, 43.15, 37.78, 29.61, 18.48. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 394.2047 (theor 394.2043).</div></div><div id="sec4_8_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83">4.8.50.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(4-Chloro-3-(trifluoromethyl)phenyl)piperidin-3-yl)-3-methyl-5-(1-methyl-1<i>H</i>-pyrazol-5-yl)picolinamide Hydrochloride (<b>D3</b>)</h4><div class="NLM_p last">General procedure G, yield: 67%; retention time: 10.122 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.91–9.71 (m, 2H), 8.90 (d, <i>J</i> = 9.4 Hz, 1H), 8.55 (d, <i>J</i> = 1.1 Hz, 1H), 7.91 (s, 1H), 7.71 (s, 1H), 7.66 (d, <i>J</i> = 8.2 Hz, 1H), 7.60–7.54 (m, 1H), 7.54 (s, 1H), 6.55 (d, <i>J</i> = 1.4 Hz, 1H), 4.71–4.64 (m, 1H), 3.86 (s, 3H), 3.35 (d, <i>J</i> = 10.6 Hz, 2H), 3.20 (dd, <i>J</i> = 16.3, 7.1 Hz, 1H), 3.05–2.84 (m, 2H), 2.23–2.10 (m, 4H), 2.05–1.94 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.02, 148.51, 144.38, 141.85, 139.67, 138.76, 138.12, 133.28, 133.10, 131.64, 128.98, 127.65, 127.45 (q, <i>J</i> = 5.1 Hz), 126.23 (q, <i>J</i> = 30.4 Hz), 122.88 (q, <i>J</i> = 271.4 Hz), 107.16, 46.59, 46.16, 44.39, 43.06, 37.73, 28.88, 18.22. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 478.1626 (theor 478.1621).</div></div><div id="sec4_8_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84">4.8.51.  5-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)picolinamide Hydrochloride (<b>D4</b>)</h4><div class="NLM_p last">General procedure G, yield: 80%; retention time: 9.598 min, purity: 98.55%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.64 (d, <i>J</i> = 9.7 Hz, 1H), 9.52 (d, <i>J</i> = 10.1 Hz, 1H), 9.04 (d, <i>J</i> = 9.5 Hz, 1H), 8.72 (d, <i>J</i> = 1.5 Hz, 1H), 8.12 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 8.06 (d, <i>J</i> = 8.0 Hz, 1H), 7.73 (s, 1H), 7.30 (dd, <i>J</i> = 14.3, 7.8 Hz, 1H), 7.09 (dd, <i>J</i> = 18.3, 9.0 Hz, 2H), 6.98 (td, <i>J</i> = 8.6, 2.2 Hz, 1H), 4.71–4.64 (m, 1H), 3.80 (s, 3H), 3.40–3.23 (m, 3H), 3.04 (q, <i>J</i> = 11.3 Hz, 1H), 2.89 (dd, <i>J</i> = 22.6, 11.3 Hz, 1H), 2.10–1.97 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.87, 162.00 (d, <i>J</i> = 241.4 Hz), 149.35, 148.74, 144.84 (d, <i>J</i> = 7.0 Hz), 138.96, 138.76, 136.92, 130.27(d, <i>J</i> = 8.3 Hz), 126.80, 123.59, 122.08, 114.11 (d, <i>J</i> = 20.9 Hz), 113.58 (d, <i>J</i> = 20.8 Hz), 93.58, 46.72, 46.03, 44.23, 43.18, 38.51, 29.73. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 458.0995 (theor 458.0992).</div></div><div id="sec4_8_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85">4.8.52.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-Difluorophenyl)piperidin-3-yl)-6-(1-methyl-1<i>H</i>-pyrazol-5-yl)nicotinamide Hydrochloride (<b>D5</b>)</h4><div class="NLM_p last">General procedure G, yield: 47%; retention time: 9.166 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.74–9.58 (m, 2H), 9.25 (d, <i>J</i> = 8.9 Hz, 1H), 8.97 (d, <i>J</i> = 1.9 Hz, 1H), 8.24 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.85 (d, <i>J</i> = 8.3 Hz, 1H), 7.51 (d, <i>J</i> = 1.9 Hz, 1H), 7.35–7.29 (m, 2H), 7.14 (d, <i>J</i> = 4.5 Hz, 1H), 6.87 (d, <i>J</i> = 1.9 Hz, 1H), 4.63–4.55 (m, 1H), 4.10 (s, 3H), 3.41–3.33 (m, 2H), 3.32–3.25 (m, 1H), 3.06–2.89 (m, 2H), 2.18–2.09 (m, 1H), 2.03–1.96 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.76, 150.86, 149.16 (dd, <i>J</i> = 243.8, 12.5 Hz), 148.31 (dd, <i>J</i> = 242.5, 12.5 Hz), 147.89, 139.75, 139.70, 137.90, 136.57, 127.71, 124.46, 122.39, 117.33 (d, <i>J</i> = 16.3 Hz), 116.69 (d, <i>J</i> = 16.3 Hz), 107.93, 47.64, 46.33, 43.89, 43.25, 39.65, 29.00. HRMS <i>m</i>/<i>z</i>: (ES<sup>+</sup>) [M + H]<sup>+</sup> 398.1789 (theor 398.1792).</div></div><div id="sec4_8_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86">4.8.53.  6-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-difluorophenyl) piperidin-3-yl)nicotinamide Hydrochloride (<b>D6</b>)</h4><div class="NLM_p last">General procedure G, yield: 54%; retention time: 9.801 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.62–9.49 (m, 2H), 9.23 (d, <i>J</i> = 8.9 Hz, 1H), 9.03 (d, <i>J</i> = 1.8 Hz, 1H), 8.30 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 7.78 (d, <i>J</i> = 8.2 Hz, 1H), 7.69 (s, 1H), 7.36–7.29 (m, 2H), 7.15 (d, <i>J</i> = 4.7 Hz, 1H), 4.65–4.57 (m, 1H), 3.92 (s, 3H), 3.43–3.34 (m, 2H), 3.27–3.21 (m, 1H), 3.04–2.91 (m, 2H), 2.16–2.07 (m, 1H), 2.00 (d, <i>J</i> = 12.6 Hz, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.78, 149.16 (dd, <i>J</i> = 243.8, 12.5 Hz), 148.78, 148.59, 148.30 (dd, <i>J</i> = 243.8, 12.5 Hz), 139.62, 136.73, 136.47, 136.19, 128.64, 124.42, 124.17, 117.34 (d, <i>J</i> = 16.3 Hz), 116.51 (d, <i>J</i> = 16.3 Hz), 108.59, 47.56, 46.27, 43.88, 43.19, 39.19, 29.08. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 432.1405 (theor 432.1403).</div></div><div id="sec4_8_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87">4.8.54.  6-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-difluorophenyl)piperidin-3-yl)nicotinamide Hydrochloride (<b>D7</b>)</h4><div class="NLM_p last">General procedure G, yield: 54%; retention time: 9.831 min, purity: 98.63%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.68–9.53 (m, 2H), 9.27 (d, <i>J</i> = 8.9 Hz, 1H), 9.03 (d, <i>J</i> = 1.7 Hz, 1H), 8.31 (dd, <i>J</i> = 8.2, 2.2 Hz, 1H), 7.78 (d, <i>J</i> = 8.2 Hz, 1H), 7.68 (s, 1H), 7.37–7.30 (m, 2H), 7.15 (d, <i>J</i> = 4.5 Hz, 1H), 4.66–4.58 (m, 1H), 3.90 (s, 3H), 3.42–3.34 (m, 2H), 3.28–3.22 (m, 1H), 3.05–2.91 (m, 2H), 2.18–2.06 (m, 1H), 2.04–1.97 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.77, 149.16 (dd, <i>J</i> = 243.8, 12.5 Hz), 149.23, 148.60, 148.30 (dd, <i>J</i> = 243.8, 12.5 Hz), 139.65, 138.89, 138.12, 136.12, 128.72, 124.55, 124.43, 117.34 (d, <i>J</i> = 17.5 Hz), 116.52 (d, <i>J</i> = 17.5 Hz), 93.53, 47.57, 46.27, 43.87, 43.20, 39.19, 29.09. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 476.0894 (theor 476.0898).</div></div><div id="sec4_8_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88">4.8.55.  4-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-3-chloro-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)benzamide Hydrochloride (<b>D8</b>)</h4><div class="NLM_p last">General procedure G, yield: 59%; retention time: 10.046 min, purity: 97.09%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.37 (d, <i>J</i> = 9.7 Hz, 1H), 9.29 (d, <i>J</i> = 9.9 Hz, 1H), 8.91 (d, <i>J</i> = 7.7 Hz, 1H), 7.91 (dd, <i>J</i> = 12.2, 1.6 Hz, 1H), 7.81–7.73 (m, 1H), 7.69 (s, 1H), 7.54 (dd, <i>J</i> = 8.0, 1.1 Hz, 1H), 7.34 (dd, <i>J</i> = 14.4, 7.1 Hz, 1H), 7.15–7.07 (m, 2H), 7.05–7.00 (m, 1H), 4.62–4.55 (m, 1H), 3.61 (s, 3H), 3.42–3.33 (m, 2H), 3.21–3.13 (m, 1H), 3.05–2.85 (m, 2H), 2.09–1.99 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>, 1:1 ratio due to atropisomers): δ 163.94, 162.00 (d, <i>J</i> = 241.6 Hz), 144.62 (d, <i>J</i> = 6.8 Hz), 138.43, 137.77, 136.94, 133.70 and 133.66, 132.84, 130.28 (d, <i>J</i> = 8.0 Hz), 129.86, 128.31 and 128.19, 126.40 and 126.26, 123.56, 114.19 (d, <i>J</i> = 21.8 Hz), 113.64 (d, <i>J</i> = 20.6 Hz), 93.93, 47.36, 46.27, 44.35, 43.19, 37.92, 29.42. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 491.0653 (theor 491.0650).</div></div><div id="sec4_8_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89">4.8.56.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)-3-methylbenzamide Hydrochloride (<b>D9</b>)</h4><div class="NLM_p last">General procedure G, yield: 55%; retention time: 9.871 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.52 (d, <i>J</i> = 9.9 Hz, 1H), 9.41 (d, <i>J</i> = 10.4 Hz, 1H), 8.76 (d, <i>J</i> = 8.9 Hz, 1H), 7.70 (d, <i>J</i> = 14.0 Hz, 1H), 7.65 (s, 1H), 7.63–7.59 (m, 1H), 7.36–7.29 (m, 2H), 7.14 (d, <i>J</i> = 7.7 Hz, 1H), 7.11 (d, <i>J</i> = 10.1 Hz, 1H), 7.04–6.99 (m, 1H), 4.66–4.56 (m, 1H), 3.54 (s, 3H), 3.40–3.33 (m, 2H), 3.25–3.18 (m, 1H), 3.00–2.92 (m, 2H), 2.09 (s, 3H), 2.07–1.97 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>, 1:1 ratio due to atropisomers): δ 165.33, 162.00 (d, <i>J</i> = 241.5 Hz), 144.80 (d, <i>J</i> = 7.1 Hz), 138.01, 137.89 and 137.86, 136.24, 135.23 and 135.21, 130.58, 130.21 (d, <i>J</i> = 8.4 Hz), 129.90, 129.16 and 129.09, 124.90 and 124.81, 123.62 and 123.60, 114.22 (d, <i>J</i> = 19.5 Hz), 113.56 (d, <i>J</i> = 20.5 Hz), 107.95, 47.20 and 47.16, 46.32, 44.36, 43.19, 37.67, 29.42, 18.98 and 18.97. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 427.1696 (theor 427.1701).</div></div><div id="sec4_8_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90">4.8.57.  4-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)-3-methylbenzamide Hydrochloride (<b>D10</b>)</h4><div class="NLM_p last">General procedure G, yield: 46%; retention time: 9.908 min, purity: 98.96%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.43 (s, 1H), 9.32 (s, 1H), 8.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.71–7.66 (m, 1H), 7.66 (s, 1H), 7.60 (t, <i>J</i> = 8.8 Hz, 1H), 7.34 (dd, <i>J</i> = 14.4, 7.7 Hz, 1H), 7.29 (dd, <i>J</i> = 7.9, 1.9 Hz, 1H), 7.14 (d, <i>J</i> = 7.7 Hz, 1H), 7.10 (dd, <i>J</i> = 10.4, 1.5 Hz, 1H), 7.04–7.00 (m, 1H), 4.65–4.55 (m, 1H), 3.55 (s, 3H), 3.40–3.35 (m, 2H), 3.22–3.16 (m, 1H), 3.02–2.88 (m, 2H), 2.08 (s, 3H), 2.06–1.99 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>, 1:1 ratio due to atropisomers): δ 165.41, 161.02 (d, <i>J</i> = 241.6 Hz), 144.78 (d, <i>J</i> = 6.6 Hz), 139.80, 138.32, 137.83 and 137.80, 135.23 and 135.21, 130.64, 130.59 and 130.57, 130.25 (d, <i>J</i> = 8.1 Hz), 129.13 and 129.03, 124.90 and 124.79, 123.60 (d, <i>J</i> = 2.3 Hz), 114.23 (d, <i>J</i> = 21.6 Hz), 113.60 (d, <i>J</i> = 20.9 Hz), 93.21, 47.19 and 47.15, 46.36, 44.39, 43.21, 37.73, 29.52 and 29.49, 19.07 and 19.05. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 471.1198 (theor 471.1196).</div></div><div id="sec4_8_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91">4.8.58.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)benzamide Hydrochloride (<b>D11</b>)</h4><div class="NLM_p last">General procedure G, yield: 81%; retention time: 9.661 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.75 (d, <i>J</i> = 8.4 Hz, 2H), 7.56 (s, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 2H), 7.36–7.30 (m, 1H), 7.19 (d, <i>J</i> = 7.8 Hz, 1H), 7.15–7.11 (m, 1H), 6.99–6.94 (m, 1H), 4.70–4.62 (m, 1H), 3.77 (s, 3H), 3.66–3.62 (m, 1H), 3.55 (d, <i>J</i> = 12.8 Hz, 1H), 3.26–3.17 (m, 2H), 3.14 (t, <i>J</i> = 12.0 Hz, 1H), 2.21 (dd, <i>J</i> = 14.5, 2.3 Hz, 1H), 2.15–2.05 (m, 1H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 169.02, 152.53, 152.43, 151.75, 151.65, 150.57, 150.47, 149.79, 149.70, 140.15, 139.56, 137.98, 135.63, 132.35, 131.00, 128.74, 125.42, 118.50, 118.37, 117.67, 117.53, 110.14, 49.29, 48.04, 46.08, 45.21, 38.65, 31.25. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 413.1547 (theor 413.1544).</div></div><div id="sec4_8_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92">4.8.59.  2-Fluoro-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3-fluorophenyl)piperidin-3-yl)-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide Hydrochloride (<b>D12</b>)</h4><div class="NLM_p last">General procedure G, yield: 61%; retention time: 9.023 min, purity: 98.63%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.73 (d, <i>J</i> = 8.7 Hz, 1H), 9.65 (d, <i>J</i> = 10.0 Hz, 1H), 8.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.49 (d, <i>J</i> = 1.8 Hz, 1H), 7.45 (d, <i>J</i> = 11.2 Hz, 1H), 7.41–7.33 (m, 3H), 7.12 (d, <i>J</i> = 7.7 Hz, 1H), 7.05 (dd, <i>J</i> = 17.0, 9.0 Hz, 2H), 6.49 (d, <i>J</i> = 1.8 Hz, 1H), 4.63–4.55 (m, 1H), 3.85 (s, 3H), 3.44–3.30 (m, 2H), 3.11–3.05 (m, 1H), 3.00–2.85 (m, 2H), 2.17–1.98 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.86, 162.02 (d, <i>J</i> = 241.5 Hz), 158.72 (d, <i>J</i> = 249.0 Hz), 144.58 (d, <i>J</i> = 7.1 Hz), 140.74 (d, <i>J</i> = 1.6 Hz), 137.95, 133.94 (d, <i>J</i> = 8.9 Hz), 130.19 (d, <i>J</i> = 8.3 Hz), 130.07 (d, <i>J</i> = 3.4 Hz), 124.21 (d, <i>J</i> = 3.0 Hz), 123.65, 123.29 (d, <i>J</i> = 14.9 Hz), 115.80 (d, <i>J</i> = 23.5 Hz), 114.36 (d, <i>J</i> = 21.1 Hz), 113.59 (d, <i>J</i> = 20.6 Hz), 106.78, 47.34, 46.14, 44.52, 43.06, 37.77, 29.22. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 397.1839 (theor 397.1840).</div></div><div id="sec4_8_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93">4.8.60.  3-Chloro-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidin-3-yl)-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide Hydrochloride (<b>D13</b>)</h4><div class="NLM_p last">General procedure G, yield: 52%; retention time: 10.395 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.69 (d, <i>J</i> = 9.2 Hz, 1H), 9.55 (d, <i>J</i> = 10.1 Hz, 1H), 9.11 (d, <i>J</i> = 8.9 Hz, 1H), 7.92 (d, <i>J</i> = 1.3 Hz, 1H), 7.77 (dd, <i>J</i> = 7.7, 1.1 Hz, 2H), 7.65 (d, <i>J</i> = 8.3 Hz, 1H), 7.59 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.47 (m, 2H), 6.34 (d, <i>J</i> = 1.5 Hz, 1H), 4.66–4.58 (m, 1H), 3.60 (s, 3H), 3.41–3.29 (m, 3H), 3.03–2.91 (m, 2H), 2.21–2.10 (m, 1H), 2.03 (d, <i>J</i> = 12.8 Hz, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.96, 141.80, 138.82, 137.98, 135.85, 133.08, 132.95, 132.26, 132.15, 131.70, 128.91, 128.30, 127.46 (q, <i>J</i> = 4.9 Hz), 126.24 (q, <i>J</i> = 30.4 Hz), 126.20, 122.85 (q, <i>J</i> = 271.5 Hz), 107.32, 47.47, 46.21, 43.98, 43.13, 36.83, 28.60. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 497.1119 (theor 497.1123).</div></div><div id="sec4_8_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94">4.8.61.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidin-3-yl)-3-methylbenzamide Hydrochloride (<b>D14</b>)</h4><div class="NLM_p last">General procedure G, yield: 77%; retention time: 10.631 min, purity: 96.58%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.58 (s, 1H), 9.43 (s, 1H), 8.87 (d, <i>J</i> = 8.6 Hz, 1H), 7.79 (s, 1H), 7.73–7.56 (m, 5H), 7.30 (d, <i>J</i> = 7.5 Hz, 1H), 4.67–4.54 (m, 1H), 3.53 (s, 3H), 3.46–3.26 (m, 3H), 3.06–2.89 (m, 2H), 2.21–2.00 (m, 5H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>, 1:1 ratio due to atropisomers): δ 165.41, 141.79, 137.96, 137.86 and 137.82, 136.24, 135.08 and 135.05, 132.85, 131.65, 130.58 and 130.55, 129.91, 129.09 and 128.98, 128.85, 127.43 (q, <i>J</i> = 4.5 Hz), 126.19 (q, <i>J</i> = 30.8 Hz), 124.90 and 124.79, 122.80 (q, <i>J</i> = 271.4 Hz), 107.93, 47.24 and 47.20, 46.27, 43.96, 43.12, 37.63, 28.70 and 28.65, 18.90. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 511.1276 (theor 511.1279).</div></div><div id="sec4_8_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95">4.8.62.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(4-chloro-3-(trifluoromethyl) phenyl)piperidin-3-yl)-2-fluorobenzamide Hydrochloride (<b>D15</b>)</h4><div class="NLM_p last">General procedure G, yield: 59%; retention time: 10.468, purity: 95.37%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.64 (d, <i>J</i> = 9.4 Hz, 1H), 9.51 (d, <i>J</i> = 10.4 Hz, 1H), 8.71 (d, <i>J</i> = 8.9 Hz, 1H), 7.73 (d, <i>J</i> = 1.8 Hz, 1H), 7.71 (d, <i>J</i> = 8.3 Hz, 1H), 7.67 (s, 1H), 7.59 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.47–7.42 (m, 2H), 7.36 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 4.65–4.57 (m, 1H), 3.76 (s, 3H), 3.41–3.31 (m, 2H), 3.15 (td, <i>J</i> = 11.9, 3.7 Hz, 1H), 3.02–2.85 (m, 2H), 2.18–2.08 (m, 1H), 2.03 (d, <i>J</i> = 12.3 Hz, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.93, 158.44 (d, <i>J</i> = 249.3 Hz), 141.60, 136.93 (d, <i>J</i> = 1.8 Hz), 136.54, 133.08, 131.68, 131.10 (d, <i>J</i> = 8.9 Hz), 129.99 (d, <i>J</i> = 3.5 Hz), 129.02, 127.41 (q, <i>J</i> = 4.6 Hz), 126.32 (q, <i>J</i> = 30.4 Hz), 125.69 (d, <i>J</i> = 3.3 Hz), 124.43 (d, <i>J</i> = 15.3 Hz), 122.92 (q, <i>J</i> = 271.3 Hz), 117.28 (d, <i>J</i> = 23.5 Hz), 107.84, 47.23, 46.16, 44.28, 43.02, 38.44, 28.83. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 515.1026 (theor 515.1029).</div></div><div id="sec4_8_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96">4.8.63.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(4-chloro-3-(trifluoromethyl) phenyl)piperidin-3-yl)benzamide Hydrochloride (<b>D16</b>)</h4><div class="NLM_p last">General procedure G, yield: 59%; retention time: 10.505 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.55 (d, <i>J</i> = 9.5 Hz, 1H), 9.40 (d, <i>J</i> = 10.3 Hz, 1H), 8.90 (d, <i>J</i> = 8.9 Hz, 1H), 7.83 (d, <i>J</i> = 8.2 Hz, 2H), 7.78 (d, <i>J</i> = 0.9 Hz, 1H), 7.70–7.64 (m, 2H), 7.60 (d, <i>J</i> = 8.2 Hz, 1H), 7.54 (d, <i>J</i> = 8.2 Hz, 2H), 4.68–4.59 (m, 1H), 3.74 (s, 3H), 3.47–3.28 (m, 3H), 3.02–2.93 (m, 2H), 2.17–2.00 (m, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.28, 141.81, 138.01, 136.47, 134.21, 132.95, 131.63, 130.08, 129.42, 128.87, 127.58, 127.28 (q, <i>J</i> = 4.1 Hz), 126.26 (q, <i>J</i> = 30.4 Hz), 122.82 (q, <i>J</i> = 271.3 Hz), 107.50, 47.20, 46.27, 43.97, 43.13, 38.33, 28.83. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 497.1127 (theor 497.1123).</div></div><div id="sec4_8_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97">4.8.64.  3-Chloro-4-(4-chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-difluorophenyl)piperidin-3-yl)benzamide Hydrochloride (<b>D17</b>)</h4><div class="NLM_p last">General procedure G, yield: 78%; retention time: 10.171 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.83 (dd, <i>J</i> = 16.2, 1.4 Hz, 1H), 7.73–7.66 (m, 1H), 7.55 (s, 1H), 7.47 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.32–7.26 (m, 1H), 7.25–7.19 (m, 1H), 7.16 (s, 1H), 4.58 (td, <i>J</i> = 11.6, 4.2 Hz, 1H), 3.68–3.61 (m, 4H), 3.55 (d, <i>J</i> = 12.9 Hz, 1H), 3.22–3.07 (m, 3H), 2.26–2.18 (m, 1H), 2.10–2.02 (m, 1H). <sup>13</sup>C NMR (125 MHz, MeOD, 1:1 ratio due to atropisomers): δ 167.52, 151.65 (dd, <i>J</i> = 257.5, 11.25 Hz), 150.83 (dd, <i>J</i> = 257.5, 11.25 Hz), 139.42, 138.20, 138.08, 137.84, 136.25 and 136.17, 134.03 and 134.00, 131.50, 129.86 and 129.62, 127.28 and 127.00, 125.29, 118.52 (d, <i>J</i> = 17.5 Hz), 117.56 (d, <i>J</i> = 17.5 Hz), 111.25, 49.59, 47.97, 46.13, 45.15, 38.25, 31.30. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 465.1064 (theor 465.1060).</div></div><div id="sec4_8_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98">4.8.65.  4-(4-Chloro-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-difluorophenyl)piperidin-3-yl)benzamide(2<i>R</i>,3<i>R</i>)-2,3-dihydroxysuccinate (<b>D18</b>)</h4><div class="NLM_p last">General procedure G, yield: 70%; retention time: 9.842 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.77 (d, <i>J</i> = 7.9 Hz, 2H), 7.54 (s, 1H), 7.52 (d, <i>J</i> = 7.9 Hz, 2H), 7.29 (dd, <i>J</i> = 11.0, 7.9 Hz, 1H), 7.22–7.14 (m, 2H), 4.61 (t, <i>J</i> = 9.2 Hz, 1H), 3.77 (s, 3H), 3.67–3.60 (m, 1H), 3.59–3.51 (m, 1H), 3.25–3.10 (m, 3H), 2.27–2.02 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.07, 165.35, 149.07 (dd, <i>J</i> = 234.0, 11.0 Hz), 148.17(dd, <i>J</i> = 234.0, 11.0 Hz), 139.75, 138.03, 136.48, 134.44, 130.07, 129.50, 127.54, 124.30, 117.27 (d, <i>J</i> = 17.0 Hz), 116.39 (d, <i>J</i> = 18.0 Hz), 107.51, 71.88, 47.69, 46.71, 44.29, 43.29, 38.35, 29.90. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 431.1452 (theor 431.1450).</div></div><div id="sec4_8_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99">4.8.66.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide Hydrochloride (<b>D19</b>)</h4><div class="NLM_p last">General procedure G, yield: 70%; retention time: 9.280 min, purity: 100.00%; <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.69 (d, <i>J</i> = 2.2 Hz, 1H), 7.55 (t, <i>J</i> = 7.6 Hz, 1H), 7.42–7.35 (m, 2H), 7.31–7.25 (m, 1H), 7.25–7.20 (m, 1H), 7.18–7.14 (m, 1H), 6.56 (d, <i>J</i> = 2.2 Hz, 1H), 4.61–4.55 (m, 1H), 3.92 (s, 3H), 3.66 (dd, <i>J</i> = 12.4, 4.0 Hz, 1H), 3.57–3.51 (m, 1H), 3.20–3.07 (m, 3H), 2.20 (d, <i>J</i> = 12.0 Hz, 1H), 2.11–2.02 (m, 1H). HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 415.1746 (theor 415.1746).</div></div><div id="sec4_8_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100">4.8.67.  <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-Difluorophenyl)piperidin-3-yl)-4-(1-methyl-1<i>H</i>-pyrazol-5-yl)benzamide (2<i>R</i>,3<i>R</i>)-2,3-dihydroxysuccinate (<b>D20</b>)</h4><div class="NLM_p last">General procedure G, yield: 51%; retention time: 9.318 min, purity: 95.52%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.75 (d, <i>J</i> = 8.3 Hz, 2H), 7.58 (d, <i>J</i> = 8.3 Hz, 2H), 7.47 (d, <i>J</i> = 1.9 Hz, 1H), 7.37–7.27 (m, 2H), 7.14 (s, 1H), 6.44 (d, <i>J</i> = 1.9 Hz, 1H), 4.56–4.46 (m, 1H), 4.14 (s, 2H), 3.84 (s, 3H), 3.42–3.36 (m, 2H), 3.14–3.04 (m, 1H), 3.03–2.86 (m, 2H), 2.01–1.95 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 173.92, 165.36, 149.13 (dd, <i>J</i> = 244.0, 12.0 Hz), 148.38 (dd, <i>J</i> = 244.0, 12.0 Hz), 141.78, 139.70, 138.00, 133.39, 132.94, 128.20, 127.54, 124.27, 117.25 (d, <i>J</i> = 16.0 Hz), 116.41 (d, <i>J</i> = 16.0 Hz), 106.31, 71.94, 47.62, 46.63, 44.23, 43.24, 37.66, 29.73. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 397.1843 (theor 397.1840).</div></div><div id="sec4_8_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101">4.8.68.  4-(4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-((3<i>S</i>,4<i>S</i>)-4-(3,4-difluorophenyl)piperidin-3-yl)benzamide(2<i>R</i>,3<i>R</i>)-2,3-dihydroxysuccinate (<b>D21</b>)</h4><div class="NLM_p last">General procedure G, yield: 73%; retention time: 9.980 min, purity: 95.07%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.64 (d, <i>J</i> = 8.3 Hz, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 2H), 7.66 (s, 1H), 7.55 (d, <i>J</i> = 7.9 Hz, 2H), 7.41–7.27 (m, 2H), 7.14 (s, 1H), 4.51–4.42 (m, 1H), 4.07 (s, 2H), 3.75 (s, 3H), 3.43–3.28 (m, 2H), 3.13–3.02 (m, 1H), 3.00–2.82 (m, 2H), 2.08–1.89 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.22, 165.36, 149.15 (dd, <i>J</i> = 243.0, 11.0 Hz), 148.58 (dd, <i>J</i> = 243.0, 11.0 Hz), 139.82, 139.64, 138.58, 134.48, 130.65, 129.67, 127.47, 124.29, 117.25 (d, <i>J</i> = 16.0 Hz), 116.39 (d, <i>J</i> = 17.0 Hz), 92.68, 71.84, 47.81, 46.84, 44.37, 43.34, 38.35, 30.07. HRMS <i>m</i>/<i>z</i> (ES<sup>+</sup>): [M + H]<sup>+</sup> 475.0948 (theor 475.0945).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102">4.9.  Cell Culture</h3><div class="NLM_p last">BMDMs were flushed from femurs and tibias of C57BL/6J mice.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> BMDMs were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplied with 10% FBS (Gibco), 1% penicillin–streptomycin (Invitrogen), and 20% L929 conditioned media (a source of M-CSF) for 7 days. The purity of adherent macrophages (F4/80<sup>+</sup>) was more than 90%, analyzed by FACS. RAW264.7 (Murine macrophages cell line) was purchased from Cell Bank of China Science and cultured in DMEM containing 10% FBS.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103">4.10.  Drug Screening</h3><div class="NLM_p last">RAW264.7 and BMDMs were plated in six-well plates and incubated at 37 °C in 5% CO<sub>2</sub>. To evaluate the effect of compounds on promoting macrophages M2 polarization, cells were treated with 300 nM compounds or 20 ng/mL IL-4 (used as a positive control to promote M2 polarization, Peprotech) for 24 h. Macrophages M2 polarization was determined by measuring <i>Arg1</i>, <i>Mrc1</i>, and <i>Fizz1</i> mRNA level. To evaluate the effect of compounds on inhibiting macrophages M1 polarization, cells were preincubated 50 ng/mL LPS for 24 h to induce M1 polarization and then treated with 300 nM compounds for 24 h. Macrophages M1 polarization was determined by measuring <i>Mcp1</i>, <i>Inos</i>, <i>Tnf-</i>α mRNA level.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104">4.11.  qRT-PCR</h3><div class="NLM_p last">Total RNA was extracted using Trizol (Invitrogen) according to manufacturer’s procedures. cDNA synthesis was performed using “TransScript One-Step gDNA Removal and cDNA Synthesis SuperMix” kit (Transgen). qRT-PCR was carried out using an Applied Biosystems Fast 7500 real-time PCR instrument with SYBR Premix Ex Taq (TAKARA). Primers used are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">Table S4</a>. The results were normalized to housekeeping gene GAPDH.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105">4.12.  Pharmacokinetic Study</h3><div class="NLM_p last">This study was performed in strict accordance with the Laboratory Animal Management Regulations (State Scientific and Technological Commission publication no. 8-27 Rev. 2017) and was approved by Zhejiang University Laboratory Animal Center (Hangzhou, China). SD rats (purchased from Zhejiang Academy of Medical Sciences) were administered compound in saline by oral gavage. Venous blood (100 μL) samples were collected at 0, 0.5, 1, 2, 4, 8, and 12 h. Plasma was separated from whole blood by centrifugation and stored at −20 °C until analysis. Compound levels were determined using an API4000 + LC/MS system. The <i>C</i><sub>max</sub>, <i>T</i><sub>max</sub>, <i>t</i><sub>1/2</sub>, and AUC were evaluated using Analyst 1.5.1.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106">4.13.  Animals and EAE Induction</h3><div class="NLM_p last">This study was performed in strict accordance with the Laboratory Animal Management Regulations (State Scientific and Technological Commission publication no. 8-27 Rev. 2017) and was approved by Zhejiang University Laboratory Animal Center (Hangzhou, China). Mice (C57BL/6J, female, 8–10 weeks) were obtained from Shanghai Slac Laboratory Animal Co. Ltd, housed, and fed in a specific pathogen-free animal facility at Experimental Animal Center of Zhejiang University. To induce EAE, 2 mg/mL MOG<sub>35–55</sub> peptide dissolved in PBS was mixed with Complete Freund’s Adjuvant (Sigma) containing 4 mg/mL heat-killed <i>Mycobacterium tuberculosis</i> (strain H37Ra, BD Biosciences). Then, the mixture was injected subcutaneously into neck (0.1 mL) and both hindlegs (0.05 mL each) of mice. Pertussis toxin (200 ng; List Biological Lab, Inc) was administered intravenously on days 0 and 1 post-immunization. Clinical score and body weight were recorded daily. Clinical scoring system: 0 = healthy; 0.5 = limp tail tip; 1 = limp tail; 1.5 = waddling gait with partial tail weakness; 2 = partial hind limb paralysis; 2.5 = unilateral complete hind limb paralysis; 3 = complete bilateral hind limb paralysis; 3.5 = complete hind limb paralysis and partial forelimb paralysis; 4 = tetraplegia; 4.5 = moribund; and 5 = death.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> To determine the therapeutic effect of <b>D11</b> on EAE mice, all of the compounds were dissolved in saline, 100 mg/kg <b>D11</b>, 200 mg/kg <b>D11</b>, and 10 mg/kg DXM, or vehicle (saline) was intraperitoneally administrated daily from day 7 post-immunization.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107">4.14.  Isolation of MNCs</h3><div class="NLM_p last">Spleens and dLNs from vehicle or <b>D11</b>-treated EAE mice were homogenized in a gentleMACS Dissociator (Miltenyi Biotec) to obtain single-cell suspensions. Brains and spinal cords (CNS) from vehicle or <b>D11</b>-treated EAE mice were dissected and digested with Collagenase Type IV (Gibco) and separated on discontinuous 70%/30% Percoll gradients, centrifuged for 30 min at 500<i>g</i>, 18 °C. The interphase was diluted by transferring to a clean conical tube containing HBSS and then centrifuged for 5 min at 500<i>g</i> and 18 °C. MNCs were collected for further FACS analysis.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108">4.15.  Flow Cytometry</h3><div class="NLM_p last">For cell surface markers staining, cells were incubated with Fluorochrome-labeled antibodies against CD4, CD11b, CD11c, MHC-II (all from BD Biosciences), F4/80, CD86, and CD206 (MMR) (all from Biolegend). For intracellular cytokine staining, single-cell suspensions from spleens, dLNs, and CNS were restimulated with 2 μg/mL brefeldin A (Sigma) and 0.1 μg/mL PMA (Sigma) and 0.5 μg/mL ionomycin (Sigma) for 5 h. After cell surface markers were stained, cells were fixed and permeabilized with Cytofix/Cytoperm and Perm/Wash buffer (BD Biosciences) according to the manufacturer’s instruction. Anti-IFN-γ (Biolegend) and anti-IL-17A (Biolegend) were used for intracellular cytokines staining to determine the proportion of Th1 and Th17 cells. Cells were analyzed by a BD FACScaliber flow cytometer. The fluorescence intensity was analyzed by Cell Quest Software.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109">4.16.  Histological Analysis</h3><div class="NLM_p last">Vehicle or <b>D11</b>-treated EAE mice were fixed in 4% paraformaldehyde immediately after perfusion with PBS, and spinal cords were isolated. For LFB staining, fresh spinal cords were embedded in OCT (Tissue-Tek) and frozen at −80 °C. The frozen sections were immersed for 3 h in 0.1% LFB solution (Solvent Blue 38, Sigma-Aldrich) at 56–60 °C. The sections were rinsed in deionized water, and differentiation was initiated in 0.05% aqueous lithium carbonate for 10–12 s, followed by termination in multiple immersions in fresh 70% ethanol until gray and white matter could be distinguished. After being washed in deionized water, sections were dehydrated in 80% ethanol (1 min), 95% ethanol (2 × 1 min), 100% ethanol (3 min), and xylene and finally coverslipped. For hematoxylin–eosin (H&E) staining, fresh spinal cords were embedded in paraffin. Paraffin-embedded sections were stained with H&E by Leica ST5010 to estimate inflammation in CNS. Images were acquired using Zeiss LSM510 Meta fluorescence confocal microscope or Leica DM2500 microscope.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110">4.17.  Suppression Assays</h3><div class="NLM_p last">To evaluate the suppressive capacity of macrophages, BMDMs were treated with 300 nM <b>D11</b> in combination with 50 ng/mL LPS (used to promote M1 polarization) or 10 ng/mL IL-4 (used to promote M2 polarization) for 48 h on day 5 of differentiation; drugs were removed on day 7. Naïve CD4<sup>+</sup> T cells were negatively selected using an EasySep Mouse Naïve CD4<sup>+</sup> T cells Isolation kit (STEMCELL Technologies Inc) and then labeled with CFSE (Biolegend). BMDMs were cocultured with CFSE-labeled naïve CD4<sup>+</sup> T cells in the presence of 500 ng/mL anti-CD3 mAb and 500 ng/mL anti-CD28 mAb (Biolegend) at a ratio of 1:1. After 72 h, proliferation of CD4<sup>+</sup> T cells was determined by FACS.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111">4.18.  Statistical Analysis</h3><div class="NLM_p last">Independent experiments were carried out at least three times. Data were shown as mean ± SEM in the graphs. Results were analyzed using unpaired two-tailed Student’s <i>t</i>-test or One-Way ANOVA.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112">4.19.  Microarray Analysis</h3><div class="NLM_p">Total RNA was amplified, labeled, and purified by using a GeneChip 3′ IVT PLUS Reagent Kit (Cat#902416, Affymetrix, Santa Clara, CA, US)/Ovation FFPE WTA System (Cat#3403, NuGEN, San Carlos, CA, US)/Ovation Pico WTA System V2 (Cat#3302, NuGEN, San Carlos, CA, US), and FL-Ovation cDNA Biotin Module V2(Cat#4200, NuGEN, San Carlos, CA, US) followed the manufacturer’s instructions to obtain biotin-labeled cRNA.</div><div class="NLM_p">Array hybridization and wash was performed using GeneChip Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US) in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US) and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturer’s instructions.</div><div class="NLM_p last">Slides were scanned by GeneChip Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US) and Command Console Software 4.0 (Affymetrix, Santa Clara, CA, US) with default settings. Raw data were normalized by MAS 5.0/RMA algorithm, Affy packages in R.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113">4.20.  Western Blotting and ELISA</h3><div class="NLM_p last">BMDMs were lysed in buffer (PH = 7.6) containing 1% Triton X-100, 1% phosphatase inhibitor, and 1 mM PMSF. Protein extracts were electrophoresed by SDS-PAGE and transferred to poly(vinylidene difluoride) membrane and probed with primary antibodies. The primary antibodies were as follows: anti-AKT, anti-p-AKT(308), anti-p-AKT(473), anti-Arg-1, anti-Ym1, anti-TNF-α, anti-STAT3, anti-p-STAT3(705), anti-STAT6, and anti-p-STAT6 (all purchased from Cell Signaling Technology). Appropriate secondary antibodies and ECL were performed to visualize the protein signaling. GAPDH was used as a loading control. IFN-γ and IL-17A concentrations in cell culture supernatants were determined by an ELISA kit (DAKEWE).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01635" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01635" class="ext-link">10.1021/acs.jmedchem.8b01635</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Structures of 28 compounds from in-house library; expression level of Arg1/Ym1/Tnf-α protein; mice weight change and serum parameters during 14 days repeated dose toxicity study; flow cytometry analysis of dendritic cells and Treg cells; changes of gene expression in the KEGG pathway analysis; gene biomarker expression fold change of the in-house compounds; organ-to-body weight ratio during 14 days repeated dose toxicity study; organ-to-brain weight ratio during 14 days repeated dose toxicity study; primers used in qRT-PCR; compound information for the intermediates and target compounds; and NMR spectra and HPLC results for the target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf">jm8b01635_si_001.pdf (5.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_003.csv">jm8b01635_si_003.csv (5.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01635" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaowu Dong</span> - <span class="hlFld-Affiliation affiliation">ZJU-ENS
Joint Laboratory of Medicinal Chemistry, Hangzhou Institute
of Innovative Medicine, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2178-4372" title="Orcid link">http://orcid.org/0000-0002-2178-4372</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#55313a3b322d22152f3f207b3031207b363b"><span class="__cf_email__" data-cfemail="d0b4bfbeb7a8a790aabaa5feb5b4a5feb3be">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qinjie Weng</span> - <span class="hlFld-Affiliation affiliation">Institute of
Pharmacology & Toxicology, Zhejiang Province Key Laboratory of
Anti-Cancer Drug Research, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinxin Che</span> - <span class="hlFld-Affiliation affiliation">ZJU-ENS
Joint Laboratory of Medicinal Chemistry, Hangzhou Institute
of Innovative Medicine, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhikang Zhang</span> - <span class="hlFld-Affiliation affiliation">Institute of
Pharmacology & Toxicology, Zhejiang Province Key Laboratory of
Anti-Cancer Drug Research, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiahuan Zheng</span> - <span class="hlFld-Affiliation affiliation">Institute of
Pharmacology & Toxicology, Zhejiang Province Key Laboratory of
Anti-Cancer Drug Research, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenhu Zhan</span> - <span class="hlFld-Affiliation affiliation">ZJU-ENS
Joint Laboratory of Medicinal Chemistry, Hangzhou Institute
of Innovative Medicine, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sendong Lin</span> - <span class="hlFld-Affiliation affiliation">ZJU-ENS
Joint Laboratory of Medicinal Chemistry, Hangzhou Institute
of Innovative Medicine, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tian Tian</span> - <span class="hlFld-Affiliation affiliation">ZJU-ENS
Joint Laboratory of Medicinal Chemistry, Hangzhou Institute
of Innovative Medicine, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jincheng Wang</span> - <span class="hlFld-Affiliation affiliation">Institute of
Pharmacology & Toxicology, Zhejiang Province Key Laboratory of
Anti-Cancer Drug Research, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renhua Gai</span> - <span class="hlFld-Affiliation affiliation">Institute of
Pharmacology & Toxicology, Zhejiang Province Key Laboratory of
Anti-Cancer Drug Research, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongzhou Hu</span> - <span class="hlFld-Affiliation affiliation">ZJU-ENS
Joint Laboratory of Medicinal Chemistry, Hangzhou Institute
of Innovative Medicine, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Yang</span> - <span class="hlFld-Affiliation affiliation">Institute of
Pharmacology & Toxicology, Zhejiang Province Key Laboratory of
Anti-Cancer Drug Research, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiaojun He</span> - <span class="hlFld-Affiliation affiliation">Institute of
Pharmacology & Toxicology, Zhejiang Province Key Laboratory of
Anti-Cancer Drug Research, College of Pharmaceutical Sciences and , Zhejiang University, Hangzhou 310058, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Q.W., J.C., and Z.Z. contributed equally to this work. Q.W. and X.D. conceived the study and analyzed the data. J.C. synthesized the compounds, analyzed the data, and drafted the manuscript. Z.Z., J.Z., J.W., and R.G. performed the biological experiments and analyzed the data. W.Z., S.L., and T.T. synthesized the compounds. Y.H., B.Y., and Q.H. conceived the study.</p></li><li><span class="author-information-subsection-header">Funding</span><p>National Natural Science Foundation of China; Public Welfare Technology Research Program of Zhejiang Province; National Major Scientific and Technological Special Project for “Significant New Drugs Development”.</p></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i116">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jianyang Pan (Research and Service Center, College of Pharmaceutical Sciences, Zhejiang University) for performing NMR spectrometry for structure elucidation. This work was supported by grant from the National Natural Science Foundation of China (81673294, 81872878, 81741172, and 81473226), Zhejiang Provincial Natural Science Foundation of China (LGF18H310001), National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2018ZX09711002-011-023).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">encephalomyelitis</p></td></tr><tr><td class="NLM_term">MOG</td><td class="NLM_def"><p class="first last">myelin oligodendrocyte glycoprotein</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last"><i>N</i>-chlorosuccinimide</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoracetic acid</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">qRT-PCR</td><td class="NLM_def"><p class="first last">quantitative real-time polymerase chain reaction</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span> <span> </span><span class="NLM_article-title">Immunology of relapse and remission in multiple sclerosis</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-032713-120227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1146%2Fannurev-immunol-032713-120227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=24438352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=257-281&author=L.+Steinman&title=Immunology+of+relapse+and+remission+in+multiple+sclerosis&doi=10.1146%2Fannurev-immunol-032713-120227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Immunology of relapse and remission in multiple sclerosis</span></div><div class="casAuthors">Steinman, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-281</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Eighty percent of individuals with multiple sclerosis (MS) initially develop a clin. pattern with periodic relapses followed by remissions, called relapsing-remitting MS (RRMS).  This period of fluctuating disease may last for a decade or more.  Clin. relapses reflect acute inflammation in the central nervous system (CNS), composed of the brain and spinal cord.  Often, different anat. areas in the CNS are involved each time a relapse occurs, resulting in varied clin. manifestations in each instance.  Relapses are nearly always followed by some degree of remission, though recovery to baseline status before the flare is often incomplete.  There are nine approved drugs for treatment of RRMS.  The most potent drug for inhibiting relapses, the humanized anti-α4 integrin antibody known as Natalizumab, blocks homing of mononuclear cells to the CNS.  The mechanisms of action of the approved drugs for RRMS provide a strong foundation for understanding the pathobiol. of the relapse.  Despite substantial progress in controlling relapses with the current armamentarium of medications, there is much to learn and ever more effective and safe therapies to develop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMFgjCftGNkLVg90H21EOLACvtfcHk0lh52-bdAon1xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVemt78%253D&md5=41c7de7582a583a5626b3b97ff2f77b2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032713-120227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032713-120227%26sid%3Dliteratum%253Aachs%26aulast%3DSteinman%26aufirst%3DL.%26atitle%3DImmunology%2520of%2520relapse%2520and%2520remission%2520in%2520multiple%2520sclerosis%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D32%26spage%3D257%26epage%3D281%26doi%3D10.1146%2Fannurev-immunol-032713-120227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, B. D.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.pneurobio.2010.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=20946934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvVyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=1-12&author=R.+Duttaauthor=B.+D.+Trapp&title=Mechanisms+of+neuronal+dysfunction+and+degeneration+in+multiple+sclerosis&doi=10.1016%2Fj.pneurobio.2010.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis</span></div><div class="casAuthors">Dutta Ranjan; Trapp Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.  Due to its high prevalence, MS is the leading cause of non-traumatic neurological disability in young adults in the United States and Europe.  The clinical disease course is variable and starts with reversible episodes of neurological disability in the third or fourth decade of life.  This transforms into a disease of continuous and irreversible neurological decline by the sixth or seventh decade.  Available therapies for MS patients have little benefit for patients who enter this irreversible phase of the disease.  It is well established that irreversible loss of axons and neurons are the major cause of the irreversible and progressive neurological decline that most MS patients endure.  This review discusses the etiology, mechanisms and progress made in determining the cause of axonal and neuronal loss in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIGys_IlOfaWx8TEN9K18QfW6udTcc2eZ8AcNZZsuIvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvVyitA%253D%253D&md5=b3a3c9a85106fb1a09482d7d510241dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DR.%26aulast%3DTrapp%26aufirst%3DB.%2BD.%26atitle%3DMechanisms%2520of%2520neuronal%2520dysfunction%2520and%2520degeneration%2520in%2520multiple%2520sclerosis%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26volume%3D93%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.pneurobio.2010.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Valk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Groot, C. J. A.</span></span> <span> </span><span class="NLM_article-title">Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS</span>. <i>Neuropathol. Appl. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2990.2000.00217.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1046%2Fj.1365-2990.2000.00217.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10736062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVeht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2000&pages=2&author=P.+van%0Ader+Valkauthor=C.+J.+A.+De+Groot&title=Staging+of+multiple+sclerosis+%28MS%29+lesions%3A+pathology+of+the+time+frame+of+MS&doi=10.1046%2Fj.1365-2990.2000.00217.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS</span></div><div class="casAuthors">Van der Valk, P.; De Groot, C. J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-10</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Several processes take place during an attack of demyelination in multiple sclerosis (MS).  The timing of these various processes, and thus of the attack in its entirety, is important if therapeutic strategies are to be planned.  Attempts have been made to introduce and investigate variables relevant to timing the disease processes, leading to staging systems for MS.  Here, the terminol. and the various parameters used are reviewed, including inflammatory cells, glial cells, axonal loss and myelin staining: then the different systems are compared, including the system put forward by Bo and Trapp, our own modification of that, the Bruck and Lassmann system and the recent consensus reached at a Vienna meeting.  It is concluded that an ideal staging system does not yet exist, and that, more than anything else, the material dictates the choice for a staging system.  The terminol. of the Vienna consensus could be used as a ref. to facilitate international comparison.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJpNtqckbqO7Vg90H21EOLACvtfcHk0lgzeDIwtjHnkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVeht7k%253D&md5=87ac6a124477576cea0ee01203e7668e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2990.2000.00217.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2990.2000.00217.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26aulast%3DDe%2BGroot%26aufirst%3DC.%2BJ.%2BA.%26atitle%3DStaging%2520of%2520multiple%2520sclerosis%2520%2528MS%2529%2520lesions%253A%2520pathology%2520of%2520the%2520time%2520frame%2520of%2520MS%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2000%26volume%3D26%26spage%3D2%26doi%3D10.1046%2Fj.1365-2990.2000.00217.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bitsch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brück, W.</span></span> <span> </span><span class="NLM_article-title">Acute axonal injury in multiple sclerosis - correlation with demyelination and inflammation</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">1174</span>, <span class="refDoi"> DOI: 10.1093/brain/123.6.1174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1093%2Fbrain%2F123.6.1174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10825356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BD3czktVamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2000&pages=1174&author=A.+Bitschauthor=J.+Schuchardtauthor=S.+Bunkowskiauthor=T.+Kuhlmannauthor=W.+Br%C3%BCck&title=Acute+axonal+injury+in+multiple+sclerosis+-+correlation+with+demyelination+and+inflammation&doi=10.1093%2Fbrain%2F123.6.1174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation</span></div><div class="casAuthors">Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Bruck W</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">123 ( Pt 6)</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1174-83</span>
        ISSN:<span class="NLM_cas:issn">0006-8950</span>.
    </div><div class="casAbstract">Damage to axons is taken as a key factor of disability in multiple sclerosis, but its pathogenesis is largely unknown.  Axonal injury is believed to occur as a consequence of demyelination and was recently shown to be a feature even of the early disease stages.  The present study was aimed at characterizing the association of axonal injury and histopathological hallmarks of multiple sclerosis such as demyelination, cellular infiltration and expression of inflammatory mediators.  Therefore, axon reduction and signs of acute axonal damage were quantified in early lesion development of chronic multiple sclerosis and correlated with demyelinating activity and inflammation.  Patients with secondary progressive multiple sclerosis revealed the most pronounced axonal injury, whereas primary progressive multiple sclerosis patients surprisingly showed relatively little acute axonal injury.  Acute axonal damage, as defined by the accumulation of amyloid precursor protein (APP), was found to occur not only in active demyelinating but also in remyelinating and inactive demyelinated lesions with a large inter-individual variability.  Only few remyelinating lesions were adjacent to areas of active demyelination.  In this minority of lesions, axonal damage may have originated from the neighbourhood.  APP expression in damaged axons correlated with the number of macrophages and CD8-positive T lymphocytes within the lesions, but not with the expression of tumour necrosis factor-alpha (TNF-alpha) or inducible nitric oxide synthase (iNOS).  Axonal injury is therefore, at least in part, independent of demyelinating activity, and its pathogenesis may be different from demyelination.  This has major implications for therapeutic strategies, which aim at preventing both demyelination and axonal loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNHAXTCmcm5cULxIEhxUjPfW6udTcc2eYy3124XAlqGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czktVamsA%253D%253D&md5=24a8005c2dc3ebedd61437bae6d6d5d4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2F123.6.1174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252F123.6.1174%26sid%3Dliteratum%253Aachs%26aulast%3DBitsch%26aufirst%3DA.%26aulast%3DSchuchardt%26aufirst%3DJ.%26aulast%3DBunkowski%26aufirst%3DS.%26aulast%3DKuhlmann%26aufirst%3DT.%26aulast%3DBr%25C3%25BCck%26aufirst%3DW.%26atitle%3DAcute%2520axonal%2520injury%2520in%2520multiple%2520sclerosis%2520-%2520correlation%2520with%2520demyelination%2520and%2520inflammation%26jtitle%3DBrain%26date%3D2000%26volume%3D123%26spage%3D1174%26doi%3D10.1093%2Fbrain%2F123.6.1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pugliatti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosati, G.</span></span> <span> </span><span class="NLM_article-title">The worldwide prevalence of multiple sclerosis</span>. <i>Clin. Neurol. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/s0303-8467(02)00036-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fs0303-8467%2802%2900036-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=12127652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BD38zotFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2002&pages=182-191&author=M.+Pugliattiauthor=S.+Sotgiuauthor=G.+Rosati&title=The+worldwide+prevalence+of+multiple+sclerosis&doi=10.1016%2Fs0303-8467%2802%2900036-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The worldwide prevalence of multiple sclerosis</span></div><div class="casAuthors">Pugliatti Maura; Sotgiu Stefano; Rosati Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neurology and neurosurgery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-91</span>
        ISSN:<span class="NLM_cas:issn">0303-8467</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPU8-88-HE49TiMd2aNQVUfW6udTcc2eYy3124XAlqGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zotFGruw%253D%253D&md5=5dac36805f5bc3e6c04f0a0e7793f424</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fs0303-8467%2802%2900036-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0303-8467%252802%252900036-7%26sid%3Dliteratum%253Aachs%26aulast%3DPugliatti%26aufirst%3DM.%26aulast%3DSotgiu%26aufirst%3DS.%26aulast%3DRosati%26aufirst%3DG.%26atitle%3DThe%2520worldwide%2520prevalence%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neurol.%2520Neurosurg.%26date%3D2002%26volume%3D104%26spage%3D182%26epage%3D191%26doi%3D10.1016%2Fs0303-8467%2802%2900036-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamm, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polman, C. H.</span></span> <span> </span><span class="NLM_article-title">Multiple sclerosis: current knowledge and future outlook</span>. <i>Eur. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1159/000360528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1159%2F000360528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=25095894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGktL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2014&pages=132-141&author=C.+P.+Kammauthor=B.+M.+Uitdehaagauthor=C.+H.+Polman&title=Multiple+sclerosis%3A+current+knowledge+and+future+outlook&doi=10.1159%2F000360528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Sclerosis: Current Knowledge and Future Outlook</span></div><div class="casAuthors">Kamm, Christian P.; Uitdehaag, Bernard M.; Polman, Chris H.</div><div class="citationInfo"><span class="NLM_cas:title">European Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">132-141</span>CODEN:
                <span class="NLM_cas:coden">EUNEAP</span>;
        ISSN:<span class="NLM_cas:issn">0014-3022</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Background: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by demyelination and axonal loss.  The etiol. of MS is unknown; however, environmental and genetic factors play a key role in the development of MS.  Diagnostic criteria have been adapted to facilitate earlier diagnosis with increased sensitivity and specificity.  Our understanding of the pathophysiol. of MS has deepened considerably in recent years, resulting in different therapies to modify the disease course.  Furthermore, several drugs have lately shown efficacy in phase III studies and their approval is expected in the near future.  As treatment options expand, a future challenge will be to find the optimal treatment for the individual patient.  Summary: This mini-review gives an overview of the current knowledge of MS with emphasis on the latest diagnostic criteria and both current and upcoming treatment options.  Key Messages: Treatment of MS changes rapidly as the knowledge and therapeutic options in MS expand.  Clin. Impact: Diagnosis of MS is based on McDonald criteria.  MS therapy can be divided into relapse, disease-modifying and symptomatic treatment.  Relapses are commonly treated with i.v. methylprednisolone.  First-line therapy consists of either interferon-β, glatiramer acetate or teriflunomide.  In general, agents used as escalation therapies (natalizumab, fingolimod and mitoxantrone) are more potent than the agents used for first-line therapy; however, these have potentially serious side effects and should be used with care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFiNY-P0ciGLVg90H21EOLACvtfcHk0lhrAKvN8X2agQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGktL7P&md5=e4e840fb6a61260c68092e1ae37ab90c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000360528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000360528%26sid%3Dliteratum%253Aachs%26aulast%3DKamm%26aufirst%3DC.%2BP.%26aulast%3DUitdehaag%26aufirst%3DB.%2BM.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26atitle%3DMultiple%2520sclerosis%253A%2520current%2520knowledge%2520and%2520future%2520outlook%26jtitle%3DEur.%2520Neurol.%26date%3D2014%26volume%3D72%26spage%3D132%26epage%3D141%26doi%3D10.1159%2F000360528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrithers, M. D.</span></span> <span> </span><span class="NLM_article-title">Update on disease-modifying treatments for multiple sclerosis</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1938</span>– <span class="NLM_lpage">1945</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2014.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.clinthera.2014.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=25218310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFSjt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=1938-1945&author=M.+D.+Carrithers&title=Update+on+disease-modifying+treatments+for+multiple+sclerosis&doi=10.1016%2Fj.clinthera.2014.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Disease-Modifying Treatments for Multiple Sclerosis</span></div><div class="casAuthors">Carrithers, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1938-1945</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The purpose of this review is to discuss the selection and use of disease- modifying treatments for patients with relapsing forms of multiple sclerosis (MS).PubMed was searched (1966-2014) using the terms multiple sclerosis, treatment, interferon, glatiramer acetate, di-Me fumarate, fingolimod, teriflunomide, natalizumab, rituximab, and alemtuzumab.MS is a chronic neurol. disorder that can cause a substantial degree of disability.  Because of its usual onset in young adults, patients may require treatment for several decades.  Currently available agents include platform injectable therapies, newer oral agents, and second-line monoclonal antibody treatments.  Treatment decisions have become more complex with the introduction of new approaches, and a major goal is to balance perceived efficacy and tolerability in a specific patient with the relative impact of disease activity and adverse events on quality of life.  Here the options for disease-modifying treatments for relapsing forms of MS are reviewed, and current and future challenges are discussed.An evidence-based approach can be used for the selection of disease-modifying treatments based on disease phenotype and severity, adverse events, and perceived efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCBELzvhJBqbVg90H21EOLACvtfcHk0lhrAKvN8X2agQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFSjt73M&md5=86899e97b217b978902e837491f422d6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2014.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2014.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DCarrithers%26aufirst%3DM.%2BD.%26atitle%3DUpdate%2520on%2520disease-modifying%2520treatments%2520for%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Ther.%26date%3D2014%26volume%3D36%26spage%3D1938%26epage%3D1945%26doi%3D10.1016%2Fj.clinthera.2014.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dendrou, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese, M. A.</span></span> <span> </span><span class="NLM_article-title">Immunopathology of multiple sclerosis</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/nri3871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnri3871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26250739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12gurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=545-558&author=C.+A.+Dendrouauthor=L.+Fuggerauthor=M.+A.+Friese&title=Immunopathology+of+multiple+sclerosis&doi=10.1038%2Fnri3871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunopathology of multiple sclerosis</span></div><div class="casAuthors">Dendrou, Calliope A.; Fugger, Lars; Friese, Manuel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">545-558</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two decades of clin. experience with immunomodulatory treatments for multiple sclerosis point to distinct immunol. pathways that drive disease relapses and progression.  In light of this, we discuss our current understanding of multiple sclerosis immunopathol., evaluate long-standing hypotheses regarding the role of the immune system in the disease and delineate key questions that are still unanswered.  Recent and anticipated advances in the field of immunol., and the increasing recognition of inflammation as an important component of neurodegeneration, are shaping our conceptualization of disease pathophysiol., and we explore the potential implications for improved healthcare provision to patients in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfbvqTYZdO37Vg90H21EOLACvtfcHk0lhrAKvN8X2agQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12gurvE&md5=928ac7775883ce6c78c169c13979eacf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnri3871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3871%26sid%3Dliteratum%253Aachs%26aulast%3DDendrou%26aufirst%3DC.%2BA.%26aulast%3DFugger%26aufirst%3DL.%26aulast%3DFriese%26aufirst%3DM.%2BA.%26atitle%3DImmunopathology%2520of%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D545%26epage%3D558%26doi%3D10.1038%2Fnri3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-X.</span></span> <span> </span><span class="NLM_article-title">Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2014.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.imlet.2014.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2014&pages=17&author=Z.+Jiangauthor=J.+X.+Jiangauthor=G.-X.+Zhang&title=Macrophages%3A+a+double-edged+sword+in+experimental+autoimmune+encephalomyelitis&doi=10.1016%2Fj.imlet.2014.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DZhang%26aufirst%3DG.-X.%26atitle%3DMacrophages%253A%2520a%2520double-edged%2520sword%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DImmunol.%2520Lett.%26date%3D2014%26volume%3D160%26spage%3D17%26doi%3D10.1016%2Fj.imlet.2014.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Icyuz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">miR-125a-5p regulates differential activation of macrophages and inflammation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">35428</span>– <span class="NLM_lpage">35436</span>, <span class="refDoi"> DOI: 10.1074/jbc.m112.426866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1074%2Fjbc.m112.426866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=35428-35436&author=S.+Banerjeeauthor=H.+Cuiauthor=N.+Xieauthor=Z.+Tanauthor=S.+Yangauthor=M.+Icyuzauthor=V.+J.+Thannickalauthor=E.+Abrahamauthor=G.+Liu&title=miR-125a-5p+regulates+differential+activation+of+macrophages+and+inflammation&doi=10.1074%2Fjbc.m112.426866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m112.426866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m112.426866%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DN.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DIcyuz%26aufirst%3DM.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DAbraham%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DmiR-125a-5p%2520regulates%2520differential%2520activation%2520of%2520macrophages%2520and%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D35428%26epage%3D35436%26doi%3D10.1074%2Fjbc.m112.426866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natoli, G.</span></span> <span> </span><span class="NLM_article-title">Transcriptional regulation of macrophage polarization: enabling diversity with identity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/nri3088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnri3088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22025054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=750-761&author=T.+Lawrenceauthor=G.+Natoli&title=Transcriptional+regulation+of+macrophage+polarization%3A+enabling+diversity+with+identity&doi=10.1038%2Fnri3088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional regulation of macrophage polarization: enabling diversity with identity</span></div><div class="casAuthors">Lawrence, Toby; Natoli, Gioacchino</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">750-761</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In terms of both phenotype and function, macrophages have remarkable heterogeneity, which reflects the specialization of tissue-resident macrophages in microenvironments as different as liver, brain and bone.  Also, marked changes in the activity and gene expression programs of macrophages can occur when they come into contact with invading microorganisms or injured tissues.  Therefore, the macrophage lineage includes a remarkable diversity of cells with different functions and functional states that are specified by a complex interplay between microenvironmental signals and a hardwired differentiation program that dets. macrophage identity.  In this Review, the authors summarize the current knowledge of transcriptional and chromatin-mediated control of macrophage polarization in physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVPgvAtgoULrVg90H21EOLACvtfcHk0ljFbrwwVAAYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7vF&md5=6443d41bf1a43f96f5a29d14d83a7979</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnri3088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3088%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DT.%26aulast%3DNatoli%26aufirst%3DG.%26atitle%3DTranscriptional%2520regulation%2520of%2520macrophage%2520polarization%253A%2520enabling%2520diversity%2520with%2520identity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2011%26volume%3D11%26spage%3D750%26epage%3D761%26doi%3D10.1038%2Fnri3088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawji, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">The benefits and detriments of macrophages/microglia in models of multiple sclerosis</span>. <i>Clin. Dev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">948976</span>, <span class="refDoi"> DOI: 10.1155/2013/948976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1155%2F2013%2F948976" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=948976&author=K.+S.+Rawjiauthor=V.+W.+Yong&title=The+benefits+and+detriments+of+macrophages%2Fmicroglia+in+models+of+multiple+sclerosis&doi=10.1155%2F2013%2F948976"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1155%2F2013%2F948976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F948976%26sid%3Dliteratum%253Aachs%26aulast%3DRawji%26aufirst%3DK.%2BS.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DThe%2520benefits%2520and%2520detriments%2520of%2520macrophages%252Fmicroglia%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2013%26volume%3D2013%26spage%3D948976%26doi%3D10.1155%2F2013%2F948976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helming, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span> <span> </span><span class="NLM_article-title">Alternative activation of macrophages: an immunologic functional perspective</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">451</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1146%2Fannurev.immunol.021908.132532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=19105661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=451&author=F.+O.+Martinezauthor=L.+Helmingauthor=S.+Gordon&title=Alternative+activation+of+macrophages%3A+an+immunologic+functional+perspective&doi=10.1146%2Fannurev.immunol.021908.132532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative activation of macrophages: an immunologic functional perspective</span></div><div class="casAuthors">Martinez, Fernando O.; Helming, Laura; Gordon, Siamon</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">451-483</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Macrophages are innate immune cells with well-established roles in the primary response to pathogens, but also in tissue homeostasis, coordination of the adaptive immune response, inflammation, resoln., and repair.  These cells recognize danger signals through receptors capable of inducing specialized activation programs.  The classically known macrophage activation is induced by IFN-γ, which triggers a harsh proinflammatory response that is required to kill intracellular pathogens.  Macrophages also undergo alternative activation by IL-4 and IL-13, which trigger a different phenotype that is important for the immune response to parasites.  Here the authors review the cellular sources of these cytokines, receptor signaling pathways, and induced markers and gene signatures.  The authors draw attention to discrepancies found between mouse and human models of alternative activation.  The evidence for in vivo alternative activation of macrophages is also analyzed, with nematode infection as prototypic disease.  Finally, the authors revisit the concept of macrophage activation in the context of the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox_SbgbsE_ZLVg90H21EOLACvtfcHk0ljFbrwwVAAYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrk%253D&md5=f3fa9ce9796eb4cee37bc7c5f9d86a2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132532%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DF.%2BO.%26aulast%3DHelming%26aufirst%3DL.%26aulast%3DGordon%26aufirst%3DS.%26atitle%3DAlternative%2520activation%2520of%2520macrophages%253A%2520an%2520immunologic%2520functional%2520perspective%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D451%26doi%3D10.1146%2Fannurev.immunol.021908.132532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Nun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushansky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamoorthy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liblau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohlfeld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wekerle, H.</span></span> <span> </span><span class="NLM_article-title">From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2014.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.jaut.2014.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=25175979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2nsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=33-50&author=A.+Ben-Nunauthor=N.+Kaushanskyauthor=N.+Kawakamiauthor=G.+Krishnamoorthyauthor=K.+Bererauthor=R.+Liblauauthor=R.+Hohlfeldauthor=H.+Wekerle&title=From+classic+to+spontaneous+and+humanized+models+of+multiple+sclerosis%3A+impact+on+understanding+pathogenesis+and+drug+development&doi=10.1016%2Fj.jaut.2014.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development</span></div><div class="casAuthors">Ben-Nun, Avraham; Kaushansky, Nathali; Kawakami, Naoto; Krishnamoorthy, Gurumoorthy; Berer, Kerstin; Liblau, Roland; Hohlfeld, Reinhard; Wekerle, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-50</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS), a demyelinating disease of the central nervous system (CNS), presents as a complex disease with variable clin. and pathol. manifestations, involving different pathogenic pathways.  Animal models, particularly exptl. autoimmune encephalomyelitis (EAE), have been key to deciphering the pathophysiol. of MS, although no single model can recapitulate the complexity and diversity of MS, or can, to date, integrate the diverse pathogenic pathways.  Since the first EAE model was introduced decades ago, multiple classic (induced), spontaneous, and humanized EAE models have been developed, each recapitulating particular aspects of MS pathogenesis.  The advances in technologies of genetic ablation and transgenesis in mice of C57BL/6J background and the development of myelin-oligodendrocyte glycoprotein (MOG)-induced EAE in C57BL/6J mice yielded several spontaneous and humanized EAE models, and resulted in a plethora of EAE models in which the role of specific genes or cell populations could be precisely interrogated, towards modeling specific pathways of MS pathogenesis/regulation in MS.  Collectively, the numerous studies on the different EAE models contributed immensely to our basic understanding of cellular and mol. pathways in MS pathogenesis as well as to the development of therapeutic agents: several drugs available today as disease modifying treatments were developed from direct studies on EAE models, and many others were tested or validated in EAE.  In this review, we discuss the contribution of major classic, spontaneous, and humanized EAE models to our understanding of MS pathophysiol. and to insights leading to devising current and future therapies for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRat10EU9_RLVg90H21EOLACvtfcHk0ljFbrwwVAAYQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2nsbbO&md5=172f38a5831cbb2564f73fc431b5ec94</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2014.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2014.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Nun%26aufirst%3DA.%26aulast%3DKaushansky%26aufirst%3DN.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKrishnamoorthy%26aufirst%3DG.%26aulast%3DBerer%26aufirst%3DK.%26aulast%3DLiblau%26aufirst%3DR.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DWekerle%26aufirst%3DH.%26atitle%3DFrom%2520classic%2520to%2520spontaneous%2520and%2520humanized%2520models%2520of%2520multiple%2520sclerosis%253A%2520impact%2520on%2520understanding%2520pathogenesis%2520and%2520drug%2520development%26jtitle%3DJ.%2520Autoimmun.%26date%3D2014%26volume%3D54%26spage%3D33%26epage%3D50%26doi%3D10.1016%2Fj.jaut.2014.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abourbeh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brulon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontyn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavitian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisgard, R.</span></span> <span> </span><span class="NLM_article-title">Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">5728</span>– <span class="NLM_lpage">5736</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.2900-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1523%2Fjneurosci.2900-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22539835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslOiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=5728-5736&author=G.+Abourbehauthor=B.+Thezeauthor=R.+Maroyauthor=A.+Duboisauthor=V.+Brulonauthor=Y.+Fontynauthor=F.+Dolleauthor=B.+Tavitianauthor=R.+Boisgard&title=Imaging+Microglial%2FMacrophage+Activation+in+Spinal+Cords+of+Experimental+Autoimmune+Encephalomyelitis+Rats+by+Positron+Emission+Tomography+Using+the+Mitochondrial+18+kDa+Translocator+Protein+Radioligand+%5B18F%5DDPA-714&doi=10.1523%2Fjneurosci.2900-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [18F]DPA-714</span></div><div class="casAuthors">Abourbeh, Galith; Theze, Benoit; Maroy, Renaud; Dubois, Albertine; Brulon, Vincent; Fontyn, Yoann; Dolle, Frederic; Tavitian, Bertrand; Boisgard, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5728-5736</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS.  Activated microglia/macrophages play a key role in the immunopathogenesis of MS and its corresponding animal models, exptl. autoimmune encephalomyelitis (EAE).  Microglia activation begins at early stages of the disease and is assocd. with elevated expression of the 18 kDa mitochondrial translocator protein (TSPO).  Thus, positron emission tomog. (PET) imaging of microglial activation using TSPO-specific radioligands could be valuable for monitoring disease-assocd. neuroinflammatory processes.  EAE was induced in rats using a fragment of myelin basic protein, yielding acute clin. disease that reflects extensive spinal cord inflammation.  Enhanced TSPO expression in spinal cords of EAE rats vs. those of controls was confirmed by Western blot and immunohistochem.  Biodistribution studies in control and EAE rats were performed using the TSPO radioligand [18F]DPA-714 [N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide].  At 1 h after injection, almost fivefold higher levels of [18F]DPA-714 were measured in spinal cords of EAE rats vs. controls.  The specific binding of [18F]DPA-714 to TSPO in spinal cords was confirmed in competition studies, using unlabeled (R,S)-PK11195 ((R,S)-N-methyl-N-(1-methylpropyl)-1-(2-chlorophenyl)isoquinoline-3-carboxamide) or DPA-714 in excess.  MicroPET studies affirm that this differential radioactivity uptake in spinal cords of EAE vs. control rats could be detected and quantified.  Using [18F]DPA-714, neuroinflammation in spinal cords of EAE-induced rats could be visualized by PET, offering a sensitive technique for monitoring neuroinflammatory lesions in the CNS and particularly in the spinal cord.  In addn. to current MRI protocols, this approach could provide mol. images of neuroinflammation for detection, monitoring, and research in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd4IwlSovCSbVg90H21EOLACvtfcHk0ljleeSmrBUedw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslOiu74%253D&md5=4abe5bd7407ccb6e39469c869e5cfc7b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.2900-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.2900-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DAbourbeh%26aufirst%3DG.%26aulast%3DTheze%26aufirst%3DB.%26aulast%3DMaroy%26aufirst%3DR.%26aulast%3DDubois%26aufirst%3DA.%26aulast%3DBrulon%26aufirst%3DV.%26aulast%3DFontyn%26aufirst%3DY.%26aulast%3DDolle%26aufirst%3DF.%26aulast%3DTavitian%26aufirst%3DB.%26aulast%3DBoisgard%26aufirst%3DR.%26atitle%3DImaging%2520Microglial%252FMacrophage%2520Activation%2520in%2520Spinal%2520Cords%2520of%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520Rats%2520by%2520Positron%2520Emission%2520Tomography%2520Using%2520the%2520Mitochondrial%252018%2520kDa%2520Translocator%2520Protein%2520Radioligand%2520%255B18F%255DDPA-714%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D5728%26epage%3D5736%26doi%3D10.1523%2Fjneurosci.2900-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawji, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">The benefits and detriments of macrophages/microglia in models of multiple sclerosis</span>. <i>Clin. Dev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">948976</span>, <span class="refDoi"> DOI: 10.1155/2013/948976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1155%2F2013%2F948976" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=948976&author=K.+S.+Rawjiauthor=V.+W.+Yong&title=The+benefits+and+detriments+of+macrophages%2Fmicroglia+in+models+of+multiple+sclerosis&doi=10.1155%2F2013%2F948976"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2013%2F948976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F948976%26sid%3Dliteratum%253Aachs%26aulast%3DRawji%26aufirst%3DK.%2BS.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DThe%2520benefits%2520and%2520detriments%2520of%2520macrophages%252Fmicroglia%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2013%26volume%3D2013%26spage%3D948976%26doi%3D10.1155%2F2013%2F948976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span> <span> </span><span class="NLM_article-title">Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">507</span>, <span class="refDoi"> DOI: 10.1189/jlb.3a0116-028rr</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1189%2Fjlb.3a0116-028rr" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27443879" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=507&author=Y.+Xuauthor=Z.+Heauthor=Z.+Liauthor=S.+Fangauthor=Y.+Zhangauthor=C.+Wanauthor=Y.+Maauthor=P.+Linauthor=C.+Liuauthor=G.+Wangauthor=R.+Liauthor=J.+Zhuauthor=Y.+Liauthor=L.+Muauthor=Y.+Zhangauthor=J.+Wangauthor=Q.+Kongauthor=H.+Liauthor=B.+Sun&title=Irgm1+is+required+for+the+inflammatory+function+of+M1+macrophage+in+early+experimental+autoimmune+encephalomyelitis&doi=10.1189%2Fjlb.3a0116-028rr"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3a0116-028rr&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3a0116-028rr%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DB.%26atitle%3DIrgm1%2520is%2520required%2520for%2520the%2520inflammatory%2520function%2520of%2520M1%2520macrophage%2520in%2520early%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2016%26volume%3D101%26spage%3D507%26doi%3D10.1189%2Fjlb.3a0116-028rr" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kigerl, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gensel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankeny, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovich, P. G.</span></span> <span> </span><span class="NLM_article-title">Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">13435</span>– <span class="NLM_lpage">13444</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3257-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1523%2FJNEUROSCI.3257-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=19864556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=13435-13444&author=K.+A.+Kigerlauthor=J.+C.+Genselauthor=D.+P.+Ankenyauthor=J.+K.+Alexanderauthor=D.+J.+Donnellyauthor=P.+G.+Popovich&title=Identification+of+two+distinct+macrophage+subsets+with+divergent+effects+causing+either+neurotoxicity+or+regeneration+in+the+injured+mouse+spinal+cord&doi=10.1523%2Fjneurosci.3257-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord</span></div><div class="casAuthors">Kigerl, Kristina A.; Gensel, John C.; Ankeny, Daniel P.; Alexander, Jessica K.; Donnelly, Dustin J.; Popovich, Phillip G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">13435-13444</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Macrophages dominate sites of CNS injury in which they promote both injury and repair.  These divergent effects may be caused by distinct macrophage subsets, i.e., "classically activated" proinflammatory (M1) or "alternatively activated" anti-inflammatory (M2) cells.  Here, the authors show that an M1 macrophage response is rapidly induced and then maintained at sites of traumatic spinal cord injury and that this response overwhelms a comparatively smaller and transient M2 macrophage response.  The high M1/M2 macrophage ratio has significant implications for CNS repair.  Indeed, the authors present novel data showing that only M1 macrophages are neurotoxic and M2 macrophages promote a regenerative growth response in adult sensory axons, even in the context of inhibitory substrates that dominate sites of CNS injury (e.g., proteoglycans and myelin).  Together, these data suggest that polarizing the differentiation of resident microglia and infiltrating blood monocytes toward an M2 or "alternatively" activated macrophage phenotype could promote CNS repair while limiting secondary inflammatory-mediated injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdAcBQ_zl-ObVg90H21EOLACvtfcHk0ljleeSmrBUedw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmtrnJ&md5=f4af0c8ede9ec37bf14176994b8090fe</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3257-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3257-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DKigerl%26aufirst%3DK.%2BA.%26aulast%3DGensel%26aufirst%3DJ.%2BC.%26aulast%3DAnkeny%26aufirst%3DD.%2BP.%26aulast%3DAlexander%26aufirst%3DJ.%2BK.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DPopovich%26aufirst%3DP.%2BG.%26atitle%3DIdentification%2520of%2520two%2520distinct%2520macrophage%2520subsets%2520with%2520divergent%2520effects%2520causing%2520either%2520neurotoxicity%2520or%2520regeneration%2520in%2520the%2520injured%2520mouse%2520spinal%2520cord%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D13435%26epage%3D13444%26doi%3D10.1523%2Fjneurosci.3257-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschborn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freise, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engbers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meuth, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, L.</span></span> <span> </span><span class="NLM_article-title">Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2015.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.jaut.2015.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26584738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVKmsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=90-101&author=S.+Huckeauthor=M.+Eschbornauthor=M.+Liebmannauthor=M.+Heroldauthor=N.+Freiseauthor=A.+Engbersauthor=P.+Ehlingauthor=S.+G.+Meuthauthor=J.+Rothauthor=T.+Kuhlmannauthor=H.+Wiendlauthor=L.+Klotz&title=Sodium+chloride+promotes+pro-inflammatory+macrophage+polarization+thereby+aggravating+CNS+autoimmunity&doi=10.1016%2Fj.jaut.2015.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity</span></div><div class="casAuthors">Hucke, Stephanie; Eschborn, Melanie; Liebmann, Marie; Herold, Martin; Freise, Nicole; Engbers, Annika; Ehling, Petra; Meuth, Sven G.; Roth, Johannes; Kuhlmann, Tanja; Wiendl, Heinz; Klotz, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90-101</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The increasing incidence in Multiple Sclerosis (MS) during the last decades in industrialized countries might be linked to a change in dietary habits.  Nowadays, enhanced salt content is an important characteristic of Western diet and increased dietary salt (NaCl) intake promotes pathogenic T cell responses contributing to central nervous system (CNS) autoimmunity.  Given the importance of macrophage responses for CNS disease propagation, we addressed the influence of salt consumption on macrophage responses in CNS autoimmunity.  We obsd. that EAE-diseased mice receiving a NaCl-high diet showed strongly enhanced macrophage infiltration and activation within the CNS accompanied by disease aggravation during the effector phase of EAE.  NaCl treatment of macrophages elicited a strong pro-inflammatory phenotype characterized by enhanced pro-inflammatory cytokine prodn., increased expression of immune-stimulatory mols., and an antigen-independent boost of T cell proliferation.  This NaCl-induced pro-inflammatory macrophage phenotype was accompanied by increased activation of NF-κB and MAPK signaling pathways.  The pathogenic relevance of NaCl-conditioned macrophages is illustrated by the finding that transfer into EAE-diseased animals resulted in significant disease aggravation compared to untreated macrophages.  Importantly, also in human monocytes, NaCl promoted a pro-inflammatory phenotype that enhanced human T cell proliferation.  Taken together, high dietary salt intake promotes pro-inflammatory macrophages that aggravate CNS autoimmunity.  Together with other studies, these results underline the need to further det. the relevance of increased dietary salt intake for MS disease severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnzqByzdvFnrVg90H21EOLACvtfcHk0ljbCXGXyiIl2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVKmsb3P&md5=23cd922d25435637f9f3ba847a65b157</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2015.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2015.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DHucke%26aufirst%3DS.%26aulast%3DEschborn%26aufirst%3DM.%26aulast%3DLiebmann%26aufirst%3DM.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DFreise%26aufirst%3DN.%26aulast%3DEngbers%26aufirst%3DA.%26aulast%3DEhling%26aufirst%3DP.%26aulast%3DMeuth%26aufirst%3DS.%2BG.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DKuhlmann%26aufirst%3DT.%26aulast%3DWiendl%26aufirst%3DH.%26aulast%3DKlotz%26aufirst%3DL.%26atitle%3DSodium%2520chloride%2520promotes%2520pro-inflammatory%2520macrophage%2520polarization%2520thereby%2520aggravating%2520CNS%2520autoimmunity%26jtitle%3DJ.%2520Autoimmun.%26date%3D2016%26volume%3D67%26spage%3D90%26epage%3D101%26doi%3D10.1016%2Fj.jaut.2015.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coull, J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beggs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudreau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Koninck, Y.</span></span> <span> </span><span class="NLM_article-title">BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>438</i></span>,  <span class="NLM_fpage">1017</span>, <span class="refDoi"> DOI: 10.1038/nature04223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnature04223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=16355225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=1017&author=J.+A.+M.+Coullauthor=S.+Beggsauthor=D.+Boudreauauthor=D.+Boivinauthor=M.+Tsudaauthor=K.+Inoueauthor=C.+Gravelauthor=M.+W.+Salterauthor=Y.+De+Koninck&title=BDNF+from+microglia+causes+the+shift+in+neuronal+anion+gradient+underlying+neuropathic+pain&doi=10.1038%2Fnature04223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain</span></div><div class="casAuthors">Coull, Jeffrey A. M.; Beggs, Simon; Boudreau, Dominic; Boivin, Dominick; Tsuda, Makoto; Inoue, Kazuhide; Gravel, Claude; Salter, Michael W.; De Koninck, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">7070</span>),
    <span class="NLM_cas:pages">1017-1021</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuropathic pain that occurs after peripheral nerve injury depends on the hyper-excitability of neurons in the dorsal horn of the spinal cord.  Spinal microglia stimulated by ATP contribute to tactile allodynia, a highly debilitating symptom of pain induced by nerve injury.  Signaling between microglia and neurons is therefore an essential link in neuropathic pain transmission, but how this signaling occurs is unknown.  Here we show that ATP-stimulated microglia cause a de-polarizing shift in the anion reversal potential (Eanion) in spinal lamina I neurons.  This shift inverts the polarity of currents activated by GABA (γ-amino butyric acid), as has been shown to occur after peripheral nerve injury.  Applying brain-derived neurotrophic factor (BDNF) mimics the alteration in Eanion.  Blocking signaling between BDNF and the receptor TrkB reverses the allodynia and the Eanion shift that follows both nerve injury and administration of ATP-stimulated microglia.  ATP stimulation evokes the release of BDNF from microglia.  Preventing BDNF release from microglia by pretreating them with interfering RNA directed against BDNF before ATP stimulation also inhibits the effects of these cells on the withdrawal threshold and Eanion.  Our results show that ATP-stimulated microglia signal to lamina I neurons, causing a collapse of their transmembrane anion gradient, and that BDNF is a crucial signaling mol. between microglia and neurons.  Blocking this microglia-neuron signaling pathway may represent a therapeutic strategy for treating neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4cwNgaNvCy7Vg90H21EOLACvtfcHk0ljbCXGXyiIl2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrvJ&md5=7e7187a8adc7be9929f94eafcb265a1f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature04223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04223%26sid%3Dliteratum%253Aachs%26aulast%3DCoull%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DBoudreau%26aufirst%3DD.%26aulast%3DBoivin%26aufirst%3DD.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DGravel%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26aulast%3DDe%2BKoninck%26aufirst%3DY.%26atitle%3DBDNF%2520from%2520microglia%2520causes%2520the%2520shift%2520in%2520neuronal%2520anion%2520gradient%2520underlying%2520neuropathic%2520pain%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D1017%26doi%3D10.1038%2Fnature04223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreyfus, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, I. B.</span></span> <span> </span><span class="NLM_article-title">Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1006/nbdi.2000.0318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1006%2Fnbdi.2000.0318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=11114257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslSms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=574-585&author=K.+D.+Doughertyauthor=C.+F.+Dreyfusauthor=I.+B.+Black&title=Brain-derived+neurotrophic+factor+in+astrocytes%2C+oligodendrocytes%2C+and+microglia%2Fmacrophages+after+spinal+cord+injury&doi=10.1006%2Fnbdi.2000.0318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-Derived Neurotrophic Factor in Astrocytes, Oligodendrocytes, and Microglia/Macrophages after Spinal Cord Injury</span></div><div class="casAuthors">Dougherty, Karen D.; Dreyfus, Cheryl F.; Black, Ira B.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">574-585</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Recent studies suggest that the injured adult spinal cord responds to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3) with enhanced neuron survival and axon regeneration.  Potential neurotrophin sources and cellular localization in spinal cord are largely undefined.  We examd. glial BDNF localization in normal cord and its temporospatial distribution after injury in vivo.  We used dual immunolabeling for BDNF and glial fibrillary acidic protein (GFAP) in astrocytes, adenomatous polyposis coli tumor suppressor protein (APC) for oligodendrocytes or type III CDH receptor (OX42) for microglia/macrophages.  In normal cord, small subsets of astrocytes and microglia/macrophages and most oligodendrocytes exhibited BDNF-immunoreactivity.  Following injury, the no. of BDNF-immunopos. astrocytes and microglia/macrophages increased dramatically at the injury site over time.  Most oligodendrocytes contained BDNF 1 day and 1 wk following injury, but APC-pos. cells were largely absent at the injury site 6 wk postinjury.  Glial BDNF-immunolabeling was also examd. 10 and 20 mm from the wound.  Ten millimeters from the lesion, astrocyte and microglia/macrophage BDNF-immunolabeling resembled that at the injury at all times examd.  Twenty millimeters from injury, BDNF localization in all three glial subtypes resembled controls, regardless of time postlesion.  Our findings suggest that in normal adult cord, astrocytes, oligodendrocytes, and microglia/macrophages play roles in local trophin availability and in trophin-mediated injury and healing responses directly within and surrounding the wound site.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofhzvUBvhkV7Vg90H21EOLACvtfcHk0lil38Yncba1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslSms7g%253D&md5=6be9bd5c0adbd6d214b1b04576af570b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.2000.0318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.2000.0318%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DK.%2BD.%26aulast%3DDreyfus%26aufirst%3DC.%2BF.%26aulast%3DBlack%26aufirst%3DI.%2BB.%26atitle%3DBrain-derived%2520neurotrophic%2520factor%2520in%2520astrocytes%252C%2520oligodendrocytes%252C%2520and%2520microglia%252Fmacrophages%2520after%2520spinal%2520cord%2520injury%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2000%26volume%3D7%26spage%3D574%26epage%3D585%26doi%3D10.1006%2Fnbdi.2000.0318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shechter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusimano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yovel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolls, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluchino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M.</span></span> <span> </span><span class="NLM_article-title">Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1000113</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.1000113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1371%2Fjournal.pmed.1000113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&author=R.+Shechterauthor=A.+Londonauthor=C.+Varolauthor=C.+Raposoauthor=M.+Cusimanoauthor=G.+Yovelauthor=A.+Rollsauthor=M.+Mackauthor=S.+Pluchinoauthor=G.+Martinoauthor=S.+Jungauthor=M.+Schwartz&title=Infiltrating+blood-derived+macrophages+are+vital+cells+playing+an+anti-inflammatory+role+in+recovery+from+spinal+cord+injury+in+mice&doi=10.1371%2Fjournal.pmed.1000113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.1000113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.1000113%26sid%3Dliteratum%253Aachs%26aulast%3DShechter%26aufirst%3DR.%26aulast%3DLondon%26aufirst%3DA.%26aulast%3DVarol%26aufirst%3DC.%26aulast%3DRaposo%26aufirst%3DC.%26aulast%3DCusimano%26aufirst%3DM.%26aulast%3DYovel%26aufirst%3DG.%26aulast%3DRolls%26aufirst%3DA.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DPluchino%26aufirst%3DS.%26aulast%3DMartino%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DM.%26atitle%3DInfiltrating%2520blood-derived%2520macrophages%2520are%2520vital%2520cells%2520playing%2520an%2520anti-inflammatory%2520role%2520in%2520recovery%2520from%2520spinal%2520cord%2520injury%2520in%2520mice%26jtitle%3DPLoS%2520Med.%26date%3D2009%26volume%3D6%26doi%3D10.1371%2Fjournal.pmed.1000113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schonberg, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahinkaya, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovich, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mctigue, D. M.</span></span> <span> </span><span class="NLM_article-title">Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">5374</span>– <span class="NLM_lpage">5384</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3517-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1523%2Fjneurosci.3517-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22514302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1akt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=5374-5384&author=D.+L.+Schonbergauthor=E.+Z.+Goldsteinauthor=F.+R.+Sahinkayaauthor=P.+Weiauthor=P.+G.+Popovichauthor=D.+M.+Mctigue&title=Ferritin+stimulates+oligodendrocyte+genesis+in+the+adult+spinal+cord+and+can+be+transferred+from+macrophages+to+NG2+cells+in+vivo&doi=10.1523%2Fjneurosci.3517-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo</span></div><div class="casAuthors">Schonberg, David L.; Goldstein, Evan Z.; Sahinkaya, Fatma Rezan; Wei, Ping; Popovich, Phillip G.; McTigue, Dana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5374-5384</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Injured CNS tissue often contains elevated iron and its storage protein ferritin, which may exacerbate tissue damage through pro-oxidative mechanisms.  Therefore, therapeutic studies often target iron redn. as a neuroprotective strategy.  However, iron may be crucial for oligodendrocyte replacement and remyelination.  For instance, we previously showed that intraspinal toll-like receptor 4 macrophage activation induced the generation of new ferritin-pos. oligodendrocytes, and that iron chelation significantly reduced this oligodendrogenic response.  Since macrophages can secrete ferritin, we hypothesize that ferritin is a macrophage-derived signal that promotes oligodendrogenesis.  To test this, we microinjected ferritin into intact adult rat spinal cords.  Within 6 h, NG2+ progenitor cells proliferated and accumulated ferritin.  By 3 d, many of these cells had differentiated into new oligodendrocytes.  However, acute neuron and oligodendrocyte toxicity occurred in gray matter.  Interestingly, ferritin-pos. NG2 cells and macrophages accumulated in the area of cell loss, revealing that NG2 cells thrive in an environment that is toxic to other CNS cells.  To test whether ferritin can be transferred from macrophages to NG2 cells in vivo, we loaded macrophages with fluorescent ferritin then transplanted them into intact spinal white matter.  Within 3-6 d, proliferating NG2 cells migrated into the macrophage transplants and accumulated fluorescently labeled ferritin.  These results show that activated macrophages can be an in vivo source of ferritin for NG2 cells, which induces their proliferation and differentiation into new oligodendrocytes.  This work has relevance for conditions in which iron-mediated injury and/or repair likely occur, such as hemorrhage, stroke, spinal cord injury, aging, Parkinson's disease, and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiiQR3QeD-kLVg90H21EOLACvtfcHk0lil38Yncba1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1akt78%253D&md5=a4325df8eb5514377e6c9d61d210e1a8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.3517-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.3517-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DSchonberg%26aufirst%3DD.%2BL.%26aulast%3DGoldstein%26aufirst%3DE.%2BZ.%26aulast%3DSahinkaya%26aufirst%3DF.%2BR.%26aulast%3DWei%26aufirst%3DP.%26aulast%3DPopovich%26aufirst%3DP.%2BG.%26aulast%3DMctigue%26aufirst%3DD.%2BM.%26atitle%3DFerritin%2520stimulates%2520oligodendrocyte%2520genesis%2520in%2520the%2520adult%2520spinal%2520cord%2520and%2520can%2520be%2520transferred%2520from%2520macrophages%2520to%2520NG2%2520cells%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D5374%26epage%3D5384%26doi%3D10.1523%2Fjneurosci.3517-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubourdieu-Cassagno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deloire, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canron, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franconi, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boiziau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petry, K. G.</span></span> <span> </span><span class="NLM_article-title">Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration</span>. <i>Mult. Scler. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1177/1352458510379243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1177%2F1352458510379243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=20813772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFWiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2-15&author=J.+Mikitaauthor=N.+Dubourdieu-Cassagnoauthor=M.+S.+Deloireauthor=A.+Vekrisauthor=M.+Biranauthor=G.+Raffardauthor=B.+Brochetauthor=M.-H.+Canronauthor=J.-M.+Franconiauthor=C.+Boiziauauthor=K.+G.+Petry&title=Altered+M1%2FM2+activation+patterns+of+monocytes+in+severe+relapsing+experimental+rat+model+of+multiple+sclerosis.+Amelioration+of+clinical+status+by+M2+activated+monocyte+administration&doi=10.1177%2F1352458510379243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration</span></div><div class="casAuthors">Mikita, Joanna; Dubourdieu-Cassagno, Nadege; Deloire, Mathilde S. A.; Vekris, Antoine; Biran, Marc; Raffard, Gerard; Brochet, Bruno; Canron, Marie-Helene; Franconi, Jean-Michel; Boiziau, Claudine; Petry, Klaus G.</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Sclerosis Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-15</span>CODEN:
                <span class="NLM_cas:coden">MSJUAP</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">We investigated proinflammatory M1 and immunomodulatory M2 activation profiles of circulating monocytes in relapsing exptl. autoimmune encephalomyelitis (EAE) model of multiple sclerosis, and tested whether altered M1/M2 equil. promotes CNS inflammation.  Approaches of MRI macrophage tracking with USPIO nanoparticles and expression patterns of M1/M2 macrophages and microglia in brain and M1/M2 monocytes in blood samples at various disease stages revealed that M1/M2 equil. in blood and CNS favors mild EAE, while imbalance towards M1 promotes relapsing EAE.  We consequently investigated whether M2 activated monocyte restoration in peripheral blood could cure acute clin. EAE disease.  Administration of ex vivo activated M2 monocytes both suppressed ongoing severe EAE and increased immunomodulatory expression pattern in lesions, confirming their role in the induction of recovery.  We conclude that imbalance of monocyte activation profiles and impaired M2 expression, are key factors in development of relapses.  Our study opens new perspectives for therapeutic applications in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfuJPvDvHx_LVg90H21EOLACvtfcHk0lg05P8OMxoZDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFWiu74%253D&md5=051e900a285e94c22121ce4955de190e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1177%2F1352458510379243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1352458510379243%26sid%3Dliteratum%253Aachs%26aulast%3DMikita%26aufirst%3DJ.%26aulast%3DDubourdieu-Cassagno%26aufirst%3DN.%26aulast%3DDeloire%26aufirst%3DM.%2BS.%26aulast%3DVekris%26aufirst%3DA.%26aulast%3DBiran%26aufirst%3DM.%26aulast%3DRaffard%26aufirst%3DG.%26aulast%3DBrochet%26aufirst%3DB.%26aulast%3DCanron%26aufirst%3DM.-H.%26aulast%3DFranconi%26aufirst%3DJ.-M.%26aulast%3DBoiziau%26aufirst%3DC.%26aulast%3DPetry%26aufirst%3DK.%2BG.%26atitle%3DAltered%2520M1%252FM2%2520activation%2520patterns%2520of%2520monocytes%2520in%2520severe%2520relapsing%2520experimental%2520rat%2520model%2520of%2520multiple%2520sclerosis.%2520Amelioration%2520of%2520clinical%2520status%2520by%2520M2%2520activated%2520monocyte%2520administration%26jtitle%3DMult.%2520Scler.%2520J.%26date%3D2011%26volume%3D17%26spage%3D2%26epage%3D15%26doi%3D10.1177%2F1352458510379243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prod’Homme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youssef, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rundle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patarroyo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stüve, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamvil, S. S.</span></span> <span> </span><span class="NLM_article-title">Type II monocytes modulate T cell-mediated central nervous system autoimmune disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1038/nm1620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnm1620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=17676050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos1Cjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=935-943&author=M.+S.+Weberauthor=T.+Prod%E2%80%99Hommeauthor=S.+Youssefauthor=S.+E.+Dunnauthor=C.+D.+Rundleauthor=L.+Leeauthor=J.+C.+Patarroyoauthor=O.+St%C3%BCveauthor=R.+A.+Sobelauthor=L.+Steinmanauthor=S.+S.+Zamvil&title=Type+II+monocytes+modulate+T+cell-mediated+central+nervous+system+autoimmune+disease&doi=10.1038%2Fnm1620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Type II monocytes modulate T cell-mediated central nervous system autoimmune disease</span></div><div class="casAuthors">Weber, Martin S.; Prod'homme, Thomas; Youssef, Sawsan; Dunn, Shannon E.; Rundle, Cynthia D.; Lee, Linda; Patarroyo, Juan C.; Stueve, Olaf; Sobel, Raymond A.; Steinman, Lawrence; Zamvil, Scott S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">935-943</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment with glatiramer acetate (GA, copolymer-1, Copaxone), a drug approved for multiple sclerosis (MS), in a mouse model promoted development of anti-inflammatory type II monocytes, characterized by increased secretion of interleukin (IL)-10 and transforming growth factor (TGF)-β, and decreased prodn. of IL-12 and tumor necrosis factor (TNF).  This anti-inflammatory cytokine shift was assocd. with reduced STAT-1 signaling.  Type II monocytes directed differentiation of TH2 cells and CD4+CD25+FoxP3+ regulatory T cells (Treg) independent of antigen specificity.  Type II monocyte-induced regulatory T cells specific for a foreign antigen ameliorated exptl. autoimmune encephalomyelitis (EAE), indicating that neither GA specificity nor recognition of self-antigen was required for their therapeutic effect.  Adoptive transfer of type II monocytes reversed EAE, suppressed TH17 cell development and promoted both TH2 differentiation and expansion of Treg cells in recipient mice.  This demonstration of adoptive immunotherapy by type II monocytes identifies a central role for these cells in T cell immune modulation of autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2iNL9F6Jpq7Vg90H21EOLACvtfcHk0lg05P8OMxoZDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos1Cjsbc%253D&md5=d128334f56d2cc67936cb109d20cc9ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnm1620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1620%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DM.%2BS.%26aulast%3DProd%25E2%2580%2599Homme%26aufirst%3DT.%26aulast%3DYoussef%26aufirst%3DS.%26aulast%3DDunn%26aufirst%3DS.%2BE.%26aulast%3DRundle%26aufirst%3DC.%2BD.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DPatarroyo%26aufirst%3DJ.%2BC.%26aulast%3DSt%25C3%25BCve%26aufirst%3DO.%26aulast%3DSobel%26aufirst%3DR.%2BA.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DZamvil%26aufirst%3DS.%2BS.%26atitle%3DType%2520II%2520monocytes%2520modulate%2520T%2520cell-mediated%2520central%2520nervous%2520system%2520autoimmune%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D935%26epage%3D943%26doi%3D10.1038%2Fnm1620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miron, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shadrach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Wijngaarden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ffrench-Constant, C.</span></span> <span> </span><span class="NLM_article-title">M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1038/nn.3469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnn.3469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=23872599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCjtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=1211-1218&author=V.+E.+Mironauthor=A.+Boydauthor=J.-W.+Zhaoauthor=T.+J.+Yuenauthor=J.+M.+Ruckhauthor=J.+L.+Shadrachauthor=P.+van+Wijngaardenauthor=A.+J.+Wagersauthor=A.+Williamsauthor=R.+J.+M.+Franklinauthor=C.+ffrench-Constant&title=M2+microglia+and+macrophages+drive+oligodendrocyte+differentiation+during+CNS+remyelination&doi=10.1038%2Fnn.3469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination</span></div><div class="casAuthors">Miron, Veronique E.; Boyd, Amanda; Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; Shadrach, Jennifer L.; van Wijngaarden, Peter; Wagers, Amy J.; Williams, Anna; Franklin, Robin J. M.; ffrench-Constant, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1211-1218</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The lack of therapies for progressive multiple sclerosis highlights the need to understand the regenerative process of remyelination that can follow CNS demyelination.  This involves an innate immune response consisting of microglia and macrophages, which can be polarized to distinct functional phenotypes: pro-inflammatory (M1) and anti-inflammatory or immunoregulatory (M2).  We found that a switch from an M1- to an M2-dominant response occurred in microglia and peripherally derived macrophages as remyelination started.  Oligodendrocyte differentiation was enhanced in vitro with M2 cell conditioned media and impaired in vivo following intra-lesional M2 cell depletion.  M2 cell densities were increased in lesions of aged mice in which remyelination was enhanced by parabiotic coupling to a younger mouse and in multiple sclerosis lesions that normally show remyelination.  Blocking M2 cell-derived activin-A inhibited oligodendrocyte differentiation during remyelination in cerebellar slice cultures.  Thus, our results indicate that M2 cell polarization is essential for efficient remyelination and identify activin-A as a therapeutic target for CNS regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1mjEZhQn3Y7Vg90H21EOLACvtfcHk0lg05P8OMxoZDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCjtL7E&md5=f9aea67a2f87eb20d7be5305c643c5b7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnn.3469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3469%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DBoyd%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DJ.-W.%26aulast%3DYuen%26aufirst%3DT.%2BJ.%26aulast%3DRuckh%26aufirst%3DJ.%2BM.%26aulast%3DShadrach%26aufirst%3DJ.%2BL.%26aulast%3Dvan%2BWijngaarden%26aufirst%3DP.%26aulast%3DWagers%26aufirst%3DA.%2BJ.%26aulast%3DWilliams%26aufirst%3DA.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26aulast%3Dffrench-Constant%26aufirst%3DC.%26atitle%3DM2%2520microglia%2520and%2520macrophages%2520drive%2520oligodendrocyte%2520differentiation%2520during%2520CNS%2520remyelination%26jtitle%3DNat.%2520Neurosci.%26date%3D2013%26volume%3D16%26spage%3D1211%26epage%3D1218%26doi%3D10.1038%2Fnn.3469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotter, M.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooijen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. J. M.</span></span> <span> </span><span class="NLM_article-title">Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2004.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.nbd.2004.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=15649707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=166-175&author=M.%0AR.+Kotterauthor=C.+Zhaoauthor=N.+van+Rooijenauthor=R.+J.+M.+Franklin&title=Macrophage-depletion+induced+impairment+of+experimental+CNS+remyelination+is+associated+with+a+reduced+oligodendrocyte+progenitor+cell+response+and+altered+growth+factor+expression&doi=10.1016%2Fj.nbd.2004.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage depletion-induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression</span></div><div class="casAuthors">Kotter, Mark R.; Zhao, Chao; van Rooijen, Nico; Franklin, Robin J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">166-175</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Although macrophages are mediators of CNS demyelination, they are also implicated in remyelination.  To examine the role of macrophages in CNS remyelination, adult rats were depleted of monocytes using clodronate liposomes and demyelination induced in the spinal cord white matter using lysolecithin.  In situ hybridization for scavenger receptor-B and myelin basic protein (MBP) revealed a transiently impaired macrophage response assocd. with delayed remyelination in liposome-treated animals.  Macrophage redn. corresponded with delayed recruitment of PDGFRα+ oligodendrocyte progenitor cells (OPCs), which preceded changes in myelin phagocytosis, indicating a macrophage effect on OPCs independent of myelin debris clearance.  Macrophage depletion-induced changes in the mRNA expression of insulin-like growth factor-1 and transforming growth factor β1, but not platelet-derived growth factor-A and fibroblast growth factor-2.  Thus, the macrophage response to toxin-induced demyelination influences the growth factor environment, thereby affecting the behavior of OPCs and hence the efficiency of remyelination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-WXcb8RIsqLVg90H21EOLACvtfcHk0lgcAW-hX-OG2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslOgtQ%253D%253D&md5=c4c544e09699e93b7c8082e2d9485aee</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2004.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2004.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DKotter%26aufirst%3DM.%2BR.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3Dvan%2BRooijen%26aufirst%3DN.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26atitle%3DMacrophage-depletion%2520induced%2520impairment%2520of%2520experimental%2520CNS%2520remyelination%2520is%2520associated%2520with%2520a%2520reduced%2520oligodendrocyte%2520progenitor%2520cell%2520response%2520and%2520altered%2520growth%2520factor%2520expression%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2005%26volume%3D18%26spage%3D166%26epage%3D175%26doi%3D10.1016%2Fj.nbd.2004.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miron, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. J. M.</span></span> <span> </span><span class="NLM_article-title">Macrophages and CNS remyelination</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1111/jnc.12705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1111%2Fjnc.12705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=24601941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2mu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=165-171&author=V.+E.+Mironauthor=R.+J.+M.+Franklin&title=Macrophages+and+CNS+remyelination&doi=10.1111%2Fjnc.12705"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophages and CNS remyelination</span></div><div class="casAuthors">Miron, Veronique E.; Franklin, Robin J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-171</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Microglia are the resident macrophages of the central nervous system that survey the microenvironment for signals of injury or infection.  The response to such signals induces an inflammatory response involving macrophages derived from both resident microglia and recruited circulating monocytes.  Although implicated as contributors to autoimmune-mediated injury, microglia/ macrophages have recently been shown to be crit. for the important central nervous system regenerative process of remyelination.  This functional dichotomy may reflect their ability to be polarized along a continuum of activation states including the well-characterized cytotoxic M1 and regenerative M2 phenotypes.  Here, we review the roles of microglia, monocytes and the macrophages which they give rise to in creating lesion environments favorable to remyelination, highlighting the specific roles of M1 and M2 phenotypes and how the pro-regenerative role of the innate immune system is altered by aging.  Here, we review the roles of microglia, monocytes and the macrophages, which they give rise to in creating lesion environments favorable to remyelination, highlighting the specific roles of activation phenotypes and how the pro-regenerative role of the innate immune system is altered by aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqzgWf932yJrVg90H21EOLACvtfcHk0lgcAW-hX-OG2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2mu7%252FP&md5=8d369e8d6051132ac63f8dab5059f677</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12705%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26atitle%3DMacrophages%2520and%2520CNS%2520remyelination%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D165%26epage%3D171%26doi%3D10.1111%2Fjnc.12705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span>; <span class="NLM_string-name">Drowley, L.</span></span> <span> </span><span class="NLM_article-title">Phenotypic screening</span>.  <i>Annual Reports in Medicinal Chemistry</i>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">50</span>, pp  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">299</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=263-299&author=A.+T.+Plowright&author=L.+Drowley&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DPhenotypic%2520screening%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D2017%26volume%3D50%26spage%3D263%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warchal, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unciti-Broceta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, N. O.</span></span> <span> </span><span class="NLM_article-title">Next-generation phenotypic screening</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1331</span>– <span class="NLM_lpage">1347</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4155%2Ffmc-2016-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27357617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gitb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1331-1347&author=S.+J.+Warchalauthor=A.+Unciti-Brocetaauthor=N.+O.+Carragher&title=Next-generation+phenotypic+screening&doi=10.4155%2Ffmc-2016-0025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Next-generation phenotypic screening</span></div><div class="casAuthors">Warchal, Scott J.; Unciti-Broceta, Asier; Carragher, Neil O.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1331-1347</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Phenotypic drug discovery (PDD) strategies are defined by screening and selection of hit or lead compds. based on quantifiable phenotypic endpoints without prior knowledge of the drug target.  We outline the challenges assocd. with traditional phenotypic screening strategies and propose solns. and new opportunities to be gained by adopting modern PDD technologies.  We highlight both historical and recent examples of approved drugs and new drug candidates discovered by modern phenotypic screening.  Finally, we offer a prospective view of a new era of PDD underpinned by a wealth of technol. advances in the areas of in vitro model development, high-content imaging and image informatics, mechanism-of-action profiling and target deconvolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlMrsHccIf7Vg90H21EOLACvtfcHk0lgcAW-hX-OG2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gitb3L&md5=129d42ecd36bb0d636dcf78e4e0ba946</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0025%26sid%3Dliteratum%253Aachs%26aulast%3DWarchal%26aufirst%3DS.%2BJ.%26aulast%3DUnciti-Broceta%26aufirst%3DA.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26atitle%3DNext-generation%2520phenotypic%2520screening%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1331%26epage%3D1347%26doi%3D10.4155%2Ffmc-2016-0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span> <span> </span><span class="NLM_article-title">Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-0290-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fs41419-018-0290-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=29445144" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=251-263&author=Q.+Wengauthor=J.+Wangauthor=J.+Wangauthor=J.+Wangauthor=F.+Sattarauthor=Z.+Zhangauthor=J.+Zhengauthor=Z.+Xuauthor=M.+Zhaoauthor=X.+Liuauthor=L.+Yangauthor=G.+Haoauthor=L.+Fangauthor=Q.+R.+Luauthor=B.+Yangauthor=Q.+He&title=Lenalidomide+regulates+CNS+autoimmunity+by+promoting+M2+macrophages+polarization&doi=10.1038%2Fs41419-018-0290-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-0290-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-0290-x%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSattar%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DQ.%2BR.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DLenalidomide%2520regulates%2520CNS%2520autoimmunity%2520by%2520promoting%2520M2%2520macrophages%2520polarization%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2018%26volume%3D9%26spage%3D251%26epage%3D263%26doi%3D10.1038%2Fs41419-018-0290-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ying, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazer, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B. Y.</span></span> <span> </span><span class="NLM_article-title">Investigation of macrophage polarization using bone marrow derived macrophages</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>76</i></span>, <span class="NLM_elocation-id">e50323</span> <span class="refDoi"> DOI: 10.3791/50323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.3791%2F50323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&author=W.+Yingauthor=P.+S.+Cherukuauthor=F.+W.+Bazerauthor=S.+H.+Safeauthor=B.+Y.+Zhou&title=Investigation+of+macrophage+polarization+using+bone+marrow+derived+macrophages&doi=10.3791%2F50323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3791%2F50323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F50323%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DW.%26aulast%3DCheruku%26aufirst%3DP.%2BS.%26aulast%3DBazer%26aufirst%3DF.%2BW.%26aulast%3DSafe%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DB.%2BY.%26atitle%3DInvestigation%2520of%2520macrophage%2520polarization%2520using%2520bone%2520marrow%2520derived%2520macrophages%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2013%26volume%3D76%26doi%3D10.3791%2F50323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montalban, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero-Romero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandraratna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clanet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derfuss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazekas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havrdova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liblau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubetzki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmaj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sormani, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalheim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, F.</span></span> <span> </span><span class="NLM_article-title">ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis</span>. <i>Eur. J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1111/ene.13536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1111%2Fene.13536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=29352526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BC1MvisFOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=215-237&author=X.+Montalbanauthor=R.+Goldauthor=A.+J.+Thompsonauthor=S.+Otero-Romeroauthor=M.+P.+Amatoauthor=D.+Chandraratnaauthor=M.+Clanetauthor=G.+Comiauthor=T.+Derfussauthor=F.+Fazekasauthor=H.+P.+Hartungauthor=E.+Havrdovaauthor=B.+Hemmerauthor=L.+Kapposauthor=R.+Liblauauthor=C.+Lubetzkiauthor=E.+Marcusauthor=D.+H.+Millerauthor=T.+Olssonauthor=S.+Pillingauthor=K.+Selmajauthor=A.+Sivaauthor=P.+S.+Sorensenauthor=M.+P.+Sormaniauthor=C.+Thalheimauthor=H.+Wiendlauthor=F.+Zipp&title=ECTRIMS%2FEAN+guideline+on+the+pharmacological+treatment+of+people+with+multiple+sclerosis&doi=10.1111%2Fene.13536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis</span></div><div class="casAuthors">Montalban X; Otero-Romero S; Gold R; Thompson A J; Otero-Romero S; Amato M P; Chandraratna D; Clanet M; Comi G; Derfuss T; Fazekas F; Hartung H P; Havrdova E; Hemmer B; Hemmer B; Kappos L; Liblau R; Lubetzki C; Marcus E; Pilling S; Miller D H; Olsson T; Selmaj K; Siva A; Sorensen P S; Sormani M P; Thalheim C; Wiendl H; Zipp F</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-237</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Multiple sclerosis (MS) is a complex disease of the central nervous system.  As new drugs are becoming available, knowledge on diagnosis and treatment must continuously evolve.  There is therefore a need for a reference tool compiling current data on benefit and safety, to aid professionals in treatment decisions and use of resources across Europe.  The European Committee of Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have joined forces to meet this need.  The objective was to develop an evidence-based clinical practice guideline for the pharmacological treatment of people with MS to guide healthcare professionals in the decision-making process.  METHODS:  This guideline has been developed using the GRADE methodology and following the recently updated EAN recommendations for guideline development.  Clinical questions were formulated in PICO format (patient, intervention, comparator, outcome) and outcomes were prioritized according to their relevance to clinical practice.  An exhaustive literature search up to December 2016 was performed for each question and the evidence is presented narratively and, when possible, combined in a meta-analysis using a random-effects model.  The quality of evidence for each outcome was rated into four categories - very high, high, low and very low - according to the risk of bias.  GRADE evidence profiles were created using GRADEprofiler (GRADEpro) software (Version 3.6).  The recommendations with assigned strength (strong, weak) were formulated based on the quality of evidence and the risk-benefit balance.  Consensus between the panellists was reached by use of the modified nominal group technique.  RESULTS:  A total of 10 questions have been agreed, encompassing treatment efficacy, response criteria, strategies to address suboptimal response and safety concerns and treatment strategies in MS and pregnancy.  The guideline takes into account all disease-modifying drugs approved by the European Medicine Agency at the time of publication.  A total of 20 recommendations were agreed by the guideline working group members after three rounds of consensus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMt1B7Ade6MY3yKPtYViAGfW6udTcc2ebh22Yec8gwVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvisFOmsQ%253D%253D&md5=f72465d89cfdf294d80b4212798cf0b4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fene.13536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fene.13536%26sid%3Dliteratum%253Aachs%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DGold%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DOtero-Romero%26aufirst%3DS.%26aulast%3DAmato%26aufirst%3DM.%2BP.%26aulast%3DChandraratna%26aufirst%3DD.%26aulast%3DClanet%26aufirst%3DM.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DDerfuss%26aufirst%3DT.%26aulast%3DFazekas%26aufirst%3DF.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26aulast%3DHavrdova%26aufirst%3DE.%26aulast%3DHemmer%26aufirst%3DB.%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DLiblau%26aufirst%3DR.%26aulast%3DLubetzki%26aufirst%3DC.%26aulast%3DMarcus%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DOlsson%26aufirst%3DT.%26aulast%3DPilling%26aufirst%3DS.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DSiva%26aufirst%3DA.%26aulast%3DSorensen%26aufirst%3DP.%2BS.%26aulast%3DSormani%26aufirst%3DM.%2BP.%26aulast%3DThalheim%26aufirst%3DC.%26aulast%3DWiendl%26aufirst%3DH.%26aulast%3DZipp%26aufirst%3DF.%26atitle%3DECTRIMS%252FEAN%2520guideline%2520on%2520the%2520pharmacological%2520treatment%2520of%2520people%2520with%2520multiple%2520sclerosis%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2018%26volume%3D25%26spage%3D215%26epage%3D237%26doi%3D10.1111%2Fene.13536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Brandt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tischner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuckermann, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luhder, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichardt, H. M.</span></span> <span> </span><span class="NLM_article-title">Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">8434</span>– <span class="NLM_lpage">8443</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.180.12.8434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.180.12.8434" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=8434-8443&author=S.+Wustauthor=J.+van+den+Brandtauthor=D.+Tischnerauthor=A.+Kleimanauthor=J.+P.+Tuckermannauthor=R.+Goldauthor=F.+Luhderauthor=H.+M.+Reichardt&title=Peripheral+T+cells+are+the+therapeutic+targets+of+glucocorticoids+in+experimental+autoimmune+encephalomyelitis&doi=10.4049%2Fjimmunol.180.12.8434"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.180.12.8434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.180.12.8434%26sid%3Dliteratum%253Aachs%26aulast%3DWust%26aufirst%3DS.%26aulast%3Dvan%2Bden%2BBrandt%26aufirst%3DJ.%26aulast%3DTischner%26aufirst%3DD.%26aulast%3DKleiman%26aufirst%3DA.%26aulast%3DTuckermann%26aufirst%3DJ.%2BP.%26aulast%3DGold%26aufirst%3DR.%26aulast%3DLuhder%26aufirst%3DF.%26aulast%3DReichardt%26aufirst%3DH.%2BM.%26atitle%3DPeripheral%2520T%2520cells%2520are%2520the%2520therapeutic%2520targets%2520of%2520glucocorticoids%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D8434%26epage%3D8443%26doi%3D10.4049%2Fjimmunol.180.12.8434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-X.</span></span> <span> </span><span class="NLM_article-title">Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2014.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.imlet.2014.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2014&pages=17-22&author=Z.+Jiangauthor=J.+X.+Jiangauthor=G.-X.+Zhang&title=Macrophages%3A+A+double-edged+sword+in+experimental+autoimmune+encephalomyelitis&doi=10.1016%2Fj.imlet.2014.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DZhang%26aufirst%3DG.-X.%26atitle%3DMacrophages%253A%2520A%2520double-edged%2520sword%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DImmunol.%2520Lett.%26date%3D2014%26volume%3D160%26spage%3D17%26epage%3D22%26doi%3D10.1016%2Fj.imlet.2014.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, N. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of macrophage, dendritic cell, and microglial phenotype and function by the SOCS proteins</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2015.00549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.3389%2Ffimmu.2015.00549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26579124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVSjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=549-567&author=S.+M.+McCormickauthor=N.+M.+Heller&title=Regulation+of+macrophage%2C+dendritic+cell%2C+and+microglial+phenotype+and+function+by+the+SOCS+proteins&doi=10.3389%2Ffimmu.2015.00549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of macrophage, dendritic cell, and microglial phenotype and function by the SOCS proteins</span></div><div class="casAuthors">McCormick, Sarah M.; Heller, Nicola M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">549/1-549/19</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Macrophages are innate immune cells of dynamic phenotype that rapidly respond to external stimuli in the microenvironment by altering their phenotype to respond to and to direct the immune response.  The ability to dynamically change phenotype must be carefully regulated to prevent uncontrolled inflammatory responses and subsequently to promote resoln. of inflammation.  The suppressor of cytokine signaling (SOCS) proteins play a key role in regulating macrophage phenotype.  In this review, we summarize research to date from mouse and human studies on the role of the SOCS proteins in detg. the phenotype and function of macrophages.  We will also touch on the influence of the SOCS on dendritic cell (DC) and microglial phenotype and function.  The mol. mechanisms of SOCS function in macrophages and DCs are discussed, along with how dysregulation of SOCS expression or function can lead to alterations in macrophage/DC/microglial phenotype and function and to disease.  Regulation of SOCS expression by microRNA is discussed.  Novel therapies and unanswered questions with regard to SOCS regulation of monocyte-macrophage phenotype and function are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbx8YAlehZOLVg90H21EOLACvtfcHk0ligmyxKmBfhyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVSjsr4%253D&md5=8daa9ee8c8e976eed2b24d82516ee02e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00549%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormick%26aufirst%3DS.%2BM.%26aulast%3DHeller%26aufirst%3DN.%2BM.%26atitle%3DRegulation%2520of%2520macrophage%252C%2520dendritic%2520cell%252C%2520and%2520microglial%2520phenotype%2520and%2520function%2520by%2520the%2520SOCS%2520proteins%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D549%26epage%3D567%26doi%3D10.3389%2Ffimmu.2015.00549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutschman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, P. J.</span></span> <span> </span><span class="NLM_article-title">Shaping gene expression in activated and resting primary macrophages by IL-10</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">2253</span>– <span class="NLM_lpage">2263</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.169.5.2253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.169.5.2253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=2253-2263&author=R.+Langauthor=D.+Patelauthor=J.+J.+Morrisauthor=R.+L.+Rutschmanauthor=P.+J.+Murray&title=Shaping+gene+expression+in+activated+and+resting+primary+macrophages+by+IL-10&doi=10.4049%2Fjimmunol.169.5.2253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.169.5.2253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.169.5.2253%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DJ.%2BJ.%26aulast%3DRutschman%26aufirst%3DR.%2BL.%26aulast%3DMurray%26aufirst%3DP.%2BJ.%26atitle%3DShaping%2520gene%2520expression%2520in%2520activated%2520and%2520resting%2520primary%2520macrophages%2520by%2520IL-10%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D2253%26epage%3D2263%26doi%3D10.4049%2Fjimmunol.169.5.2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Macrophage plasticity and polarization: in vivo veritas</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1172/jci59643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1172%2FJCI59643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22378047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsV2ms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=787-795&author=A.+Sicaauthor=A.+Mantovani&title=Macrophage+plasticity+and+polarization%3A+in+vivo+veritas&doi=10.1172%2Fjci59643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage plasticity and polarization: in vivo veritas</span></div><div class="casAuthors">Sica, Antonio; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Diversity and plasticity are hallmarks of cells of the monocyte-macrophage lineage.  In response to IFNs, Toll-like receptor engagement, or IL-4/IL-13 signaling, macrophages undergo M1 (classical) or M2 (alternative) activation, which represent extremes of a continuum in a universe of activation states.  Progress has now been made in defining the signaling pathways, transcriptional networks, and epigenetic mechanisms underlying M1-M2 or M2-like polarized activation.  Functional skewing of mononuclear phagocytes occurs in vivo under physiol. conditions (e.g., ontogenesis and pregnancy) and in pathol. (allergic and chronic inflammation, tissue repair, infection, and cancer).  However, in selected preclin. and clin. conditions, coexistence of cells in different activation states and unique or mixed phenotypes have been obsd., a reflection of dynamic changes and complex tissue-derived signals.  The identification of mechanisms and mols. assocd. with macrophage plasticity and polarized activation provides a basis for macrophage-centered diagnostic and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv8WH5pFgWLrVg90H21EOLACvtfcHk0ligmyxKmBfhyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsV2ms7g%253D&md5=2789f6879df4dea15e294b335f086598</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1172%2FJCI59643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI59643%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DMacrophage%2520plasticity%2520and%2520polarization%253A%2520in%2520vivo%2520veritas%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D787%26epage%3D795%26doi%3D10.1172%2Fjci59643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Draghici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarca, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Done, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voichita, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgescu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, R.</span></span> <span> </span><span class="NLM_article-title">A systems biology approach for pathway level analysis</span>. <i>Genome Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1537</span>– <span class="NLM_lpage">1545</span>, <span class="refDoi"> DOI: 10.1101/gr.6202607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1101%2Fgr.6202607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=17785539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGms73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1537-1545&author=S.+Draghiciauthor=P.+Khatriauthor=A.+L.+Tarcaauthor=K.+Aminauthor=A.+Doneauthor=C.+Voichitaauthor=C.+Georgescuauthor=R.+Romero&title=A+systems+biology+approach+for+pathway+level+analysis&doi=10.1101%2Fgr.6202607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A systems biology approach for pathway level analysis</span></div><div class="casAuthors">Draghici, Sorin; Khatri, Purvesh; Tarca, Adi Laurentiu; Amin, Kashyap; Done, Arina; Voichita, Calin; Georgescu, Constantin; Romero, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Genome Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1537-1545</span>CODEN:
                <span class="NLM_cas:coden">GEREFS</span>;
        ISSN:<span class="NLM_cas:issn">1088-9051</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A common challenge in the anal. of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions taking place on various signaling pathways.  A statistical approach using various models is universally used to identify the most relevant pathways in a given expt.  Here, the authors show that the existing pathway anal. methods fail to take into consideration important biol. aspects and may provide incorrect results in certain situations.  By using a systems biol. approach, the authors developed an impact anal. that includes the classical statistics but also considers other crucial factors such as the magnitude of each gene's expression change, their type and position in the given pathways, their interactions, etc.  The impact anal. is an attempt to a deeper level of statistical anal., informed by more pathway-specific biol. than the existing techniques.  On several illustrative data sets, the classical anal. produces both false positives and false negatives, while the impact anal. provides biol. meaningful results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWV8EpdOnA3rVg90H21EOLACvtfcHk0ligmyxKmBfhyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGms73K&md5=e08fbe0c3aab7d34d786f052bfe38af9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fgr.6202607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.6202607%26sid%3Dliteratum%253Aachs%26aulast%3DDraghici%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DP.%26aulast%3DTarca%26aufirst%3DA.%2BL.%26aulast%3DAmin%26aufirst%3DK.%26aulast%3DDone%26aufirst%3DA.%26aulast%3DVoichita%26aufirst%3DC.%26aulast%3DGeorgescu%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DR.%26atitle%3DA%2520systems%2520biology%2520approach%2520for%2520pathway%2520level%2520analysis%26jtitle%3DGenome%2520Res.%26date%3D2007%26volume%3D17%26spage%3D1537%26epage%3D1545%26doi%3D10.1101%2Fgr.6202607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanehisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, M.</span></span> <span> </span><span class="NLM_article-title">The KEGG resource for deciphering the genome</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">D277</span>– <span class="NLM_lpage">D280</span>, <span class="refDoi"> DOI: 10.1093/nar/gkh063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1093%2Fnar%2Fgkh063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=14681412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSrurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=D277-D280&author=M.+Kanehisaauthor=S.+Gotoauthor=S.+Kawashimaauthor=Y.+Okunoauthor=M.+Hattori&title=The+KEGG+resource+for+deciphering+the+genome&doi=10.1093%2Fnar%2Fgkh063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The KEGG resource for deciphering the genome</span></div><div class="casAuthors">Kanehisa, Minoru; Goto, Susumu; Kawashima, Shuichi; Okuno, Yasushi; Hattori, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Database</span>),
    <span class="NLM_cas:pages">D277-D280</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A grand challenge in the post-genomic era is a complete computer representation of the cell and the organism, which will enable computational prediction of higher-level complexity of cellular processes and organism behavior from genomic information.  Toward this end we have been developing a knowledge-based approach for network prediction, which is to predict, given a complete set of genes in the genome, the protein interaction networks that are responsible for various cellular processes.  KEGG at is the ref. knowledge base that integrates current knowledge on mol. interaction networks such as pathways and complexes (PATHWAY database), information about genes and proteins generated by genome projects (GENES/SSDB/KO databases) and information about biochem. compds. and reactions (Compd./GLYCAN/REACTION databases).  These three types of database actually represent three graph objects, called the protein network, the gene universe and the chem. universe.  New efforts are being made to abstr. knowledge, both computationally and manually, about ortholog clusters in the KO (KEGG Orthol.) database, and to collect and analyze carbohydrate structures in the GLYCAN database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAT9gjCrv6LVg90H21EOLACvtfcHk0li_HiCJ5nCpCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSrurvO&md5=f95eb7403a984e782e8f489a20e74a75</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkh063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkh063%26sid%3Dliteratum%253Aachs%26aulast%3DKanehisa%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DKawashima%26aufirst%3DS.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DM.%26atitle%3DThe%2520KEGG%2520resource%2520for%2520deciphering%2520the%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DD277%26epage%3DD280%26doi%3D10.1093%2Fnar%2Fgkh063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vergadi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ieronymaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyroni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaporidi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsanis, C.</span></span> <span> </span><span class="NLM_article-title">Akt signaling pathway in macrophage activation and M1/M2 polarization</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">1006</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1601515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.1601515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=28115590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=1006-1014&author=E.+Vergadiauthor=E.+Ieronymakiauthor=K.+Lyroniauthor=K.+Vaporidiauthor=C.+Tsatsanis&title=Akt+signaling+pathway+in+macrophage+activation+and+M1%2FM2+polarization&doi=10.4049%2Fjimmunol.1601515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization</span></div><div class="casAuthors">Vergadi, Eleni; Ieronymaki, Eleftheria; Lyroni, Konstantina; Vaporidi, Katerina; Tsatsanis, Christos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1006-1014</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Macrophages become activated initiating innate immune responses.  Depending on the signals, macrophages obtain an array of activation phenotypes, described by the broad terms of M1 or M2 phenotype.  The PI3K/Akt/mTOR pathway mediates signals from multiple receptors including insulin receptors, pathogen-assocd. mol. pattern receptors, cytokine receptors, adipokine receptors, and hormones.  As a result, the Akt pathway converges inflammatory and metabolic signals to regulate macrophage responses modulating their activation phenotype.  Akt is a family of three serine-threonine kinases, Akt1, Akt2, and Akt3.  Generation of mice lacking individual Akt, PI3K, or mTOR isoforms and utilization of RNA interference technol. have revealed that Akt signaling pathway components have distinct and isoform-specific roles in macrophage biol. and inflammatory disease regulation, by controlling inflammatory cytokines, miRNAs, and functions including phagocytosis, autophagy, and cell metab.  Herein, we review the current knowledge on the role of the Akt signaling pathway in macrophages, focusing on M1/M2 polarization and highlighting Akt isoform-specific functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqhN2YrKKy4bVg90H21EOLACvtfcHk0li_HiCJ5nCpCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaiu78%253D&md5=11c0393578cafc144259c81a82ee0abc</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1601515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1601515%26sid%3Dliteratum%253Aachs%26aulast%3DVergadi%26aufirst%3DE.%26aulast%3DIeronymaki%26aufirst%3DE.%26aulast%3DLyroni%26aufirst%3DK.%26aulast%3DVaporidi%26aufirst%3DK.%26aulast%3DTsatsanis%26aufirst%3DC.%26atitle%3DAkt%2520signaling%2520pathway%2520in%2520macrophage%2520activation%2520and%2520M1%252FM2%2520polarization%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26spage%3D1006%26epage%3D1014%26doi%3D10.4049%2Fjimmunol.1601515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covarrubias, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aksoylar, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horng, T.</span></span> <span> </span><span class="NLM_article-title">Control of macrophage metabolism and activation by mTOR and Akt signaling</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/j.smim.2015.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.smim.2015.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26360589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=286-296&author=A.+J.+Covarrubiasauthor=H.+I.+Aksoylarauthor=T.+Horng&title=Control+of+macrophage+metabolism+and+activation+by+mTOR+and+Akt+signaling&doi=10.1016%2Fj.smim.2015.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Control of macrophage metabolism and activation by mTOR and Akt signaling</span></div><div class="casAuthors">Covarrubias, Anthony J.; Aksoylar, H. Ibrahim; Horng, Tiffany</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">286-296</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Macrophages are pleiotropic cells that assume a variety of functions depending on their tissue of residence and tissue state.  They maintain homeostasis as well as coordinate responses to stresses such as infection and metabolic challenge.  The ability of macrophages to acquire diverse, context-dependent activities requires their activation (or polarization) to distinct functional states.  While macrophage activation is well understood at the level of signal transduction and transcriptional regulation, the metabolic underpinnings are poorly understood.  Importantly, emerging studies indicate that metabolic shifts play a pivotal role in control of macrophage activation and acquisition of context-dependent effector activities.  The signals that drive macrophage activation impinge on metabolic pathways, allowing for coordinate control of macrophage activation and metab.  Here we discuss how mTOR and Akt, major metabolic regulators and targets of such activation signals, control macrophage metab. and activation.  Dysregulated macrophage activities contribute to many diseases, including infectious, inflammatory, and metabolic diseases and cancer, thus a better understanding of metabolic control of macrophage activation could pave the way to the development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxLliB75EM7rVg90H21EOLACvtfcHk0li_HiCJ5nCpCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtbvI&md5=5d16b9dfb153050cacd50a86dcd4d0ac</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.smim.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smim.2015.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DCovarrubias%26aufirst%3DA.%2BJ.%26aulast%3DAksoylar%26aufirst%3DH.%2BI.%26aulast%3DHorng%26aufirst%3DT.%26atitle%3DControl%2520of%2520macrophage%2520metabolism%2520and%2520activation%2520by%2520mTOR%2520and%2520Akt%2520signaling%26jtitle%3DSemin.%2520Immunol.%26date%3D2015%26volume%3D27%26spage%3D286%26epage%3D296%26doi%3D10.1016%2Fj.smim.2015.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beharka, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowther, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibesar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlesinger, L. S.</span></span> <span> </span><span class="NLM_article-title">Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2227</span>– <span class="NLM_lpage">2236</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.175.4.2227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.175.4.2227" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=2227-2236&author=A.+A.+Beharkaauthor=J.+E.+Crowtherauthor=F.+X.+McCormackauthor=G.+M.+Denningauthor=J.+Leesauthor=E.+Tibesarauthor=L.+S.+Schlesinger&title=Pulmonary+surfactant+protein+A+activates+a+phosphatidylinositol+3-kinase%2Fcalcium+signal+transduction+pathway+in+human+macrophages%3A+participation+in+the+up-regulation+of+mannose+receptor+activity&doi=10.4049%2Fjimmunol.175.4.2227"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.175.4.2227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.175.4.2227%26sid%3Dliteratum%253Aachs%26aulast%3DBeharka%26aufirst%3DA.%2BA.%26aulast%3DCrowther%26aufirst%3DJ.%2BE.%26aulast%3DMcCormack%26aufirst%3DF.%2BX.%26aulast%3DDenning%26aufirst%3DG.%2BM.%26aulast%3DLees%26aufirst%3DJ.%26aulast%3DTibesar%26aufirst%3DE.%26aulast%3DSchlesinger%26aufirst%3DL.%2BS.%26atitle%3DPulmonary%2520surfactant%2520protein%2520A%2520activates%2520a%2520phosphatidylinositol%25203-kinase%252Fcalcium%2520signal%2520transduction%2520pathway%2520in%2520human%2520macrophages%253A%2520participation%2520in%2520the%2520up-regulation%2520of%2520mannose%2520receptor%2520activity%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D2227%26epage%3D2236%26doi%3D10.4049%2Fjimmunol.175.4.2227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weischenfeldt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porse, B.</span></span> <span> </span><span class="NLM_article-title">Bone marrow-derived macrophages (BMM): isolation and applications</span>. <i>Csh Protocols</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span>,  <span class="NLM_fpage">pdb.prot5080</span>, <span class="refDoi"> DOI: 10.1101/pdb.prot5080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1101%2Fpdb.prot5080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=pdb.prot5080&author=J.+Weischenfeldtauthor=B.+Porse&title=Bone+marrow-derived+macrophages+%28BMM%29%3A+isolation+and+applications&doi=10.1101%2Fpdb.prot5080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1101%2Fpdb.prot5080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fpdb.prot5080%26sid%3Dliteratum%253Aachs%26aulast%3DWeischenfeldt%26aufirst%3DJ.%26aulast%3DPorse%26aufirst%3DB.%26atitle%3DBone%2520marrow-derived%2520macrophages%2520%2528BMM%2529%253A%2520isolation%2520and%2520applications%26jtitle%3DCsh%2520Protocols%26date%3D2008%26volume%3D2008%26spage%3Dpdb.prot5080%26doi%3D10.1101%2Fpdb.prot5080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paterka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuenberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radbruch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siffrin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, F.</span></span> <span> </span><span class="NLM_article-title">Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2016.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.jaut.2016.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27707650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SitbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=108-114&author=M.+Paterkaauthor=J.+O.+Vossauthor=J.+Werrauthor=E.+Reuterauthor=S.+Franckauthor=T.+Leuenbergerauthor=J.+Herzauthor=H.+Radbruchauthor=T.+Boppauthor=V.+Siffrinauthor=F.+Zipp&title=Dendritic+cells+tip+the+balance+towards+induction+of+regulatory+T+cells+upon+priming+in+experimental+autoimmune+encephalomyelitis&doi=10.1016%2Fj.jaut.2016.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Paterka, Magdalena; Voss, Jan Oliver; Werr, Johannes; Reuter, Eva; Franck, Sophia; Leuenberger, Tina; Herz, Josephine; Radbruch, Helena; Bopp, Tobias; Siffrin, Volker; Zipp, Frauke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-114</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Counter-balancing regulatory mechanisms, such as the induction of regulatory T cells (Treg), limit the effects of autoimmune attack in neuroinflammation.  However, the role of dendritic cells (DCs) as the most powerful antigen-presenting cells, which are intriguing therapeutic targets in this context, is not fully understood.  Here, we demonstrate that conditional ablation of DCs during the priming phase of myelin-specific T cells in exptl. autoimmune encephalomyelitis (EAE) selectively aborts inducible Treg (iTreg) induction, whereas generation of T helper (Th)1/17 cells is unaltered.  DCs facilitate iTreg induction by creating a milieu with high levels of interleukin (IL)-2 due to a strong proliferative response.  In the absence of DCs, B220+ B cells take over priming of Th17 cells in the place of antigen-presenting cells (APCs), but not the induction of iTreg, thus leading to unregulated, severe autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCPpGpIRed_7Vg90H21EOLACvtfcHk0ljhZzF-gMh8mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SitbbL&md5=b92d9879c4ac0c4438f01a6e95683081</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2016.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2016.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DPaterka%26aufirst%3DM.%26aulast%3DVoss%26aufirst%3DJ.%2BO.%26aulast%3DWerr%26aufirst%3DJ.%26aulast%3DReuter%26aufirst%3DE.%26aulast%3DFranck%26aufirst%3DS.%26aulast%3DLeuenberger%26aufirst%3DT.%26aulast%3DHerz%26aufirst%3DJ.%26aulast%3DRadbruch%26aufirst%3DH.%26aulast%3DBopp%26aufirst%3DT.%26aulast%3DSiffrin%26aufirst%3DV.%26aulast%3DZipp%26aufirst%3DF.%26atitle%3DDendritic%2520cells%2520tip%2520the%2520balance%2520towards%2520induction%2520of%2520regulatory%2520T%2520cells%2520upon%2520priming%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Autoimmun.%26date%3D2017%26volume%3D76%26spage%3D108%26epage%3D114%26doi%3D10.1016%2Fj.jaut.2016.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velletri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1038/cdd.2016.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fcdd.2016.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27447115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSnsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1850-1861&author=Q.+Yangauthor=C.+Zhengauthor=J.+Caoauthor=G.+Caoauthor=P.+Shouauthor=L.+Linauthor=T.+Velletriauthor=M.+Jiangauthor=Q.+Chenauthor=Y.+Hanauthor=F.+Liauthor=Y.+Wangauthor=W.+Caoauthor=Y.+Shi&title=Spermidine+alleviates+experimental+autoimmune+encephalomyelitis+through+inducing+inhibitory+macrophages&doi=10.1038%2Fcdd.2016.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages</span></div><div class="casAuthors">Yang, Q.; Zheng, C.; Cao, J.; Cao, G.; Shou, P.; Lin, L.; Velletri, T.; Jiang, M.; Chen, Q.; Han, Y.; Li, F.; Wang, Y.; Cao, W.; Shi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1850-1861</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic and debilitating autoimmune disease, characterized by chronic inflammatory demyelination in the nervous tissue and subsequent neurol. dysfunction.  Spermidine, a natural polyamine, has been shown to affect inflammation in some exptl. models.  We show here that spermidine could alleviate exptl. autoimmune encephalomyelitis (EAE), a model for MS, through regulating the infiltration of CD4+ T cells and macrophages in central nervous system.  Unexpectedly, we found that spermidine treatment of MOG-specific T cells did not affect their pathogenic potency upon adaptive transfer; however, spermidine diminished the ability of macrophages in activating MOG-specific T cells ex vivo.  Depletion of macrophages in diseased mice completely abolished the therapeutic effect of spermidine, indicating a crit. role of spermidine-activated macrophages.  Mechanistically, spermidine was found to specifically suppress the expression of interleukin-1beta (IL-1β), IL-12 and CD80 while enhance the expression of arginase 1 in macrophages.  Interestingly, macrophages from spermidine-treated mice could also reverse EAE progression, while pretreatment of those macrophages with the arginase 1 inhibitor abrogated the therapeutic effect.  Therefore, our studies revealed a crit. role of macrophages in spermidine-mediated treatment on EAE and provided novel information for better management of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUE0So9URE07Vg90H21EOLACvtfcHk0ljhZzF-gMh8mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSnsbnF&md5=87021a9aab4b10caacfe29460dbeb4be</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2016.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2016.71%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DG.%26aulast%3DShou%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DVelletri%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DSpermidine%2520alleviates%2520experimental%2520autoimmune%2520encephalomyelitis%2520through%2520inducing%2520inhibitory%2520macrophages%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D1850%26epage%3D1861%26doi%3D10.1038%2Fcdd.2016.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jinxin Che, Zegao Jin, Fangjie Yan, Jieqiong You, Jiangfeng Xie, Binhui Chen, Gang Cheng, Hong Zhu, Qiaojun He, Yongzhou Hu, Bo Yang, Ji Cao, <span class="NLM_string-name hlFld-ContribAuthor">Xiaowu Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5,6-Bis(4-methoxy-3-methylphenyl)pyridin-2-amine as a WSB1 Degrader to Inhibit Cancer Cell Metastasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8621-8643. <a href="https://doi.org/10.1021/acs.jmedchem.1c00586" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00586</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00586%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B5%25252C6-Bis%2525284-methoxy-3-methylphenyl%252529pyridin-2-amine%252Bas%252Ba%252BWSB1%252BDegrader%252Bto%252BInhibit%252BCancer%252BCell%252BMetastasis%26aulast%3DChe%26aufirst%3DJinxin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D31032021%26date%3D01062021%26volume%3D64%26issue%3D12%26spage%3D8621%26epage%3D8643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinying  Xu</span>, <span class="hlFld-ContribAuthor ">Yangyang  Zheng</span>, <span class="hlFld-ContribAuthor ">Liangjia  Wang</span>, <span class="hlFld-ContribAuthor ">Yining  Liu</span>, <span class="hlFld-ContribAuthor ">Xishu  Wang</span>, <span class="hlFld-ContribAuthor ">Yulin  Li</span>, <span class="hlFld-ContribAuthor ">Guangfan  Chi</span>. </span><span class="cited-content_cbyCitation_article-title">miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Neurobiology</span><span> <strong>2021,</strong> <em>99 </em><a href="https://doi.org/10.1007/s10571-021-01091-6" title="DOI URL">https://doi.org/10.1007/s10571-021-01091-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10571-021-01091-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10571-021-01091-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Neurobiology%26atitle%3DmiR-124%25253A%252BA%252BPromising%252BTherapeutic%252BTarget%252Bfor%252BCentral%252BNervous%252BSystem%252BInjuries%252Band%252BDiseases%26aulast%3DXu%26aufirst%3DJinying%26date%3D2021%26date%3D2021%26volume%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue‐song  Xu</span>, <span class="hlFld-ContribAuthor ">Zhi‐hao  Feng</span>, <span class="hlFld-ContribAuthor ">Ding  Cao</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Meng‐hao  Wang</span>, <span class="hlFld-ContribAuthor ">Jin‐Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Jian‐Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">SCARF1 promotes M2 polarization of Kupffer cells via calcium‐dependent PI3K‐AKT‐STAT3 signalling to improve liver transplantation. </span><span class="cited-content_cbyCitation_journal-name">Cell Proliferation</span><span> <strong>2021,</strong> <em>54 </em>
                                    (4)
                                     <a href="https://doi.org/10.1111/cpr.13022" title="DOI URL">https://doi.org/10.1111/cpr.13022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cpr.13022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcpr.13022%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Proliferation%26atitle%3DSCARF1%252Bpromotes%252BM2%252Bpolarization%252Bof%252BKupffer%252Bcells%252Bvia%252Bcalcium%2525E2%252580%252590dependent%252BPI3K%2525E2%252580%252590AKT%2525E2%252580%252590STAT3%252Bsignalling%252Bto%252Bimprove%252Bliver%252Btransplantation%26aulast%3DXu%26aufirst%3DXue%25E2%2580%2590song%26date%3D2021%26date%3D2021%26volume%3D54%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>S-28</b> promoted macrophage M2 polarization most effectively; (blue) quantitative real-time polymerase chain reaction (qRT-PCR) analysis for expression of macrophage M2 phenotype gene <i>Arg1</i> in RAW264.7 cells treated with 28 compounds (300 nM) for a total 24 h. IL-4 (20 ng/mL) was used as a positive control; (purple) qRT-PCR analysis for expression of macrophage M1 phenotype gene <i>Mcp1</i> in RAW264.7 cells treated with 28 compounds (300 nM) for 24 h. LPS (50 ng/mL) was used as a positive control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Different strategies of structure modification for SAR study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub>, DMF; (b) NBS or NCS, Dichloromethane; (c) NaOH, H<sub>2</sub>O/EtOH</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. (a) (<i>S</i>)-2-(Diphenyl((trimethylsilyl)oxy)methyl)pyrrolidine, Dichloromethane; (i) TFA, Dichloromethane; (b) (<i>R</i>)-2-(Diphenyl((trimethylsilyl)oxy)methyl)pyrrolidine, Dichloromethane; (ii) TFA, Dichloromethane; (c) (i) EtSiH, TFA; (ii) Boc<sub>2</sub>O, TEA, Dichloromethane; and (d) Fe, NH<sub>4</sub>Cl, EtOH/H<sub>2</sub>O</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. (a) EDCI, HOBt, and DIPEA; (b) EA and HCl; and (c) <span class="smallcaps smallerCapital">l</span>-Tartaric Acid</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) (Blue) qRT-PCR analysis to determine the expression of macrophage M2 phenotype gene <i>Arg1</i> in RAW264.7 cells treated with compounds (300 nM) for 24 h. IL-4 (20 ng/mL) was used as a positive control. (Purple) qRT-PCR analysis for the determination of macrophage M1 phenotype gene <i>Mcp1</i> expression in RAW264.7 cells treated with compounds (300 nM) for 24 h. LPS (50 ng/mL) was used as a positive control; (B) qRT-PCR analysis for the determination of macrophage M1 phenotype gene <i>Mcp1</i> expression. RAW264.7 cells were pretreated with LPS (50 ng/mL) for 24 h and subsequently treated with compounds (300 nM) for 24 h. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>D11</b> promotes the polarization of M2 macrophages in combination with inhibiting M1 polarization ex vivo. (A) Numbers of altered genes after the RAW264.7 cells were treated with <b>D11</b>; (B) fold change of macrophage polarization gene markers; (C) BMDM cells were treated with 300 nM of <b>D11</b> for 24 h. qRT-PCR was performed to investigate the macrophages M2 polarization-associated genes <i>Arg1</i>, <i>Mrc1</i>, and <i>Fizz1</i> mRNA expression levels. (D) BMDM cells were pretreated with LPS (50 ng/mL) for 24 h and then treated with 300 nM of <b>D11</b> for 24 h. qRT-PCR was performed to investigate the macrophages M1 polarization-associated gene <i>Mcp1</i>, <i>Inos</i>, and <i>Cd86</i> mRNA expression levels. (E) BMDM cells were treated with 300 nM of <b>D11</b> for 24 h. The percentage of M2 macrophages (CD206<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow-cytometry. (F) BMDM cells were pretreated with LPS (50 ng/mL) for 24 h and then treated with 300 nM of <b>D11</b> for 24 h. The percentage of M1 macrophages (CD86<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow cytometry. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, ***<i>P</i> < 0.01 versus control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>D11</b> promotes macrophages M2 polarization and inhibits M1 polarization dose-dependently. (A) BMDM cells were treated with indicated concentration of <b>D11</b> for 24 h. The percentage of M2 macrophages (CD206<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow-cytometry. (B) BMDM cells were pretreated with LPS (50 ng/mL) for 24 h and then treated with indicated concentration of <b>D11</b> for 24 h. The percentage of M1 macrophages (CD86<sup>+</sup>F4/80<sup>+</sup> cells) was analyzed by flow cytometry. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, ***<i>P</i> < 0.01 vs control group. <sup>#</sup><i>P</i> < 0.05 versus LPS group. n.s. <i>P</i> > 0.05 vs control or LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>D11</b> ameliorated clinical severity and limited CNS autoimmunity of EAE mice. (A) Schematic representation of the EAE model. (B) In vivo effect of compound <b>D11</b> on EAE mice. EAE mice were treated with <b>D11</b> (100, 200 mg/kg, i.g.), DXM (10 mg/kg, i.g.), or vehicle (saline, i.g.). Mean clinical scores are shown (<i>n</i> = 5). (C,D) H&E and LFB staining of spinal cords from vehicle- and <b>D11</b>-treated EAE mice on day 14 after induction of EAE. The shown arrows indicate infiltration of inflammatory cells and demyelination in the spinal cord. Scale bars: 100 μm (upper) and 50 μm (bottom). (E,F) Flow cytometry analysis of Th1 and Th17 (IFN-γ<sup>+</sup> and IL-17<sup>+</sup>) on the range of CD4<sup>+</sup> cells isolated from the CNS of vehicle-treated and 200 mg/kg <b>D11</b>-treated EAE mice (<i>n</i> = 4 mice per group), detected between day 13 to day 19 after induction of EAE. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.01 vs vehicle control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>D11</b> promotes polarization of M2 macrophages and inhibits M1 polarization in EAE mice. (A,B) Spleen, DLN, and CNS were isolated from vehicle-treated and <b>D11</b>-treated (200 mg/kg) EAE mice (<i>n</i> = 4 mice per group) between day 13 and day 19 after induction of EAE. (A) Flow cytometry analysis of M2 marker CD206 in the range of macrophage marker F4/80<sup>+</sup> cells. (B) Flow cytometry analysis of M1 marker CD86 in the range of macrophage marker F4/80<sup>+</sup> cells. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, **<i>P</i> < 0.01 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>D11</b>-treated macrophages inhibited the proliferation of CD4<sup>+</sup> T cells. (A,B) BMDM cells were treated with 50 ng/mL LPS or with 300 nM compound <b>D11</b> for 48 h. Then, BMDM cells were cocultured with CD4<sup>+</sup> T cells, and proliferation was determined after 72 h. Histograms display proliferation profiles of CD4<sup>+</sup> T-cells. Graphs display mean fluorescence intensity of the proliferation dye carboxyfluorescein succinimidyl ester (CFSE) and proliferation percentages of CD4<sup>+</sup> T-cells. (C,D) Coculture supernatant was collected for ELISA analysis of IFN-γ and IL-17 secretion. Data are shown as mean ± SEM in the graphs. *<i>P</i> < 0.05, **<i>P</i> < 0.01, n.s. <i>P</i> > 0.05 vs control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Volcano plot of differentially expressed genes by microarray analysis on <b>D11</b>-treated macrophages RAW264.7. (B) Heatmap of differentially expressed genes by microarray analysis on <b>D11</b>-treated macrophages RAW264.7. (C) Changes of gene expression in the KEGG pathway analysis. (D) Western blotting shows the expression level of Akt/p-Akt(473)/p-Akt(308), Stat3/p-Stat3(Y705), and Stat6/p-Stat6 protein; GAPDH was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/medium/jm-2018-01635r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Schematic Representation of <b>D11</b>-Mediated M2 Polarization and Neuroprotective Effect; <b>D11</b> is Uptaken by Macrophages and Promotes Macrophages M2 Polarization by Activating Akt and Stat3; Phosphorylated Stat3 Translocated into the Nucleus Encoding M2 Macrophages Related Genes Such as <i>Mrc1</i>(CD206), <i>Arg1</i>, and <i>Fizz1</i>; <b>D11</b>-Treated Macrophages Inhibit CD4<sup>+</sup> T Cells Proliferation, Therefore, Reduce the Inflammatory Reaction Generated by Autoreactive Th1 and Th17 Cells, Finally Inhibits Demyelination and Prevents EAE</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01635/20190404/images/large/jm-2018-01635r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01635&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span> <span> </span><span class="NLM_article-title">Immunology of relapse and remission in multiple sclerosis</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-032713-120227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1146%2Fannurev-immunol-032713-120227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=24438352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVemt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=257-281&author=L.+Steinman&title=Immunology+of+relapse+and+remission+in+multiple+sclerosis&doi=10.1146%2Fannurev-immunol-032713-120227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Immunology of relapse and remission in multiple sclerosis</span></div><div class="casAuthors">Steinman, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-281</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Eighty percent of individuals with multiple sclerosis (MS) initially develop a clin. pattern with periodic relapses followed by remissions, called relapsing-remitting MS (RRMS).  This period of fluctuating disease may last for a decade or more.  Clin. relapses reflect acute inflammation in the central nervous system (CNS), composed of the brain and spinal cord.  Often, different anat. areas in the CNS are involved each time a relapse occurs, resulting in varied clin. manifestations in each instance.  Relapses are nearly always followed by some degree of remission, though recovery to baseline status before the flare is often incomplete.  There are nine approved drugs for treatment of RRMS.  The most potent drug for inhibiting relapses, the humanized anti-α4 integrin antibody known as Natalizumab, blocks homing of mononuclear cells to the CNS.  The mechanisms of action of the approved drugs for RRMS provide a strong foundation for understanding the pathobiol. of the relapse.  Despite substantial progress in controlling relapses with the current armamentarium of medications, there is much to learn and ever more effective and safe therapies to develop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMFgjCftGNkLVg90H21EOLACvtfcHk0lgFNg9l2lzRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVemt78%253D&md5=41c7de7582a583a5626b3b97ff2f77b2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032713-120227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032713-120227%26sid%3Dliteratum%253Aachs%26aulast%3DSteinman%26aufirst%3DL.%26atitle%3DImmunology%2520of%2520relapse%2520and%2520remission%2520in%2520multiple%2520sclerosis%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D32%26spage%3D257%26epage%3D281%26doi%3D10.1146%2Fannurev-immunol-032713-120227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapp, B. D.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2010.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.pneurobio.2010.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=20946934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BC3M7mvVyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=1-12&author=R.+Duttaauthor=B.+D.+Trapp&title=Mechanisms+of+neuronal+dysfunction+and+degeneration+in+multiple+sclerosis&doi=10.1016%2Fj.pneurobio.2010.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis</span></div><div class="casAuthors">Dutta Ranjan; Trapp Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.  Due to its high prevalence, MS is the leading cause of non-traumatic neurological disability in young adults in the United States and Europe.  The clinical disease course is variable and starts with reversible episodes of neurological disability in the third or fourth decade of life.  This transforms into a disease of continuous and irreversible neurological decline by the sixth or seventh decade.  Available therapies for MS patients have little benefit for patients who enter this irreversible phase of the disease.  It is well established that irreversible loss of axons and neurons are the major cause of the irreversible and progressive neurological decline that most MS patients endure.  This review discusses the etiology, mechanisms and progress made in determining the cause of axonal and neuronal loss in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIGys_IlOfaWx8TEN9K18QfW6udTcc2ebvLqDCG02A2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7mvVyitA%253D%253D&md5=b3a3c9a85106fb1a09482d7d510241dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2010.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2010.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DR.%26aulast%3DTrapp%26aufirst%3DB.%2BD.%26atitle%3DMechanisms%2520of%2520neuronal%2520dysfunction%2520and%2520degeneration%2520in%2520multiple%2520sclerosis%26jtitle%3DProg.%2520Neurobiol.%26date%3D2011%26volume%3D93%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.pneurobio.2010.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Valk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Groot, C. J. A.</span></span> <span> </span><span class="NLM_article-title">Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS</span>. <i>Neuropathol. Appl. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2990.2000.00217.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1046%2Fj.1365-2990.2000.00217.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10736062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVeht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2000&pages=2&author=P.+van%0Ader+Valkauthor=C.+J.+A.+De+Groot&title=Staging+of+multiple+sclerosis+%28MS%29+lesions%3A+pathology+of+the+time+frame+of+MS&doi=10.1046%2Fj.1365-2990.2000.00217.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS</span></div><div class="casAuthors">Van der Valk, P.; De Groot, C. J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropathology and Applied Neurobiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-10</span>CODEN:
                <span class="NLM_cas:coden">NANEDL</span>;
        ISSN:<span class="NLM_cas:issn">0305-1846</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 42 refs.  Several processes take place during an attack of demyelination in multiple sclerosis (MS).  The timing of these various processes, and thus of the attack in its entirety, is important if therapeutic strategies are to be planned.  Attempts have been made to introduce and investigate variables relevant to timing the disease processes, leading to staging systems for MS.  Here, the terminol. and the various parameters used are reviewed, including inflammatory cells, glial cells, axonal loss and myelin staining: then the different systems are compared, including the system put forward by Bo and Trapp, our own modification of that, the Bruck and Lassmann system and the recent consensus reached at a Vienna meeting.  It is concluded that an ideal staging system does not yet exist, and that, more than anything else, the material dictates the choice for a staging system.  The terminol. of the Vienna consensus could be used as a ref. to facilitate international comparison.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJpNtqckbqO7Vg90H21EOLACvtfcHk0lj855uQkff1EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVeht7k%253D&md5=87ac6a124477576cea0ee01203e7668e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2990.2000.00217.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2990.2000.00217.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26aulast%3DDe%2BGroot%26aufirst%3DC.%2BJ.%2BA.%26atitle%3DStaging%2520of%2520multiple%2520sclerosis%2520%2528MS%2529%2520lesions%253A%2520pathology%2520of%2520the%2520time%2520frame%2520of%2520MS%26jtitle%3DNeuropathol.%2520Appl.%2520Neurobiol.%26date%3D2000%26volume%3D26%26spage%3D2%26doi%3D10.1046%2Fj.1365-2990.2000.00217.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bitsch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuchardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brück, W.</span></span> <span> </span><span class="NLM_article-title">Acute axonal injury in multiple sclerosis - correlation with demyelination and inflammation</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">1174</span>, <span class="refDoi"> DOI: 10.1093/brain/123.6.1174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1093%2Fbrain%2F123.6.1174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10825356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BD3czktVamsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2000&pages=1174&author=A.+Bitschauthor=J.+Schuchardtauthor=S.+Bunkowskiauthor=T.+Kuhlmannauthor=W.+Br%C3%BCck&title=Acute+axonal+injury+in+multiple+sclerosis+-+correlation+with+demyelination+and+inflammation&doi=10.1093%2Fbrain%2F123.6.1174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation</span></div><div class="casAuthors">Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Bruck W</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">123 ( Pt 6)</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1174-83</span>
        ISSN:<span class="NLM_cas:issn">0006-8950</span>.
    </div><div class="casAbstract">Damage to axons is taken as a key factor of disability in multiple sclerosis, but its pathogenesis is largely unknown.  Axonal injury is believed to occur as a consequence of demyelination and was recently shown to be a feature even of the early disease stages.  The present study was aimed at characterizing the association of axonal injury and histopathological hallmarks of multiple sclerosis such as demyelination, cellular infiltration and expression of inflammatory mediators.  Therefore, axon reduction and signs of acute axonal damage were quantified in early lesion development of chronic multiple sclerosis and correlated with demyelinating activity and inflammation.  Patients with secondary progressive multiple sclerosis revealed the most pronounced axonal injury, whereas primary progressive multiple sclerosis patients surprisingly showed relatively little acute axonal injury.  Acute axonal damage, as defined by the accumulation of amyloid precursor protein (APP), was found to occur not only in active demyelinating but also in remyelinating and inactive demyelinated lesions with a large inter-individual variability.  Only few remyelinating lesions were adjacent to areas of active demyelination.  In this minority of lesions, axonal damage may have originated from the neighbourhood.  APP expression in damaged axons correlated with the number of macrophages and CD8-positive T lymphocytes within the lesions, but not with the expression of tumour necrosis factor-alpha (TNF-alpha) or inducible nitric oxide synthase (iNOS).  Axonal injury is therefore, at least in part, independent of demyelinating activity, and its pathogenesis may be different from demyelination.  This has major implications for therapeutic strategies, which aim at preventing both demyelination and axonal loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNHAXTCmcm5cULxIEhxUjPfW6udTcc2ebjJjVFsLo7ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czktVamsA%253D%253D&md5=24a8005c2dc3ebedd61437bae6d6d5d4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2F123.6.1174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252F123.6.1174%26sid%3Dliteratum%253Aachs%26aulast%3DBitsch%26aufirst%3DA.%26aulast%3DSchuchardt%26aufirst%3DJ.%26aulast%3DBunkowski%26aufirst%3DS.%26aulast%3DKuhlmann%26aufirst%3DT.%26aulast%3DBr%25C3%25BCck%26aufirst%3DW.%26atitle%3DAcute%2520axonal%2520injury%2520in%2520multiple%2520sclerosis%2520-%2520correlation%2520with%2520demyelination%2520and%2520inflammation%26jtitle%3DBrain%26date%3D2000%26volume%3D123%26spage%3D1174%26doi%3D10.1093%2Fbrain%2F123.6.1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pugliatti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosati, G.</span></span> <span> </span><span class="NLM_article-title">The worldwide prevalence of multiple sclerosis</span>. <i>Clin. Neurol. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/s0303-8467(02)00036-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fs0303-8467%2802%2900036-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=12127652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BD38zotFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2002&pages=182-191&author=M.+Pugliattiauthor=S.+Sotgiuauthor=G.+Rosati&title=The+worldwide+prevalence+of+multiple+sclerosis&doi=10.1016%2Fs0303-8467%2802%2900036-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The worldwide prevalence of multiple sclerosis</span></div><div class="casAuthors">Pugliatti Maura; Sotgiu Stefano; Rosati Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neurology and neurosurgery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-91</span>
        ISSN:<span class="NLM_cas:issn">0303-8467</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPU8-88-HE49TiMd2aNQVUfW6udTcc2ebjJjVFsLo7ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zotFGruw%253D%253D&md5=5dac36805f5bc3e6c04f0a0e7793f424</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fs0303-8467%2802%2900036-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0303-8467%252802%252900036-7%26sid%3Dliteratum%253Aachs%26aulast%3DPugliatti%26aufirst%3DM.%26aulast%3DSotgiu%26aufirst%3DS.%26aulast%3DRosati%26aufirst%3DG.%26atitle%3DThe%2520worldwide%2520prevalence%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Neurol.%2520Neurosurg.%26date%3D2002%26volume%3D104%26spage%3D182%26epage%3D191%26doi%3D10.1016%2Fs0303-8467%2802%2900036-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamm, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polman, C. H.</span></span> <span> </span><span class="NLM_article-title">Multiple sclerosis: current knowledge and future outlook</span>. <i>Eur. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1159/000360528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1159%2F000360528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=25095894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGktL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2014&pages=132-141&author=C.+P.+Kammauthor=B.+M.+Uitdehaagauthor=C.+H.+Polman&title=Multiple+sclerosis%3A+current+knowledge+and+future+outlook&doi=10.1159%2F000360528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Sclerosis: Current Knowledge and Future Outlook</span></div><div class="casAuthors">Kamm, Christian P.; Uitdehaag, Bernard M.; Polman, Chris H.</div><div class="citationInfo"><span class="NLM_cas:title">European Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">132-141</span>CODEN:
                <span class="NLM_cas:coden">EUNEAP</span>;
        ISSN:<span class="NLM_cas:issn">0014-3022</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Background: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by demyelination and axonal loss.  The etiol. of MS is unknown; however, environmental and genetic factors play a key role in the development of MS.  Diagnostic criteria have been adapted to facilitate earlier diagnosis with increased sensitivity and specificity.  Our understanding of the pathophysiol. of MS has deepened considerably in recent years, resulting in different therapies to modify the disease course.  Furthermore, several drugs have lately shown efficacy in phase III studies and their approval is expected in the near future.  As treatment options expand, a future challenge will be to find the optimal treatment for the individual patient.  Summary: This mini-review gives an overview of the current knowledge of MS with emphasis on the latest diagnostic criteria and both current and upcoming treatment options.  Key Messages: Treatment of MS changes rapidly as the knowledge and therapeutic options in MS expand.  Clin. Impact: Diagnosis of MS is based on McDonald criteria.  MS therapy can be divided into relapse, disease-modifying and symptomatic treatment.  Relapses are commonly treated with i.v. methylprednisolone.  First-line therapy consists of either interferon-β, glatiramer acetate or teriflunomide.  In general, agents used as escalation therapies (natalizumab, fingolimod and mitoxantrone) are more potent than the agents used for first-line therapy; however, these have potentially serious side effects and should be used with care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFiNY-P0ciGLVg90H21EOLACvtfcHk0lj855uQkff1EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGktL7P&md5=e4e840fb6a61260c68092e1ae37ab90c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000360528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000360528%26sid%3Dliteratum%253Aachs%26aulast%3DKamm%26aufirst%3DC.%2BP.%26aulast%3DUitdehaag%26aufirst%3DB.%2BM.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26atitle%3DMultiple%2520sclerosis%253A%2520current%2520knowledge%2520and%2520future%2520outlook%26jtitle%3DEur.%2520Neurol.%26date%3D2014%26volume%3D72%26spage%3D132%26epage%3D141%26doi%3D10.1159%2F000360528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrithers, M. D.</span></span> <span> </span><span class="NLM_article-title">Update on disease-modifying treatments for multiple sclerosis</span>. <i>Clin. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1938</span>– <span class="NLM_lpage">1945</span>, <span class="refDoi"> DOI: 10.1016/j.clinthera.2014.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.clinthera.2014.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=25218310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFSjt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=1938-1945&author=M.+D.+Carrithers&title=Update+on+disease-modifying+treatments+for+multiple+sclerosis&doi=10.1016%2Fj.clinthera.2014.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Disease-Modifying Treatments for Multiple Sclerosis</span></div><div class="casAuthors">Carrithers, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1938-1945</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The purpose of this review is to discuss the selection and use of disease- modifying treatments for patients with relapsing forms of multiple sclerosis (MS).PubMed was searched (1966-2014) using the terms multiple sclerosis, treatment, interferon, glatiramer acetate, di-Me fumarate, fingolimod, teriflunomide, natalizumab, rituximab, and alemtuzumab.MS is a chronic neurol. disorder that can cause a substantial degree of disability.  Because of its usual onset in young adults, patients may require treatment for several decades.  Currently available agents include platform injectable therapies, newer oral agents, and second-line monoclonal antibody treatments.  Treatment decisions have become more complex with the introduction of new approaches, and a major goal is to balance perceived efficacy and tolerability in a specific patient with the relative impact of disease activity and adverse events on quality of life.  Here the options for disease-modifying treatments for relapsing forms of MS are reviewed, and current and future challenges are discussed.An evidence-based approach can be used for the selection of disease-modifying treatments based on disease phenotype and severity, adverse events, and perceived efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCBELzvhJBqbVg90H21EOLACvtfcHk0lgECi_m--ho5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFSjt73M&md5=86899e97b217b978902e837491f422d6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.clinthera.2014.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinthera.2014.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DCarrithers%26aufirst%3DM.%2BD.%26atitle%3DUpdate%2520on%2520disease-modifying%2520treatments%2520for%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Ther.%26date%3D2014%26volume%3D36%26spage%3D1938%26epage%3D1945%26doi%3D10.1016%2Fj.clinthera.2014.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dendrou, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fugger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese, M. A.</span></span> <span> </span><span class="NLM_article-title">Immunopathology of multiple sclerosis</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/nri3871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnri3871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26250739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12gurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=545-558&author=C.+A.+Dendrouauthor=L.+Fuggerauthor=M.+A.+Friese&title=Immunopathology+of+multiple+sclerosis&doi=10.1038%2Fnri3871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunopathology of multiple sclerosis</span></div><div class="casAuthors">Dendrou, Calliope A.; Fugger, Lars; Friese, Manuel A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">545-558</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two decades of clin. experience with immunomodulatory treatments for multiple sclerosis point to distinct immunol. pathways that drive disease relapses and progression.  In light of this, we discuss our current understanding of multiple sclerosis immunopathol., evaluate long-standing hypotheses regarding the role of the immune system in the disease and delineate key questions that are still unanswered.  Recent and anticipated advances in the field of immunol., and the increasing recognition of inflammation as an important component of neurodegeneration, are shaping our conceptualization of disease pathophysiol., and we explore the potential implications for improved healthcare provision to patients in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfbvqTYZdO37Vg90H21EOLACvtfcHk0lgECi_m--ho5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12gurvE&md5=928ac7775883ce6c78c169c13979eacf</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnri3871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3871%26sid%3Dliteratum%253Aachs%26aulast%3DDendrou%26aufirst%3DC.%2BA.%26aulast%3DFugger%26aufirst%3DL.%26aulast%3DFriese%26aufirst%3DM.%2BA.%26atitle%3DImmunopathology%2520of%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D545%26epage%3D558%26doi%3D10.1038%2Fnri3871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-X.</span></span> <span> </span><span class="NLM_article-title">Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2014.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.imlet.2014.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2014&pages=17&author=Z.+Jiangauthor=J.+X.+Jiangauthor=G.-X.+Zhang&title=Macrophages%3A+a+double-edged+sword+in+experimental+autoimmune+encephalomyelitis&doi=10.1016%2Fj.imlet.2014.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DZhang%26aufirst%3DG.-X.%26atitle%3DMacrophages%253A%2520a%2520double-edged%2520sword%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DImmunol.%2520Lett.%26date%3D2014%26volume%3D160%26spage%3D17%26doi%3D10.1016%2Fj.imlet.2014.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Icyuz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thannickal, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">miR-125a-5p regulates differential activation of macrophages and inflammation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">35428</span>– <span class="NLM_lpage">35436</span>, <span class="refDoi"> DOI: 10.1074/jbc.m112.426866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1074%2Fjbc.m112.426866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=35428-35436&author=S.+Banerjeeauthor=H.+Cuiauthor=N.+Xieauthor=Z.+Tanauthor=S.+Yangauthor=M.+Icyuzauthor=V.+J.+Thannickalauthor=E.+Abrahamauthor=G.+Liu&title=miR-125a-5p+regulates+differential+activation+of+macrophages+and+inflammation&doi=10.1074%2Fjbc.m112.426866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m112.426866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m112.426866%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DN.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DIcyuz%26aufirst%3DM.%26aulast%3DThannickal%26aufirst%3DV.%2BJ.%26aulast%3DAbraham%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DmiR-125a-5p%2520regulates%2520differential%2520activation%2520of%2520macrophages%2520and%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D35428%26epage%3D35436%26doi%3D10.1074%2Fjbc.m112.426866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natoli, G.</span></span> <span> </span><span class="NLM_article-title">Transcriptional regulation of macrophage polarization: enabling diversity with identity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/nri3088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnri3088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22025054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=750-761&author=T.+Lawrenceauthor=G.+Natoli&title=Transcriptional+regulation+of+macrophage+polarization%3A+enabling+diversity+with+identity&doi=10.1038%2Fnri3088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional regulation of macrophage polarization: enabling diversity with identity</span></div><div class="casAuthors">Lawrence, Toby; Natoli, Gioacchino</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">750-761</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In terms of both phenotype and function, macrophages have remarkable heterogeneity, which reflects the specialization of tissue-resident macrophages in microenvironments as different as liver, brain and bone.  Also, marked changes in the activity and gene expression programs of macrophages can occur when they come into contact with invading microorganisms or injured tissues.  Therefore, the macrophage lineage includes a remarkable diversity of cells with different functions and functional states that are specified by a complex interplay between microenvironmental signals and a hardwired differentiation program that dets. macrophage identity.  In this Review, the authors summarize the current knowledge of transcriptional and chromatin-mediated control of macrophage polarization in physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVPgvAtgoULrVg90H21EOLACvtfcHk0lgxRAMyHcahSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7vF&md5=6443d41bf1a43f96f5a29d14d83a7979</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnri3088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3088%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DT.%26aulast%3DNatoli%26aufirst%3DG.%26atitle%3DTranscriptional%2520regulation%2520of%2520macrophage%2520polarization%253A%2520enabling%2520diversity%2520with%2520identity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2011%26volume%3D11%26spage%3D750%26epage%3D761%26doi%3D10.1038%2Fnri3088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawji, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">The benefits and detriments of macrophages/microglia in models of multiple sclerosis</span>. <i>Clin. Dev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">948976</span>, <span class="refDoi"> DOI: 10.1155/2013/948976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1155%2F2013%2F948976" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=948976&author=K.+S.+Rawjiauthor=V.+W.+Yong&title=The+benefits+and+detriments+of+macrophages%2Fmicroglia+in+models+of+multiple+sclerosis&doi=10.1155%2F2013%2F948976"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1155%2F2013%2F948976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F948976%26sid%3Dliteratum%253Aachs%26aulast%3DRawji%26aufirst%3DK.%2BS.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DThe%2520benefits%2520and%2520detriments%2520of%2520macrophages%252Fmicroglia%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2013%26volume%3D2013%26spage%3D948976%26doi%3D10.1155%2F2013%2F948976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, F. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helming, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span> <span> </span><span class="NLM_article-title">Alternative activation of macrophages: an immunologic functional perspective</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">451</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132532</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1146%2Fannurev.immunol.021908.132532" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=19105661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=451&author=F.+O.+Martinezauthor=L.+Helmingauthor=S.+Gordon&title=Alternative+activation+of+macrophages%3A+an+immunologic+functional+perspective&doi=10.1146%2Fannurev.immunol.021908.132532"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative activation of macrophages: an immunologic functional perspective</span></div><div class="casAuthors">Martinez, Fernando O.; Helming, Laura; Gordon, Siamon</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">451-483</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Macrophages are innate immune cells with well-established roles in the primary response to pathogens, but also in tissue homeostasis, coordination of the adaptive immune response, inflammation, resoln., and repair.  These cells recognize danger signals through receptors capable of inducing specialized activation programs.  The classically known macrophage activation is induced by IFN-γ, which triggers a harsh proinflammatory response that is required to kill intracellular pathogens.  Macrophages also undergo alternative activation by IL-4 and IL-13, which trigger a different phenotype that is important for the immune response to parasites.  Here the authors review the cellular sources of these cytokines, receptor signaling pathways, and induced markers and gene signatures.  The authors draw attention to discrepancies found between mouse and human models of alternative activation.  The evidence for in vivo alternative activation of macrophages is also analyzed, with nematode infection as prototypic disease.  Finally, the authors revisit the concept of macrophage activation in the context of the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox_SbgbsE_ZLVg90H21EOLACvtfcHk0lgxRAMyHcahSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrk%253D&md5=f3fa9ce9796eb4cee37bc7c5f9d86a2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132532%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DF.%2BO.%26aulast%3DHelming%26aufirst%3DL.%26aulast%3DGordon%26aufirst%3DS.%26atitle%3DAlternative%2520activation%2520of%2520macrophages%253A%2520an%2520immunologic%2520functional%2520perspective%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D451%26doi%3D10.1146%2Fannurev.immunol.021908.132532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Nun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaushansky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamoorthy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liblau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohlfeld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wekerle, H.</span></span> <span> </span><span class="NLM_article-title">From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2014.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.jaut.2014.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=25175979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2nsbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=33-50&author=A.+Ben-Nunauthor=N.+Kaushanskyauthor=N.+Kawakamiauthor=G.+Krishnamoorthyauthor=K.+Bererauthor=R.+Liblauauthor=R.+Hohlfeldauthor=H.+Wekerle&title=From+classic+to+spontaneous+and+humanized+models+of+multiple+sclerosis%3A+impact+on+understanding+pathogenesis+and+drug+development&doi=10.1016%2Fj.jaut.2014.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development</span></div><div class="casAuthors">Ben-Nun, Avraham; Kaushansky, Nathali; Kawakami, Naoto; Krishnamoorthy, Gurumoorthy; Berer, Kerstin; Liblau, Roland; Hohlfeld, Reinhard; Wekerle, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-50</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS), a demyelinating disease of the central nervous system (CNS), presents as a complex disease with variable clin. and pathol. manifestations, involving different pathogenic pathways.  Animal models, particularly exptl. autoimmune encephalomyelitis (EAE), have been key to deciphering the pathophysiol. of MS, although no single model can recapitulate the complexity and diversity of MS, or can, to date, integrate the diverse pathogenic pathways.  Since the first EAE model was introduced decades ago, multiple classic (induced), spontaneous, and humanized EAE models have been developed, each recapitulating particular aspects of MS pathogenesis.  The advances in technologies of genetic ablation and transgenesis in mice of C57BL/6J background and the development of myelin-oligodendrocyte glycoprotein (MOG)-induced EAE in C57BL/6J mice yielded several spontaneous and humanized EAE models, and resulted in a plethora of EAE models in which the role of specific genes or cell populations could be precisely interrogated, towards modeling specific pathways of MS pathogenesis/regulation in MS.  Collectively, the numerous studies on the different EAE models contributed immensely to our basic understanding of cellular and mol. pathways in MS pathogenesis as well as to the development of therapeutic agents: several drugs available today as disease modifying treatments were developed from direct studies on EAE models, and many others were tested or validated in EAE.  In this review, we discuss the contribution of major classic, spontaneous, and humanized EAE models to our understanding of MS pathophysiol. and to insights leading to devising current and future therapies for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRat10EU9_RLVg90H21EOLACvtfcHk0lgxRAMyHcahSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2nsbbO&md5=172f38a5831cbb2564f73fc431b5ec94</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2014.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2014.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Nun%26aufirst%3DA.%26aulast%3DKaushansky%26aufirst%3DN.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKrishnamoorthy%26aufirst%3DG.%26aulast%3DBerer%26aufirst%3DK.%26aulast%3DLiblau%26aufirst%3DR.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DWekerle%26aufirst%3DH.%26atitle%3DFrom%2520classic%2520to%2520spontaneous%2520and%2520humanized%2520models%2520of%2520multiple%2520sclerosis%253A%2520impact%2520on%2520understanding%2520pathogenesis%2520and%2520drug%2520development%26jtitle%3DJ.%2520Autoimmun.%26date%3D2014%26volume%3D54%26spage%3D33%26epage%3D50%26doi%3D10.1016%2Fj.jaut.2014.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abourbeh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brulon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontyn, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavitian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisgard, R.</span></span> <span> </span><span class="NLM_article-title">Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">5728</span>– <span class="NLM_lpage">5736</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.2900-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1523%2Fjneurosci.2900-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22539835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslOiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=5728-5736&author=G.+Abourbehauthor=B.+Thezeauthor=R.+Maroyauthor=A.+Duboisauthor=V.+Brulonauthor=Y.+Fontynauthor=F.+Dolleauthor=B.+Tavitianauthor=R.+Boisgard&title=Imaging+Microglial%2FMacrophage+Activation+in+Spinal+Cords+of+Experimental+Autoimmune+Encephalomyelitis+Rats+by+Positron+Emission+Tomography+Using+the+Mitochondrial+18+kDa+Translocator+Protein+Radioligand+%5B18F%5DDPA-714&doi=10.1523%2Fjneurosci.2900-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [18F]DPA-714</span></div><div class="casAuthors">Abourbeh, Galith; Theze, Benoit; Maroy, Renaud; Dubois, Albertine; Brulon, Vincent; Fontyn, Yoann; Dolle, Frederic; Tavitian, Bertrand; Boisgard, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5728-5736</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS.  Activated microglia/macrophages play a key role in the immunopathogenesis of MS and its corresponding animal models, exptl. autoimmune encephalomyelitis (EAE).  Microglia activation begins at early stages of the disease and is assocd. with elevated expression of the 18 kDa mitochondrial translocator protein (TSPO).  Thus, positron emission tomog. (PET) imaging of microglial activation using TSPO-specific radioligands could be valuable for monitoring disease-assocd. neuroinflammatory processes.  EAE was induced in rats using a fragment of myelin basic protein, yielding acute clin. disease that reflects extensive spinal cord inflammation.  Enhanced TSPO expression in spinal cords of EAE rats vs. those of controls was confirmed by Western blot and immunohistochem.  Biodistribution studies in control and EAE rats were performed using the TSPO radioligand [18F]DPA-714 [N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide].  At 1 h after injection, almost fivefold higher levels of [18F]DPA-714 were measured in spinal cords of EAE rats vs. controls.  The specific binding of [18F]DPA-714 to TSPO in spinal cords was confirmed in competition studies, using unlabeled (R,S)-PK11195 ((R,S)-N-methyl-N-(1-methylpropyl)-1-(2-chlorophenyl)isoquinoline-3-carboxamide) or DPA-714 in excess.  MicroPET studies affirm that this differential radioactivity uptake in spinal cords of EAE vs. control rats could be detected and quantified.  Using [18F]DPA-714, neuroinflammation in spinal cords of EAE-induced rats could be visualized by PET, offering a sensitive technique for monitoring neuroinflammatory lesions in the CNS and particularly in the spinal cord.  In addn. to current MRI protocols, this approach could provide mol. images of neuroinflammation for detection, monitoring, and research in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd4IwlSovCSbVg90H21EOLACvtfcHk0lgKLIfEjbXIdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslOiu74%253D&md5=4abe5bd7407ccb6e39469c869e5cfc7b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.2900-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.2900-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DAbourbeh%26aufirst%3DG.%26aulast%3DTheze%26aufirst%3DB.%26aulast%3DMaroy%26aufirst%3DR.%26aulast%3DDubois%26aufirst%3DA.%26aulast%3DBrulon%26aufirst%3DV.%26aulast%3DFontyn%26aufirst%3DY.%26aulast%3DDolle%26aufirst%3DF.%26aulast%3DTavitian%26aufirst%3DB.%26aulast%3DBoisgard%26aufirst%3DR.%26atitle%3DImaging%2520Microglial%252FMacrophage%2520Activation%2520in%2520Spinal%2520Cords%2520of%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520Rats%2520by%2520Positron%2520Emission%2520Tomography%2520Using%2520the%2520Mitochondrial%252018%2520kDa%2520Translocator%2520Protein%2520Radioligand%2520%255B18F%255DDPA-714%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D5728%26epage%3D5736%26doi%3D10.1523%2Fjneurosci.2900-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawji, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">The benefits and detriments of macrophages/microglia in models of multiple sclerosis</span>. <i>Clin. Dev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">948976</span>, <span class="refDoi"> DOI: 10.1155/2013/948976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1155%2F2013%2F948976" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=948976&author=K.+S.+Rawjiauthor=V.+W.+Yong&title=The+benefits+and+detriments+of+macrophages%2Fmicroglia+in+models+of+multiple+sclerosis&doi=10.1155%2F2013%2F948976"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2013%2F948976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F948976%26sid%3Dliteratum%253Aachs%26aulast%3DRawji%26aufirst%3DK.%2BS.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DThe%2520benefits%2520and%2520detriments%2520of%2520macrophages%252Fmicroglia%2520in%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2013%26volume%3D2013%26spage%3D948976%26doi%3D10.1155%2F2013%2F948976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span> <span> </span><span class="NLM_article-title">Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">507</span>, <span class="refDoi"> DOI: 10.1189/jlb.3a0116-028rr</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1189%2Fjlb.3a0116-028rr" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27443879" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2016&pages=507&author=Y.+Xuauthor=Z.+Heauthor=Z.+Liauthor=S.+Fangauthor=Y.+Zhangauthor=C.+Wanauthor=Y.+Maauthor=P.+Linauthor=C.+Liuauthor=G.+Wangauthor=R.+Liauthor=J.+Zhuauthor=Y.+Liauthor=L.+Muauthor=Y.+Zhangauthor=J.+Wangauthor=Q.+Kongauthor=H.+Liauthor=B.+Sun&title=Irgm1+is+required+for+the+inflammatory+function+of+M1+macrophage+in+early+experimental+autoimmune+encephalomyelitis&doi=10.1189%2Fjlb.3a0116-028rr"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1189%2Fjlb.3a0116-028rr&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.3a0116-028rr%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DB.%26atitle%3DIrgm1%2520is%2520required%2520for%2520the%2520inflammatory%2520function%2520of%2520M1%2520macrophage%2520in%2520early%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2016%26volume%3D101%26spage%3D507%26doi%3D10.1189%2Fjlb.3a0116-028rr" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kigerl, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gensel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ankeny, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovich, P. G.</span></span> <span> </span><span class="NLM_article-title">Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">13435</span>– <span class="NLM_lpage">13444</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3257-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1523%2FJNEUROSCI.3257-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=19864556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=13435-13444&author=K.+A.+Kigerlauthor=J.+C.+Genselauthor=D.+P.+Ankenyauthor=J.+K.+Alexanderauthor=D.+J.+Donnellyauthor=P.+G.+Popovich&title=Identification+of+two+distinct+macrophage+subsets+with+divergent+effects+causing+either+neurotoxicity+or+regeneration+in+the+injured+mouse+spinal+cord&doi=10.1523%2Fjneurosci.3257-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord</span></div><div class="casAuthors">Kigerl, Kristina A.; Gensel, John C.; Ankeny, Daniel P.; Alexander, Jessica K.; Donnelly, Dustin J.; Popovich, Phillip G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">13435-13444</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Macrophages dominate sites of CNS injury in which they promote both injury and repair.  These divergent effects may be caused by distinct macrophage subsets, i.e., "classically activated" proinflammatory (M1) or "alternatively activated" anti-inflammatory (M2) cells.  Here, the authors show that an M1 macrophage response is rapidly induced and then maintained at sites of traumatic spinal cord injury and that this response overwhelms a comparatively smaller and transient M2 macrophage response.  The high M1/M2 macrophage ratio has significant implications for CNS repair.  Indeed, the authors present novel data showing that only M1 macrophages are neurotoxic and M2 macrophages promote a regenerative growth response in adult sensory axons, even in the context of inhibitory substrates that dominate sites of CNS injury (e.g., proteoglycans and myelin).  Together, these data suggest that polarizing the differentiation of resident microglia and infiltrating blood monocytes toward an M2 or "alternatively" activated macrophage phenotype could promote CNS repair while limiting secondary inflammatory-mediated injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdAcBQ_zl-ObVg90H21EOLACvtfcHk0lgKLIfEjbXIdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmtrnJ&md5=f4af0c8ede9ec37bf14176994b8090fe</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3257-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3257-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DKigerl%26aufirst%3DK.%2BA.%26aulast%3DGensel%26aufirst%3DJ.%2BC.%26aulast%3DAnkeny%26aufirst%3DD.%2BP.%26aulast%3DAlexander%26aufirst%3DJ.%2BK.%26aulast%3DDonnelly%26aufirst%3DD.%2BJ.%26aulast%3DPopovich%26aufirst%3DP.%2BG.%26atitle%3DIdentification%2520of%2520two%2520distinct%2520macrophage%2520subsets%2520with%2520divergent%2520effects%2520causing%2520either%2520neurotoxicity%2520or%2520regeneration%2520in%2520the%2520injured%2520mouse%2520spinal%2520cord%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D13435%26epage%3D13444%26doi%3D10.1523%2Fjneurosci.3257-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eschborn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freise, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engbers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meuth, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhlmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, L.</span></span> <span> </span><span class="NLM_article-title">Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">90</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2015.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.jaut.2015.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26584738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVKmsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=90-101&author=S.+Huckeauthor=M.+Eschbornauthor=M.+Liebmannauthor=M.+Heroldauthor=N.+Freiseauthor=A.+Engbersauthor=P.+Ehlingauthor=S.+G.+Meuthauthor=J.+Rothauthor=T.+Kuhlmannauthor=H.+Wiendlauthor=L.+Klotz&title=Sodium+chloride+promotes+pro-inflammatory+macrophage+polarization+thereby+aggravating+CNS+autoimmunity&doi=10.1016%2Fj.jaut.2015.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity</span></div><div class="casAuthors">Hucke, Stephanie; Eschborn, Melanie; Liebmann, Marie; Herold, Martin; Freise, Nicole; Engbers, Annika; Ehling, Petra; Meuth, Sven G.; Roth, Johannes; Kuhlmann, Tanja; Wiendl, Heinz; Klotz, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90-101</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The increasing incidence in Multiple Sclerosis (MS) during the last decades in industrialized countries might be linked to a change in dietary habits.  Nowadays, enhanced salt content is an important characteristic of Western diet and increased dietary salt (NaCl) intake promotes pathogenic T cell responses contributing to central nervous system (CNS) autoimmunity.  Given the importance of macrophage responses for CNS disease propagation, we addressed the influence of salt consumption on macrophage responses in CNS autoimmunity.  We obsd. that EAE-diseased mice receiving a NaCl-high diet showed strongly enhanced macrophage infiltration and activation within the CNS accompanied by disease aggravation during the effector phase of EAE.  NaCl treatment of macrophages elicited a strong pro-inflammatory phenotype characterized by enhanced pro-inflammatory cytokine prodn., increased expression of immune-stimulatory mols., and an antigen-independent boost of T cell proliferation.  This NaCl-induced pro-inflammatory macrophage phenotype was accompanied by increased activation of NF-κB and MAPK signaling pathways.  The pathogenic relevance of NaCl-conditioned macrophages is illustrated by the finding that transfer into EAE-diseased animals resulted in significant disease aggravation compared to untreated macrophages.  Importantly, also in human monocytes, NaCl promoted a pro-inflammatory phenotype that enhanced human T cell proliferation.  Taken together, high dietary salt intake promotes pro-inflammatory macrophages that aggravate CNS autoimmunity.  Together with other studies, these results underline the need to further det. the relevance of increased dietary salt intake for MS disease severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnzqByzdvFnrVg90H21EOLACvtfcHk0lht9z4LTgJMXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVKmsb3P&md5=23cd922d25435637f9f3ba847a65b157</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2015.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2015.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DHucke%26aufirst%3DS.%26aulast%3DEschborn%26aufirst%3DM.%26aulast%3DLiebmann%26aufirst%3DM.%26aulast%3DHerold%26aufirst%3DM.%26aulast%3DFreise%26aufirst%3DN.%26aulast%3DEngbers%26aufirst%3DA.%26aulast%3DEhling%26aufirst%3DP.%26aulast%3DMeuth%26aufirst%3DS.%2BG.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DKuhlmann%26aufirst%3DT.%26aulast%3DWiendl%26aufirst%3DH.%26aulast%3DKlotz%26aufirst%3DL.%26atitle%3DSodium%2520chloride%2520promotes%2520pro-inflammatory%2520macrophage%2520polarization%2520thereby%2520aggravating%2520CNS%2520autoimmunity%26jtitle%3DJ.%2520Autoimmun.%26date%3D2016%26volume%3D67%26spage%3D90%26epage%3D101%26doi%3D10.1016%2Fj.jaut.2015.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coull, J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beggs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudreau, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Koninck, Y.</span></span> <span> </span><span class="NLM_article-title">BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>438</i></span>,  <span class="NLM_fpage">1017</span>, <span class="refDoi"> DOI: 10.1038/nature04223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnature04223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=16355225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=1017&author=J.+A.+M.+Coullauthor=S.+Beggsauthor=D.+Boudreauauthor=D.+Boivinauthor=M.+Tsudaauthor=K.+Inoueauthor=C.+Gravelauthor=M.+W.+Salterauthor=Y.+De+Koninck&title=BDNF+from+microglia+causes+the+shift+in+neuronal+anion+gradient+underlying+neuropathic+pain&doi=10.1038%2Fnature04223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain</span></div><div class="casAuthors">Coull, Jeffrey A. M.; Beggs, Simon; Boudreau, Dominic; Boivin, Dominick; Tsuda, Makoto; Inoue, Kazuhide; Gravel, Claude; Salter, Michael W.; De Koninck, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">438</span>
        (<span class="NLM_cas:issue">7070</span>),
    <span class="NLM_cas:pages">1017-1021</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neuropathic pain that occurs after peripheral nerve injury depends on the hyper-excitability of neurons in the dorsal horn of the spinal cord.  Spinal microglia stimulated by ATP contribute to tactile allodynia, a highly debilitating symptom of pain induced by nerve injury.  Signaling between microglia and neurons is therefore an essential link in neuropathic pain transmission, but how this signaling occurs is unknown.  Here we show that ATP-stimulated microglia cause a de-polarizing shift in the anion reversal potential (Eanion) in spinal lamina I neurons.  This shift inverts the polarity of currents activated by GABA (γ-amino butyric acid), as has been shown to occur after peripheral nerve injury.  Applying brain-derived neurotrophic factor (BDNF) mimics the alteration in Eanion.  Blocking signaling between BDNF and the receptor TrkB reverses the allodynia and the Eanion shift that follows both nerve injury and administration of ATP-stimulated microglia.  ATP stimulation evokes the release of BDNF from microglia.  Preventing BDNF release from microglia by pretreating them with interfering RNA directed against BDNF before ATP stimulation also inhibits the effects of these cells on the withdrawal threshold and Eanion.  Our results show that ATP-stimulated microglia signal to lamina I neurons, causing a collapse of their transmembrane anion gradient, and that BDNF is a crucial signaling mol. between microglia and neurons.  Blocking this microglia-neuron signaling pathway may represent a therapeutic strategy for treating neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4cwNgaNvCy7Vg90H21EOLACvtfcHk0lht9z4LTgJMXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSksrvJ&md5=7e7187a8adc7be9929f94eafcb265a1f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnature04223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04223%26sid%3Dliteratum%253Aachs%26aulast%3DCoull%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DBoudreau%26aufirst%3DD.%26aulast%3DBoivin%26aufirst%3DD.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DGravel%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26aulast%3DDe%2BKoninck%26aufirst%3DY.%26atitle%3DBDNF%2520from%2520microglia%2520causes%2520the%2520shift%2520in%2520neuronal%2520anion%2520gradient%2520underlying%2520neuropathic%2520pain%26jtitle%3DNature%26date%3D2005%26volume%3D438%26spage%3D1017%26doi%3D10.1038%2Fnature04223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreyfus, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, I. B.</span></span> <span> </span><span class="NLM_article-title">Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1006/nbdi.2000.0318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1006%2Fnbdi.2000.0318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=11114257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslSms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=574-585&author=K.+D.+Doughertyauthor=C.+F.+Dreyfusauthor=I.+B.+Black&title=Brain-derived+neurotrophic+factor+in+astrocytes%2C+oligodendrocytes%2C+and+microglia%2Fmacrophages+after+spinal+cord+injury&doi=10.1006%2Fnbdi.2000.0318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-Derived Neurotrophic Factor in Astrocytes, Oligodendrocytes, and Microglia/Macrophages after Spinal Cord Injury</span></div><div class="casAuthors">Dougherty, Karen D.; Dreyfus, Cheryl F.; Black, Ira B.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">574-585</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Recent studies suggest that the injured adult spinal cord responds to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3) with enhanced neuron survival and axon regeneration.  Potential neurotrophin sources and cellular localization in spinal cord are largely undefined.  We examd. glial BDNF localization in normal cord and its temporospatial distribution after injury in vivo.  We used dual immunolabeling for BDNF and glial fibrillary acidic protein (GFAP) in astrocytes, adenomatous polyposis coli tumor suppressor protein (APC) for oligodendrocytes or type III CDH receptor (OX42) for microglia/macrophages.  In normal cord, small subsets of astrocytes and microglia/macrophages and most oligodendrocytes exhibited BDNF-immunoreactivity.  Following injury, the no. of BDNF-immunopos. astrocytes and microglia/macrophages increased dramatically at the injury site over time.  Most oligodendrocytes contained BDNF 1 day and 1 wk following injury, but APC-pos. cells were largely absent at the injury site 6 wk postinjury.  Glial BDNF-immunolabeling was also examd. 10 and 20 mm from the wound.  Ten millimeters from the lesion, astrocyte and microglia/macrophage BDNF-immunolabeling resembled that at the injury at all times examd.  Twenty millimeters from injury, BDNF localization in all three glial subtypes resembled controls, regardless of time postlesion.  Our findings suggest that in normal adult cord, astrocytes, oligodendrocytes, and microglia/macrophages play roles in local trophin availability and in trophin-mediated injury and healing responses directly within and surrounding the wound site.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofhzvUBvhkV7Vg90H21EOLACvtfcHk0lht9z4LTgJMXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslSms7g%253D&md5=6be9bd5c0adbd6d214b1b04576af570b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.2000.0318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.2000.0318%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DK.%2BD.%26aulast%3DDreyfus%26aufirst%3DC.%2BF.%26aulast%3DBlack%26aufirst%3DI.%2BB.%26atitle%3DBrain-derived%2520neurotrophic%2520factor%2520in%2520astrocytes%252C%2520oligodendrocytes%252C%2520and%2520microglia%252Fmacrophages%2520after%2520spinal%2520cord%2520injury%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2000%26volume%3D7%26spage%3D574%26epage%3D585%26doi%3D10.1006%2Fnbdi.2000.0318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shechter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusimano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yovel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolls, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluchino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M.</span></span> <span> </span><span class="NLM_article-title">Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1000113</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.1000113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1371%2Fjournal.pmed.1000113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&author=R.+Shechterauthor=A.+Londonauthor=C.+Varolauthor=C.+Raposoauthor=M.+Cusimanoauthor=G.+Yovelauthor=A.+Rollsauthor=M.+Mackauthor=S.+Pluchinoauthor=G.+Martinoauthor=S.+Jungauthor=M.+Schwartz&title=Infiltrating+blood-derived+macrophages+are+vital+cells+playing+an+anti-inflammatory+role+in+recovery+from+spinal+cord+injury+in+mice&doi=10.1371%2Fjournal.pmed.1000113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.1000113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.1000113%26sid%3Dliteratum%253Aachs%26aulast%3DShechter%26aufirst%3DR.%26aulast%3DLondon%26aufirst%3DA.%26aulast%3DVarol%26aufirst%3DC.%26aulast%3DRaposo%26aufirst%3DC.%26aulast%3DCusimano%26aufirst%3DM.%26aulast%3DYovel%26aufirst%3DG.%26aulast%3DRolls%26aufirst%3DA.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DPluchino%26aufirst%3DS.%26aulast%3DMartino%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DM.%26atitle%3DInfiltrating%2520blood-derived%2520macrophages%2520are%2520vital%2520cells%2520playing%2520an%2520anti-inflammatory%2520role%2520in%2520recovery%2520from%2520spinal%2520cord%2520injury%2520in%2520mice%26jtitle%3DPLoS%2520Med.%26date%3D2009%26volume%3D6%26doi%3D10.1371%2Fjournal.pmed.1000113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schonberg, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, E. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahinkaya, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovich, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mctigue, D. M.</span></span> <span> </span><span class="NLM_article-title">Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">5374</span>– <span class="NLM_lpage">5384</span>, <span class="refDoi"> DOI: 10.1523/jneurosci.3517-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1523%2Fjneurosci.3517-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22514302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1akt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=5374-5384&author=D.+L.+Schonbergauthor=E.+Z.+Goldsteinauthor=F.+R.+Sahinkayaauthor=P.+Weiauthor=P.+G.+Popovichauthor=D.+M.+Mctigue&title=Ferritin+stimulates+oligodendrocyte+genesis+in+the+adult+spinal+cord+and+can+be+transferred+from+macrophages+to+NG2+cells+in+vivo&doi=10.1523%2Fjneurosci.3517-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo</span></div><div class="casAuthors">Schonberg, David L.; Goldstein, Evan Z.; Sahinkaya, Fatma Rezan; Wei, Ping; Popovich, Phillip G.; McTigue, Dana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5374-5384</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Injured CNS tissue often contains elevated iron and its storage protein ferritin, which may exacerbate tissue damage through pro-oxidative mechanisms.  Therefore, therapeutic studies often target iron redn. as a neuroprotective strategy.  However, iron may be crucial for oligodendrocyte replacement and remyelination.  For instance, we previously showed that intraspinal toll-like receptor 4 macrophage activation induced the generation of new ferritin-pos. oligodendrocytes, and that iron chelation significantly reduced this oligodendrogenic response.  Since macrophages can secrete ferritin, we hypothesize that ferritin is a macrophage-derived signal that promotes oligodendrogenesis.  To test this, we microinjected ferritin into intact adult rat spinal cords.  Within 6 h, NG2+ progenitor cells proliferated and accumulated ferritin.  By 3 d, many of these cells had differentiated into new oligodendrocytes.  However, acute neuron and oligodendrocyte toxicity occurred in gray matter.  Interestingly, ferritin-pos. NG2 cells and macrophages accumulated in the area of cell loss, revealing that NG2 cells thrive in an environment that is toxic to other CNS cells.  To test whether ferritin can be transferred from macrophages to NG2 cells in vivo, we loaded macrophages with fluorescent ferritin then transplanted them into intact spinal white matter.  Within 3-6 d, proliferating NG2 cells migrated into the macrophage transplants and accumulated fluorescently labeled ferritin.  These results show that activated macrophages can be an in vivo source of ferritin for NG2 cells, which induces their proliferation and differentiation into new oligodendrocytes.  This work has relevance for conditions in which iron-mediated injury and/or repair likely occur, such as hemorrhage, stroke, spinal cord injury, aging, Parkinson's disease, and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiiQR3QeD-kLVg90H21EOLACvtfcHk0lg8wcKz36495g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1akt78%253D&md5=a4325df8eb5514377e6c9d61d210e1a8</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2Fjneurosci.3517-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252Fjneurosci.3517-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DSchonberg%26aufirst%3DD.%2BL.%26aulast%3DGoldstein%26aufirst%3DE.%2BZ.%26aulast%3DSahinkaya%26aufirst%3DF.%2BR.%26aulast%3DWei%26aufirst%3DP.%26aulast%3DPopovich%26aufirst%3DP.%2BG.%26aulast%3DMctigue%26aufirst%3DD.%2BM.%26atitle%3DFerritin%2520stimulates%2520oligodendrocyte%2520genesis%2520in%2520the%2520adult%2520spinal%2520cord%2520and%2520can%2520be%2520transferred%2520from%2520macrophages%2520to%2520NG2%2520cells%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D5374%26epage%3D5384%26doi%3D10.1523%2Fjneurosci.3517-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikita, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubourdieu-Cassagno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deloire, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vekris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canron, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franconi, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boiziau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petry, K. G.</span></span> <span> </span><span class="NLM_article-title">Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration</span>. <i>Mult. Scler. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1177/1352458510379243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1177%2F1352458510379243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=20813772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFWiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2-15&author=J.+Mikitaauthor=N.+Dubourdieu-Cassagnoauthor=M.+S.+Deloireauthor=A.+Vekrisauthor=M.+Biranauthor=G.+Raffardauthor=B.+Brochetauthor=M.-H.+Canronauthor=J.-M.+Franconiauthor=C.+Boiziauauthor=K.+G.+Petry&title=Altered+M1%2FM2+activation+patterns+of+monocytes+in+severe+relapsing+experimental+rat+model+of+multiple+sclerosis.+Amelioration+of+clinical+status+by+M2+activated+monocyte+administration&doi=10.1177%2F1352458510379243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration</span></div><div class="casAuthors">Mikita, Joanna; Dubourdieu-Cassagno, Nadege; Deloire, Mathilde S. A.; Vekris, Antoine; Biran, Marc; Raffard, Gerard; Brochet, Bruno; Canron, Marie-Helene; Franconi, Jean-Michel; Boiziau, Claudine; Petry, Klaus G.</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Sclerosis Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-15</span>CODEN:
                <span class="NLM_cas:coden">MSJUAP</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">We investigated proinflammatory M1 and immunomodulatory M2 activation profiles of circulating monocytes in relapsing exptl. autoimmune encephalomyelitis (EAE) model of multiple sclerosis, and tested whether altered M1/M2 equil. promotes CNS inflammation.  Approaches of MRI macrophage tracking with USPIO nanoparticles and expression patterns of M1/M2 macrophages and microglia in brain and M1/M2 monocytes in blood samples at various disease stages revealed that M1/M2 equil. in blood and CNS favors mild EAE, while imbalance towards M1 promotes relapsing EAE.  We consequently investigated whether M2 activated monocyte restoration in peripheral blood could cure acute clin. EAE disease.  Administration of ex vivo activated M2 monocytes both suppressed ongoing severe EAE and increased immunomodulatory expression pattern in lesions, confirming their role in the induction of recovery.  We conclude that imbalance of monocyte activation profiles and impaired M2 expression, are key factors in development of relapses.  Our study opens new perspectives for therapeutic applications in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfuJPvDvHx_LVg90H21EOLACvtfcHk0ljKhRMG4GFOvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFWiu74%253D&md5=051e900a285e94c22121ce4955de190e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1177%2F1352458510379243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1352458510379243%26sid%3Dliteratum%253Aachs%26aulast%3DMikita%26aufirst%3DJ.%26aulast%3DDubourdieu-Cassagno%26aufirst%3DN.%26aulast%3DDeloire%26aufirst%3DM.%2BS.%26aulast%3DVekris%26aufirst%3DA.%26aulast%3DBiran%26aufirst%3DM.%26aulast%3DRaffard%26aufirst%3DG.%26aulast%3DBrochet%26aufirst%3DB.%26aulast%3DCanron%26aufirst%3DM.-H.%26aulast%3DFranconi%26aufirst%3DJ.-M.%26aulast%3DBoiziau%26aufirst%3DC.%26aulast%3DPetry%26aufirst%3DK.%2BG.%26atitle%3DAltered%2520M1%252FM2%2520activation%2520patterns%2520of%2520monocytes%2520in%2520severe%2520relapsing%2520experimental%2520rat%2520model%2520of%2520multiple%2520sclerosis.%2520Amelioration%2520of%2520clinical%2520status%2520by%2520M2%2520activated%2520monocyte%2520administration%26jtitle%3DMult.%2520Scler.%2520J.%26date%3D2011%26volume%3D17%26spage%3D2%26epage%3D15%26doi%3D10.1177%2F1352458510379243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prod’Homme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youssef, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rundle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patarroyo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stüve, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamvil, S. S.</span></span> <span> </span><span class="NLM_article-title">Type II monocytes modulate T cell-mediated central nervous system autoimmune disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1038/nm1620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnm1620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=17676050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2sXos1Cjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=935-943&author=M.+S.+Weberauthor=T.+Prod%E2%80%99Hommeauthor=S.+Youssefauthor=S.+E.+Dunnauthor=C.+D.+Rundleauthor=L.+Leeauthor=J.+C.+Patarroyoauthor=O.+St%C3%BCveauthor=R.+A.+Sobelauthor=L.+Steinmanauthor=S.+S.+Zamvil&title=Type+II+monocytes+modulate+T+cell-mediated+central+nervous+system+autoimmune+disease&doi=10.1038%2Fnm1620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Type II monocytes modulate T cell-mediated central nervous system autoimmune disease</span></div><div class="casAuthors">Weber, Martin S.; Prod'homme, Thomas; Youssef, Sawsan; Dunn, Shannon E.; Rundle, Cynthia D.; Lee, Linda; Patarroyo, Juan C.; Stueve, Olaf; Sobel, Raymond A.; Steinman, Lawrence; Zamvil, Scott S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">935-943</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment with glatiramer acetate (GA, copolymer-1, Copaxone), a drug approved for multiple sclerosis (MS), in a mouse model promoted development of anti-inflammatory type II monocytes, characterized by increased secretion of interleukin (IL)-10 and transforming growth factor (TGF)-β, and decreased prodn. of IL-12 and tumor necrosis factor (TNF).  This anti-inflammatory cytokine shift was assocd. with reduced STAT-1 signaling.  Type II monocytes directed differentiation of TH2 cells and CD4+CD25+FoxP3+ regulatory T cells (Treg) independent of antigen specificity.  Type II monocyte-induced regulatory T cells specific for a foreign antigen ameliorated exptl. autoimmune encephalomyelitis (EAE), indicating that neither GA specificity nor recognition of self-antigen was required for their therapeutic effect.  Adoptive transfer of type II monocytes reversed EAE, suppressed TH17 cell development and promoted both TH2 differentiation and expansion of Treg cells in recipient mice.  This demonstration of adoptive immunotherapy by type II monocytes identifies a central role for these cells in T cell immune modulation of autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2iNL9F6Jpq7Vg90H21EOLACvtfcHk0ljKhRMG4GFOvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXos1Cjsbc%253D&md5=d128334f56d2cc67936cb109d20cc9ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnm1620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1620%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DM.%2BS.%26aulast%3DProd%25E2%2580%2599Homme%26aufirst%3DT.%26aulast%3DYoussef%26aufirst%3DS.%26aulast%3DDunn%26aufirst%3DS.%2BE.%26aulast%3DRundle%26aufirst%3DC.%2BD.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DPatarroyo%26aufirst%3DJ.%2BC.%26aulast%3DSt%25C3%25BCve%26aufirst%3DO.%26aulast%3DSobel%26aufirst%3DR.%2BA.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DZamvil%26aufirst%3DS.%2BS.%26atitle%3DType%2520II%2520monocytes%2520modulate%2520T%2520cell-mediated%2520central%2520nervous%2520system%2520autoimmune%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D935%26epage%3D943%26doi%3D10.1038%2Fnm1620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miron, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruckh, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shadrach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Wijngaarden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagers, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ffrench-Constant, C.</span></span> <span> </span><span class="NLM_article-title">M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1218</span>, <span class="refDoi"> DOI: 10.1038/nn.3469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fnn.3469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=23872599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCjtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=1211-1218&author=V.+E.+Mironauthor=A.+Boydauthor=J.-W.+Zhaoauthor=T.+J.+Yuenauthor=J.+M.+Ruckhauthor=J.+L.+Shadrachauthor=P.+van+Wijngaardenauthor=A.+J.+Wagersauthor=A.+Williamsauthor=R.+J.+M.+Franklinauthor=C.+ffrench-Constant&title=M2+microglia+and+macrophages+drive+oligodendrocyte+differentiation+during+CNS+remyelination&doi=10.1038%2Fnn.3469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination</span></div><div class="casAuthors">Miron, Veronique E.; Boyd, Amanda; Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; Shadrach, Jennifer L.; van Wijngaarden, Peter; Wagers, Amy J.; Williams, Anna; Franklin, Robin J. M.; ffrench-Constant, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1211-1218</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The lack of therapies for progressive multiple sclerosis highlights the need to understand the regenerative process of remyelination that can follow CNS demyelination.  This involves an innate immune response consisting of microglia and macrophages, which can be polarized to distinct functional phenotypes: pro-inflammatory (M1) and anti-inflammatory or immunoregulatory (M2).  We found that a switch from an M1- to an M2-dominant response occurred in microglia and peripherally derived macrophages as remyelination started.  Oligodendrocyte differentiation was enhanced in vitro with M2 cell conditioned media and impaired in vivo following intra-lesional M2 cell depletion.  M2 cell densities were increased in lesions of aged mice in which remyelination was enhanced by parabiotic coupling to a younger mouse and in multiple sclerosis lesions that normally show remyelination.  Blocking M2 cell-derived activin-A inhibited oligodendrocyte differentiation during remyelination in cerebellar slice cultures.  Thus, our results indicate that M2 cell polarization is essential for efficient remyelination and identify activin-A as a therapeutic target for CNS regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1mjEZhQn3Y7Vg90H21EOLACvtfcHk0ljKhRMG4GFOvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCjtL7E&md5=f9aea67a2f87eb20d7be5305c643c5b7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnn.3469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3469%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DBoyd%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DJ.-W.%26aulast%3DYuen%26aufirst%3DT.%2BJ.%26aulast%3DRuckh%26aufirst%3DJ.%2BM.%26aulast%3DShadrach%26aufirst%3DJ.%2BL.%26aulast%3Dvan%2BWijngaarden%26aufirst%3DP.%26aulast%3DWagers%26aufirst%3DA.%2BJ.%26aulast%3DWilliams%26aufirst%3DA.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26aulast%3Dffrench-Constant%26aufirst%3DC.%26atitle%3DM2%2520microglia%2520and%2520macrophages%2520drive%2520oligodendrocyte%2520differentiation%2520during%2520CNS%2520remyelination%26jtitle%3DNat.%2520Neurosci.%26date%3D2013%26volume%3D16%26spage%3D1211%26epage%3D1218%26doi%3D10.1038%2Fnn.3469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotter, M.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooijen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. J. M.</span></span> <span> </span><span class="NLM_article-title">Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2004.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.nbd.2004.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=15649707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=166-175&author=M.%0AR.+Kotterauthor=C.+Zhaoauthor=N.+van+Rooijenauthor=R.+J.+M.+Franklin&title=Macrophage-depletion+induced+impairment+of+experimental+CNS+remyelination+is+associated+with+a+reduced+oligodendrocyte+progenitor+cell+response+and+altered+growth+factor+expression&doi=10.1016%2Fj.nbd.2004.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage depletion-induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression</span></div><div class="casAuthors">Kotter, Mark R.; Zhao, Chao; van Rooijen, Nico; Franklin, Robin J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">166-175</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Although macrophages are mediators of CNS demyelination, they are also implicated in remyelination.  To examine the role of macrophages in CNS remyelination, adult rats were depleted of monocytes using clodronate liposomes and demyelination induced in the spinal cord white matter using lysolecithin.  In situ hybridization for scavenger receptor-B and myelin basic protein (MBP) revealed a transiently impaired macrophage response assocd. with delayed remyelination in liposome-treated animals.  Macrophage redn. corresponded with delayed recruitment of PDGFRα+ oligodendrocyte progenitor cells (OPCs), which preceded changes in myelin phagocytosis, indicating a macrophage effect on OPCs independent of myelin debris clearance.  Macrophage depletion-induced changes in the mRNA expression of insulin-like growth factor-1 and transforming growth factor β1, but not platelet-derived growth factor-A and fibroblast growth factor-2.  Thus, the macrophage response to toxin-induced demyelination influences the growth factor environment, thereby affecting the behavior of OPCs and hence the efficiency of remyelination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-WXcb8RIsqLVg90H21EOLACvtfcHk0li4-ROwtVmXJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslOgtQ%253D%253D&md5=c4c544e09699e93b7c8082e2d9485aee</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2004.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2004.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DKotter%26aufirst%3DM.%2BR.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3Dvan%2BRooijen%26aufirst%3DN.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26atitle%3DMacrophage-depletion%2520induced%2520impairment%2520of%2520experimental%2520CNS%2520remyelination%2520is%2520associated%2520with%2520a%2520reduced%2520oligodendrocyte%2520progenitor%2520cell%2520response%2520and%2520altered%2520growth%2520factor%2520expression%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2005%26volume%3D18%26spage%3D166%26epage%3D175%26doi%3D10.1016%2Fj.nbd.2004.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miron, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R. J. M.</span></span> <span> </span><span class="NLM_article-title">Macrophages and CNS remyelination</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1111/jnc.12705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1111%2Fjnc.12705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=24601941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2mu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=165-171&author=V.+E.+Mironauthor=R.+J.+M.+Franklin&title=Macrophages+and+CNS+remyelination&doi=10.1111%2Fjnc.12705"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophages and CNS remyelination</span></div><div class="casAuthors">Miron, Veronique E.; Franklin, Robin J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-171</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Microglia are the resident macrophages of the central nervous system that survey the microenvironment for signals of injury or infection.  The response to such signals induces an inflammatory response involving macrophages derived from both resident microglia and recruited circulating monocytes.  Although implicated as contributors to autoimmune-mediated injury, microglia/ macrophages have recently been shown to be crit. for the important central nervous system regenerative process of remyelination.  This functional dichotomy may reflect their ability to be polarized along a continuum of activation states including the well-characterized cytotoxic M1 and regenerative M2 phenotypes.  Here, we review the roles of microglia, monocytes and the macrophages which they give rise to in creating lesion environments favorable to remyelination, highlighting the specific roles of M1 and M2 phenotypes and how the pro-regenerative role of the innate immune system is altered by aging.  Here, we review the roles of microglia, monocytes and the macrophages, which they give rise to in creating lesion environments favorable to remyelination, highlighting the specific roles of activation phenotypes and how the pro-regenerative role of the innate immune system is altered by aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqzgWf932yJrVg90H21EOLACvtfcHk0li4-ROwtVmXJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2mu7%252FP&md5=8d369e8d6051132ac63f8dab5059f677</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12705%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26atitle%3DMacrophages%2520and%2520CNS%2520remyelination%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D165%26epage%3D171%26doi%3D10.1111%2Fjnc.12705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span>; <span class="NLM_string-name">Drowley, L.</span></span> <span> </span><span class="NLM_article-title">Phenotypic screening</span>.  <i>Annual Reports in Medicinal Chemistry</i>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">50</span>, pp  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">299</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=263-299&author=A.+T.+Plowright&author=L.+Drowley&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DPhenotypic%2520screening%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26pub%3DAcademic%2520Press%26date%3D2017%26volume%3D50%26spage%3D263%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warchal, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unciti-Broceta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, N. O.</span></span> <span> </span><span class="NLM_article-title">Next-generation phenotypic screening</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1331</span>– <span class="NLM_lpage">1347</span>, <span class="refDoi"> DOI: 10.4155/fmc-2016-0025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4155%2Ffmc-2016-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27357617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gitb3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=1331-1347&author=S.+J.+Warchalauthor=A.+Unciti-Brocetaauthor=N.+O.+Carragher&title=Next-generation+phenotypic+screening&doi=10.4155%2Ffmc-2016-0025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Next-generation phenotypic screening</span></div><div class="casAuthors">Warchal, Scott J.; Unciti-Broceta, Asier; Carragher, Neil O.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1331-1347</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Phenotypic drug discovery (PDD) strategies are defined by screening and selection of hit or lead compds. based on quantifiable phenotypic endpoints without prior knowledge of the drug target.  We outline the challenges assocd. with traditional phenotypic screening strategies and propose solns. and new opportunities to be gained by adopting modern PDD technologies.  We highlight both historical and recent examples of approved drugs and new drug candidates discovered by modern phenotypic screening.  Finally, we offer a prospective view of a new era of PDD underpinned by a wealth of technol. advances in the areas of in vitro model development, high-content imaging and image informatics, mechanism-of-action profiling and target deconvolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlMrsHccIf7Vg90H21EOLACvtfcHk0li4-ROwtVmXJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gitb3L&md5=129d42ecd36bb0d636dcf78e4e0ba946</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2016-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2016-0025%26sid%3Dliteratum%253Aachs%26aulast%3DWarchal%26aufirst%3DS.%2BJ.%26aulast%3DUnciti-Broceta%26aufirst%3DA.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26atitle%3DNext-generation%2520phenotypic%2520screening%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D1331%26epage%3D1347%26doi%3D10.4155%2Ffmc-2016-0025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span> <span> </span><span class="NLM_article-title">Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization</span>. <i>Cell Death Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1038/s41419-018-0290-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fs41419-018-0290-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=29445144" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=251-263&author=Q.+Wengauthor=J.+Wangauthor=J.+Wangauthor=J.+Wangauthor=F.+Sattarauthor=Z.+Zhangauthor=J.+Zhengauthor=Z.+Xuauthor=M.+Zhaoauthor=X.+Liuauthor=L.+Yangauthor=G.+Haoauthor=L.+Fangauthor=Q.+R.+Luauthor=B.+Yangauthor=Q.+He&title=Lenalidomide+regulates+CNS+autoimmunity+by+promoting+M2+macrophages+polarization&doi=10.1038%2Fs41419-018-0290-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41419-018-0290-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-018-0290-x%26sid%3Dliteratum%253Aachs%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSattar%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DQ.%2BR.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DQ.%26atitle%3DLenalidomide%2520regulates%2520CNS%2520autoimmunity%2520by%2520promoting%2520M2%2520macrophages%2520polarization%26jtitle%3DCell%2520Death%2520Discovery%26date%3D2018%26volume%3D9%26spage%3D251%26epage%3D263%26doi%3D10.1038%2Fs41419-018-0290-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ying, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazer, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safe, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B. Y.</span></span> <span> </span><span class="NLM_article-title">Investigation of macrophage polarization using bone marrow derived macrophages</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>76</i></span>, <span class="NLM_elocation-id">e50323</span> <span class="refDoi"> DOI: 10.3791/50323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.3791%2F50323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2013&author=W.+Yingauthor=P.+S.+Cherukuauthor=F.+W.+Bazerauthor=S.+H.+Safeauthor=B.+Y.+Zhou&title=Investigation+of+macrophage+polarization+using+bone+marrow+derived+macrophages&doi=10.3791%2F50323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3791%2F50323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F50323%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DW.%26aulast%3DCheruku%26aufirst%3DP.%2BS.%26aulast%3DBazer%26aufirst%3DF.%2BW.%26aulast%3DSafe%26aufirst%3DS.%2BH.%26aulast%3DZhou%26aufirst%3DB.%2BY.%26atitle%3DInvestigation%2520of%2520macrophage%2520polarization%2520using%2520bone%2520marrow%2520derived%2520macrophages%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2013%26volume%3D76%26doi%3D10.3791%2F50323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montalban, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero-Romero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandraratna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clanet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derfuss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazekas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havrdova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappos, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liblau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubetzki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcus, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmaj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sormani, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalheim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiendl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, F.</span></span> <span> </span><span class="NLM_article-title">ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis</span>. <i>Eur. J. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1111/ene.13536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1111%2Fene.13536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=29352526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A280%3ADC%252BC1MvisFOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=215-237&author=X.+Montalbanauthor=R.+Goldauthor=A.+J.+Thompsonauthor=S.+Otero-Romeroauthor=M.+P.+Amatoauthor=D.+Chandraratnaauthor=M.+Clanetauthor=G.+Comiauthor=T.+Derfussauthor=F.+Fazekasauthor=H.+P.+Hartungauthor=E.+Havrdovaauthor=B.+Hemmerauthor=L.+Kapposauthor=R.+Liblauauthor=C.+Lubetzkiauthor=E.+Marcusauthor=D.+H.+Millerauthor=T.+Olssonauthor=S.+Pillingauthor=K.+Selmajauthor=A.+Sivaauthor=P.+S.+Sorensenauthor=M.+P.+Sormaniauthor=C.+Thalheimauthor=H.+Wiendlauthor=F.+Zipp&title=ECTRIMS%2FEAN+guideline+on+the+pharmacological+treatment+of+people+with+multiple+sclerosis&doi=10.1111%2Fene.13536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis</span></div><div class="casAuthors">Montalban X; Otero-Romero S; Gold R; Thompson A J; Otero-Romero S; Amato M P; Chandraratna D; Clanet M; Comi G; Derfuss T; Fazekas F; Hartung H P; Havrdova E; Hemmer B; Hemmer B; Kappos L; Liblau R; Lubetzki C; Marcus E; Pilling S; Miller D H; Olsson T; Selmaj K; Siva A; Sorensen P S; Sormani M P; Thalheim C; Wiendl H; Zipp F</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-237</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Multiple sclerosis (MS) is a complex disease of the central nervous system.  As new drugs are becoming available, knowledge on diagnosis and treatment must continuously evolve.  There is therefore a need for a reference tool compiling current data on benefit and safety, to aid professionals in treatment decisions and use of resources across Europe.  The European Committee of Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have joined forces to meet this need.  The objective was to develop an evidence-based clinical practice guideline for the pharmacological treatment of people with MS to guide healthcare professionals in the decision-making process.  METHODS:  This guideline has been developed using the GRADE methodology and following the recently updated EAN recommendations for guideline development.  Clinical questions were formulated in PICO format (patient, intervention, comparator, outcome) and outcomes were prioritized according to their relevance to clinical practice.  An exhaustive literature search up to December 2016 was performed for each question and the evidence is presented narratively and, when possible, combined in a meta-analysis using a random-effects model.  The quality of evidence for each outcome was rated into four categories - very high, high, low and very low - according to the risk of bias.  GRADE evidence profiles were created using GRADEprofiler (GRADEpro) software (Version 3.6).  The recommendations with assigned strength (strong, weak) were formulated based on the quality of evidence and the risk-benefit balance.  Consensus between the panellists was reached by use of the modified nominal group technique.  RESULTS:  A total of 10 questions have been agreed, encompassing treatment efficacy, response criteria, strategies to address suboptimal response and safety concerns and treatment strategies in MS and pregnancy.  The guideline takes into account all disease-modifying drugs approved by the European Medicine Agency at the time of publication.  A total of 20 recommendations were agreed by the guideline working group members after three rounds of consensus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMt1B7Ade6MY3yKPtYViAGfW6udTcc2eaB9XQKBMgc77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvisFOmsQ%253D%253D&md5=f72465d89cfdf294d80b4212798cf0b4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fene.13536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fene.13536%26sid%3Dliteratum%253Aachs%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DGold%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DA.%2BJ.%26aulast%3DOtero-Romero%26aufirst%3DS.%26aulast%3DAmato%26aufirst%3DM.%2BP.%26aulast%3DChandraratna%26aufirst%3DD.%26aulast%3DClanet%26aufirst%3DM.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DDerfuss%26aufirst%3DT.%26aulast%3DFazekas%26aufirst%3DF.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26aulast%3DHavrdova%26aufirst%3DE.%26aulast%3DHemmer%26aufirst%3DB.%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DLiblau%26aufirst%3DR.%26aulast%3DLubetzki%26aufirst%3DC.%26aulast%3DMarcus%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DOlsson%26aufirst%3DT.%26aulast%3DPilling%26aufirst%3DS.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DSiva%26aufirst%3DA.%26aulast%3DSorensen%26aufirst%3DP.%2BS.%26aulast%3DSormani%26aufirst%3DM.%2BP.%26aulast%3DThalheim%26aufirst%3DC.%26aulast%3DWiendl%26aufirst%3DH.%26aulast%3DZipp%26aufirst%3DF.%26atitle%3DECTRIMS%252FEAN%2520guideline%2520on%2520the%2520pharmacological%2520treatment%2520of%2520people%2520with%2520multiple%2520sclerosis%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2018%26volume%3D25%26spage%3D215%26epage%3D237%26doi%3D10.1111%2Fene.13536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Brandt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tischner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuckermann, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luhder, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichardt, H. M.</span></span> <span> </span><span class="NLM_article-title">Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">8434</span>– <span class="NLM_lpage">8443</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.180.12.8434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.180.12.8434" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=8434-8443&author=S.+Wustauthor=J.+van+den+Brandtauthor=D.+Tischnerauthor=A.+Kleimanauthor=J.+P.+Tuckermannauthor=R.+Goldauthor=F.+Luhderauthor=H.+M.+Reichardt&title=Peripheral+T+cells+are+the+therapeutic+targets+of+glucocorticoids+in+experimental+autoimmune+encephalomyelitis&doi=10.4049%2Fjimmunol.180.12.8434"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.180.12.8434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.180.12.8434%26sid%3Dliteratum%253Aachs%26aulast%3DWust%26aufirst%3DS.%26aulast%3Dvan%2Bden%2BBrandt%26aufirst%3DJ.%26aulast%3DTischner%26aufirst%3DD.%26aulast%3DKleiman%26aufirst%3DA.%26aulast%3DTuckermann%26aufirst%3DJ.%2BP.%26aulast%3DGold%26aufirst%3DR.%26aulast%3DLuhder%26aufirst%3DF.%26aulast%3DReichardt%26aufirst%3DH.%2BM.%26atitle%3DPeripheral%2520T%2520cells%2520are%2520the%2520therapeutic%2520targets%2520of%2520glucocorticoids%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D8434%26epage%3D8443%26doi%3D10.4049%2Fjimmunol.180.12.8434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.-X.</span></span> <span> </span><span class="NLM_article-title">Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2014.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.imlet.2014.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2014&pages=17-22&author=Z.+Jiangauthor=J.+X.+Jiangauthor=G.-X.+Zhang&title=Macrophages%3A+A+double-edged+sword+in+experimental+autoimmune+encephalomyelitis&doi=10.1016%2Fj.imlet.2014.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2014.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2014.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DJ.%2BX.%26aulast%3DZhang%26aufirst%3DG.-X.%26atitle%3DMacrophages%253A%2520A%2520double-edged%2520sword%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DImmunol.%2520Lett.%26date%3D2014%26volume%3D160%26spage%3D17%26epage%3D22%26doi%3D10.1016%2Fj.imlet.2014.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, N. M.</span></span> <span> </span><span class="NLM_article-title">Regulation of macrophage, dendritic cell, and microglial phenotype and function by the SOCS proteins</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">567</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2015.00549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.3389%2Ffimmu.2015.00549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26579124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVSjsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=549-567&author=S.+M.+McCormickauthor=N.+M.+Heller&title=Regulation+of+macrophage%2C+dendritic+cell%2C+and+microglial+phenotype+and+function+by+the+SOCS+proteins&doi=10.3389%2Ffimmu.2015.00549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of macrophage, dendritic cell, and microglial phenotype and function by the SOCS proteins</span></div><div class="casAuthors">McCormick, Sarah M.; Heller, Nicola M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">549/1-549/19</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Macrophages are innate immune cells of dynamic phenotype that rapidly respond to external stimuli in the microenvironment by altering their phenotype to respond to and to direct the immune response.  The ability to dynamically change phenotype must be carefully regulated to prevent uncontrolled inflammatory responses and subsequently to promote resoln. of inflammation.  The suppressor of cytokine signaling (SOCS) proteins play a key role in regulating macrophage phenotype.  In this review, we summarize research to date from mouse and human studies on the role of the SOCS proteins in detg. the phenotype and function of macrophages.  We will also touch on the influence of the SOCS on dendritic cell (DC) and microglial phenotype and function.  The mol. mechanisms of SOCS function in macrophages and DCs are discussed, along with how dysregulation of SOCS expression or function can lead to alterations in macrophage/DC/microglial phenotype and function and to disease.  Regulation of SOCS expression by microRNA is discussed.  Novel therapies and unanswered questions with regard to SOCS regulation of monocyte-macrophage phenotype and function are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbx8YAlehZOLVg90H21EOLACvtfcHk0lhD5SESS7-oMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVSjsr4%253D&md5=8daa9ee8c8e976eed2b24d82516ee02e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2015.00549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2015.00549%26sid%3Dliteratum%253Aachs%26aulast%3DMcCormick%26aufirst%3DS.%2BM.%26aulast%3DHeller%26aufirst%3DN.%2BM.%26atitle%3DRegulation%2520of%2520macrophage%252C%2520dendritic%2520cell%252C%2520and%2520microglial%2520phenotype%2520and%2520function%2520by%2520the%2520SOCS%2520proteins%26jtitle%3DFront.%2520Immunol.%26date%3D2015%26volume%3D6%26spage%3D549%26epage%3D567%26doi%3D10.3389%2Ffimmu.2015.00549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutschman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, P. J.</span></span> <span> </span><span class="NLM_article-title">Shaping gene expression in activated and resting primary macrophages by IL-10</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">2253</span>– <span class="NLM_lpage">2263</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.169.5.2253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.169.5.2253" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=2253-2263&author=R.+Langauthor=D.+Patelauthor=J.+J.+Morrisauthor=R.+L.+Rutschmanauthor=P.+J.+Murray&title=Shaping+gene+expression+in+activated+and+resting+primary+macrophages+by+IL-10&doi=10.4049%2Fjimmunol.169.5.2253"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.169.5.2253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.169.5.2253%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DJ.%2BJ.%26aulast%3DRutschman%26aufirst%3DR.%2BL.%26aulast%3DMurray%26aufirst%3DP.%2BJ.%26atitle%3DShaping%2520gene%2520expression%2520in%2520activated%2520and%2520resting%2520primary%2520macrophages%2520by%2520IL-10%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D2253%26epage%3D2263%26doi%3D10.4049%2Fjimmunol.169.5.2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Macrophage plasticity and polarization: in vivo veritas</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1172/jci59643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1172%2FJCI59643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=22378047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsV2ms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=787-795&author=A.+Sicaauthor=A.+Mantovani&title=Macrophage+plasticity+and+polarization%3A+in+vivo+veritas&doi=10.1172%2Fjci59643"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage plasticity and polarization: in vivo veritas</span></div><div class="casAuthors">Sica, Antonio; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Diversity and plasticity are hallmarks of cells of the monocyte-macrophage lineage.  In response to IFNs, Toll-like receptor engagement, or IL-4/IL-13 signaling, macrophages undergo M1 (classical) or M2 (alternative) activation, which represent extremes of a continuum in a universe of activation states.  Progress has now been made in defining the signaling pathways, transcriptional networks, and epigenetic mechanisms underlying M1-M2 or M2-like polarized activation.  Functional skewing of mononuclear phagocytes occurs in vivo under physiol. conditions (e.g., ontogenesis and pregnancy) and in pathol. (allergic and chronic inflammation, tissue repair, infection, and cancer).  However, in selected preclin. and clin. conditions, coexistence of cells in different activation states and unique or mixed phenotypes have been obsd., a reflection of dynamic changes and complex tissue-derived signals.  The identification of mechanisms and mols. assocd. with macrophage plasticity and polarized activation provides a basis for macrophage-centered diagnostic and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv8WH5pFgWLrVg90H21EOLACvtfcHk0lhD5SESS7-oMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsV2ms7g%253D&md5=2789f6879df4dea15e294b335f086598</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1172%2FJCI59643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI59643%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DMacrophage%2520plasticity%2520and%2520polarization%253A%2520in%2520vivo%2520veritas%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26spage%3D787%26epage%3D795%26doi%3D10.1172%2Fjci59643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Draghici, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarca, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Done, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voichita, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgescu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, R.</span></span> <span> </span><span class="NLM_article-title">A systems biology approach for pathway level analysis</span>. <i>Genome Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1537</span>– <span class="NLM_lpage">1545</span>, <span class="refDoi"> DOI: 10.1101/gr.6202607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1101%2Fgr.6202607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=17785539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGms73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1537-1545&author=S.+Draghiciauthor=P.+Khatriauthor=A.+L.+Tarcaauthor=K.+Aminauthor=A.+Doneauthor=C.+Voichitaauthor=C.+Georgescuauthor=R.+Romero&title=A+systems+biology+approach+for+pathway+level+analysis&doi=10.1101%2Fgr.6202607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A systems biology approach for pathway level analysis</span></div><div class="casAuthors">Draghici, Sorin; Khatri, Purvesh; Tarca, Adi Laurentiu; Amin, Kashyap; Done, Arina; Voichita, Calin; Georgescu, Constantin; Romero, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Genome Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1537-1545</span>CODEN:
                <span class="NLM_cas:coden">GEREFS</span>;
        ISSN:<span class="NLM_cas:issn">1088-9051</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A common challenge in the anal. of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions taking place on various signaling pathways.  A statistical approach using various models is universally used to identify the most relevant pathways in a given expt.  Here, the authors show that the existing pathway anal. methods fail to take into consideration important biol. aspects and may provide incorrect results in certain situations.  By using a systems biol. approach, the authors developed an impact anal. that includes the classical statistics but also considers other crucial factors such as the magnitude of each gene's expression change, their type and position in the given pathways, their interactions, etc.  The impact anal. is an attempt to a deeper level of statistical anal., informed by more pathway-specific biol. than the existing techniques.  On several illustrative data sets, the classical anal. produces both false positives and false negatives, while the impact anal. provides biol. meaningful results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWV8EpdOnA3rVg90H21EOLACvtfcHk0lhD5SESS7-oMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGms73K&md5=e08fbe0c3aab7d34d786f052bfe38af9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fgr.6202607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgr.6202607%26sid%3Dliteratum%253Aachs%26aulast%3DDraghici%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DP.%26aulast%3DTarca%26aufirst%3DA.%2BL.%26aulast%3DAmin%26aufirst%3DK.%26aulast%3DDone%26aufirst%3DA.%26aulast%3DVoichita%26aufirst%3DC.%26aulast%3DGeorgescu%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DR.%26atitle%3DA%2520systems%2520biology%2520approach%2520for%2520pathway%2520level%2520analysis%26jtitle%3DGenome%2520Res.%26date%3D2007%26volume%3D17%26spage%3D1537%26epage%3D1545%26doi%3D10.1101%2Fgr.6202607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kanehisa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, M.</span></span> <span> </span><span class="NLM_article-title">The KEGG resource for deciphering the genome</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">D277</span>– <span class="NLM_lpage">D280</span>, <span class="refDoi"> DOI: 10.1093/nar/gkh063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1093%2Fnar%2Fgkh063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=14681412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSrurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=D277-D280&author=M.+Kanehisaauthor=S.+Gotoauthor=S.+Kawashimaauthor=Y.+Okunoauthor=M.+Hattori&title=The+KEGG+resource+for+deciphering+the+genome&doi=10.1093%2Fnar%2Fgkh063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The KEGG resource for deciphering the genome</span></div><div class="casAuthors">Kanehisa, Minoru; Goto, Susumu; Kawashima, Shuichi; Okuno, Yasushi; Hattori, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Database</span>),
    <span class="NLM_cas:pages">D277-D280</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A grand challenge in the post-genomic era is a complete computer representation of the cell and the organism, which will enable computational prediction of higher-level complexity of cellular processes and organism behavior from genomic information.  Toward this end we have been developing a knowledge-based approach for network prediction, which is to predict, given a complete set of genes in the genome, the protein interaction networks that are responsible for various cellular processes.  KEGG at is the ref. knowledge base that integrates current knowledge on mol. interaction networks such as pathways and complexes (PATHWAY database), information about genes and proteins generated by genome projects (GENES/SSDB/KO databases) and information about biochem. compds. and reactions (Compd./GLYCAN/REACTION databases).  These three types of database actually represent three graph objects, called the protein network, the gene universe and the chem. universe.  New efforts are being made to abstr. knowledge, both computationally and manually, about ortholog clusters in the KO (KEGG Orthol.) database, and to collect and analyze carbohydrate structures in the GLYCAN database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAT9gjCrv6LVg90H21EOLACvtfcHk0liZGES-97_XDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSrurvO&md5=f95eb7403a984e782e8f489a20e74a75</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkh063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkh063%26sid%3Dliteratum%253Aachs%26aulast%3DKanehisa%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DKawashima%26aufirst%3DS.%26aulast%3DOkuno%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DM.%26atitle%3DThe%2520KEGG%2520resource%2520for%2520deciphering%2520the%2520genome%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DD277%26epage%3DD280%26doi%3D10.1093%2Fnar%2Fgkh063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vergadi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ieronymaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyroni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaporidi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsanis, C.</span></span> <span> </span><span class="NLM_article-title">Akt signaling pathway in macrophage activation and M1/M2 polarization</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span>,  <span class="NLM_fpage">1006</span>– <span class="NLM_lpage">1014</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1601515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.1601515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=28115590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlaiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=1006-1014&author=E.+Vergadiauthor=E.+Ieronymakiauthor=K.+Lyroniauthor=K.+Vaporidiauthor=C.+Tsatsanis&title=Akt+signaling+pathway+in+macrophage+activation+and+M1%2FM2+polarization&doi=10.4049%2Fjimmunol.1601515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization</span></div><div class="casAuthors">Vergadi, Eleni; Ieronymaki, Eleftheria; Lyroni, Konstantina; Vaporidi, Katerina; Tsatsanis, Christos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1006-1014</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Macrophages become activated initiating innate immune responses.  Depending on the signals, macrophages obtain an array of activation phenotypes, described by the broad terms of M1 or M2 phenotype.  The PI3K/Akt/mTOR pathway mediates signals from multiple receptors including insulin receptors, pathogen-assocd. mol. pattern receptors, cytokine receptors, adipokine receptors, and hormones.  As a result, the Akt pathway converges inflammatory and metabolic signals to regulate macrophage responses modulating their activation phenotype.  Akt is a family of three serine-threonine kinases, Akt1, Akt2, and Akt3.  Generation of mice lacking individual Akt, PI3K, or mTOR isoforms and utilization of RNA interference technol. have revealed that Akt signaling pathway components have distinct and isoform-specific roles in macrophage biol. and inflammatory disease regulation, by controlling inflammatory cytokines, miRNAs, and functions including phagocytosis, autophagy, and cell metab.  Herein, we review the current knowledge on the role of the Akt signaling pathway in macrophages, focusing on M1/M2 polarization and highlighting Akt isoform-specific functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqhN2YrKKy4bVg90H21EOLACvtfcHk0liZGES-97_XDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlaiu78%253D&md5=11c0393578cafc144259c81a82ee0abc</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1601515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1601515%26sid%3Dliteratum%253Aachs%26aulast%3DVergadi%26aufirst%3DE.%26aulast%3DIeronymaki%26aufirst%3DE.%26aulast%3DLyroni%26aufirst%3DK.%26aulast%3DVaporidi%26aufirst%3DK.%26aulast%3DTsatsanis%26aufirst%3DC.%26atitle%3DAkt%2520signaling%2520pathway%2520in%2520macrophage%2520activation%2520and%2520M1%252FM2%2520polarization%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26spage%3D1006%26epage%3D1014%26doi%3D10.4049%2Fjimmunol.1601515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covarrubias, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aksoylar, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horng, T.</span></span> <span> </span><span class="NLM_article-title">Control of macrophage metabolism and activation by mTOR and Akt signaling</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1016/j.smim.2015.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.smim.2015.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=26360589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=286-296&author=A.+J.+Covarrubiasauthor=H.+I.+Aksoylarauthor=T.+Horng&title=Control+of+macrophage+metabolism+and+activation+by+mTOR+and+Akt+signaling&doi=10.1016%2Fj.smim.2015.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Control of macrophage metabolism and activation by mTOR and Akt signaling</span></div><div class="casAuthors">Covarrubias, Anthony J.; Aksoylar, H. Ibrahim; Horng, Tiffany</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">286-296</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Macrophages are pleiotropic cells that assume a variety of functions depending on their tissue of residence and tissue state.  They maintain homeostasis as well as coordinate responses to stresses such as infection and metabolic challenge.  The ability of macrophages to acquire diverse, context-dependent activities requires their activation (or polarization) to distinct functional states.  While macrophage activation is well understood at the level of signal transduction and transcriptional regulation, the metabolic underpinnings are poorly understood.  Importantly, emerging studies indicate that metabolic shifts play a pivotal role in control of macrophage activation and acquisition of context-dependent effector activities.  The signals that drive macrophage activation impinge on metabolic pathways, allowing for coordinate control of macrophage activation and metab.  Here we discuss how mTOR and Akt, major metabolic regulators and targets of such activation signals, control macrophage metab. and activation.  Dysregulated macrophage activities contribute to many diseases, including infectious, inflammatory, and metabolic diseases and cancer, thus a better understanding of metabolic control of macrophage activation could pave the way to the development of new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxLliB75EM7rVg90H21EOLACvtfcHk0liZGES-97_XDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtbvI&md5=5d16b9dfb153050cacd50a86dcd4d0ac</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.smim.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smim.2015.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DCovarrubias%26aufirst%3DA.%2BJ.%26aulast%3DAksoylar%26aufirst%3DH.%2BI.%26aulast%3DHorng%26aufirst%3DT.%26atitle%3DControl%2520of%2520macrophage%2520metabolism%2520and%2520activation%2520by%2520mTOR%2520and%2520Akt%2520signaling%26jtitle%3DSemin.%2520Immunol.%26date%3D2015%26volume%3D27%26spage%3D286%26epage%3D296%26doi%3D10.1016%2Fj.smim.2015.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beharka, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowther, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormack, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lees, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibesar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlesinger, L. S.</span></span> <span> </span><span class="NLM_article-title">Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2227</span>– <span class="NLM_lpage">2236</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.175.4.2227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.4049%2Fjimmunol.175.4.2227" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=2227-2236&author=A.+A.+Beharkaauthor=J.+E.+Crowtherauthor=F.+X.+McCormackauthor=G.+M.+Denningauthor=J.+Leesauthor=E.+Tibesarauthor=L.+S.+Schlesinger&title=Pulmonary+surfactant+protein+A+activates+a+phosphatidylinositol+3-kinase%2Fcalcium+signal+transduction+pathway+in+human+macrophages%3A+participation+in+the+up-regulation+of+mannose+receptor+activity&doi=10.4049%2Fjimmunol.175.4.2227"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.175.4.2227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.175.4.2227%26sid%3Dliteratum%253Aachs%26aulast%3DBeharka%26aufirst%3DA.%2BA.%26aulast%3DCrowther%26aufirst%3DJ.%2BE.%26aulast%3DMcCormack%26aufirst%3DF.%2BX.%26aulast%3DDenning%26aufirst%3DG.%2BM.%26aulast%3DLees%26aufirst%3DJ.%26aulast%3DTibesar%26aufirst%3DE.%26aulast%3DSchlesinger%26aufirst%3DL.%2BS.%26atitle%3DPulmonary%2520surfactant%2520protein%2520A%2520activates%2520a%2520phosphatidylinositol%25203-kinase%252Fcalcium%2520signal%2520transduction%2520pathway%2520in%2520human%2520macrophages%253A%2520participation%2520in%2520the%2520up-regulation%2520of%2520mannose%2520receptor%2520activity%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D2227%26epage%3D2236%26doi%3D10.4049%2Fjimmunol.175.4.2227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weischenfeldt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porse, B.</span></span> <span> </span><span class="NLM_article-title">Bone marrow-derived macrophages (BMM): isolation and applications</span>. <i>Csh Protocols</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span>,  <span class="NLM_fpage">pdb.prot5080</span>, <span class="refDoi"> DOI: 10.1101/pdb.prot5080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1101%2Fpdb.prot5080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=pdb.prot5080&author=J.+Weischenfeldtauthor=B.+Porse&title=Bone+marrow-derived+macrophages+%28BMM%29%3A+isolation+and+applications&doi=10.1101%2Fpdb.prot5080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1101%2Fpdb.prot5080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fpdb.prot5080%26sid%3Dliteratum%253Aachs%26aulast%3DWeischenfeldt%26aufirst%3DJ.%26aulast%3DPorse%26aufirst%3DB.%26atitle%3DBone%2520marrow-derived%2520macrophages%2520%2528BMM%2529%253A%2520isolation%2520and%2520applications%26jtitle%3DCsh%2520Protocols%26date%3D2008%26volume%3D2008%26spage%3Dpdb.prot5080%26doi%3D10.1101%2Fpdb.prot5080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paterka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuenberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radbruch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bopp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siffrin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipp, F.</span></span> <span> </span><span class="NLM_article-title">Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2016.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1016%2Fj.jaut.2016.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27707650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SitbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=108-114&author=M.+Paterkaauthor=J.+O.+Vossauthor=J.+Werrauthor=E.+Reuterauthor=S.+Franckauthor=T.+Leuenbergerauthor=J.+Herzauthor=H.+Radbruchauthor=T.+Boppauthor=V.+Siffrinauthor=F.+Zipp&title=Dendritic+cells+tip+the+balance+towards+induction+of+regulatory+T+cells+upon+priming+in+experimental+autoimmune+encephalomyelitis&doi=10.1016%2Fj.jaut.2016.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Paterka, Magdalena; Voss, Jan Oliver; Werr, Johannes; Reuter, Eva; Franck, Sophia; Leuenberger, Tina; Herz, Josephine; Radbruch, Helena; Bopp, Tobias; Siffrin, Volker; Zipp, Frauke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Autoimmunity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-114</span>CODEN:
                <span class="NLM_cas:coden">JOAUEP</span>;
        ISSN:<span class="NLM_cas:issn">0896-8411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Counter-balancing regulatory mechanisms, such as the induction of regulatory T cells (Treg), limit the effects of autoimmune attack in neuroinflammation.  However, the role of dendritic cells (DCs) as the most powerful antigen-presenting cells, which are intriguing therapeutic targets in this context, is not fully understood.  Here, we demonstrate that conditional ablation of DCs during the priming phase of myelin-specific T cells in exptl. autoimmune encephalomyelitis (EAE) selectively aborts inducible Treg (iTreg) induction, whereas generation of T helper (Th)1/17 cells is unaltered.  DCs facilitate iTreg induction by creating a milieu with high levels of interleukin (IL)-2 due to a strong proliferative response.  In the absence of DCs, B220+ B cells take over priming of Th17 cells in the place of antigen-presenting cells (APCs), but not the induction of iTreg, thus leading to unregulated, severe autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCPpGpIRed_7Vg90H21EOLACvtfcHk0lgbp2Kuzlq3Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SitbbL&md5=b92d9879c4ac0c4438f01a6e95683081</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2016.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2016.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DPaterka%26aufirst%3DM.%26aulast%3DVoss%26aufirst%3DJ.%2BO.%26aulast%3DWerr%26aufirst%3DJ.%26aulast%3DReuter%26aufirst%3DE.%26aulast%3DFranck%26aufirst%3DS.%26aulast%3DLeuenberger%26aufirst%3DT.%26aulast%3DHerz%26aufirst%3DJ.%26aulast%3DRadbruch%26aufirst%3DH.%26aulast%3DBopp%26aufirst%3DT.%26aulast%3DSiffrin%26aufirst%3DV.%26aulast%3DZipp%26aufirst%3DF.%26atitle%3DDendritic%2520cells%2520tip%2520the%2520balance%2520towards%2520induction%2520of%2520regulatory%2520T%2520cells%2520upon%2520priming%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Autoimmun.%26date%3D2017%26volume%3D76%26spage%3D108%26epage%3D114%26doi%3D10.1016%2Fj.jaut.2016.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velletri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1038/cdd.2016.71</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=10.1038%2Fcdd.2016.71" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=27447115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSnsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1850-1861&author=Q.+Yangauthor=C.+Zhengauthor=J.+Caoauthor=G.+Caoauthor=P.+Shouauthor=L.+Linauthor=T.+Velletriauthor=M.+Jiangauthor=Q.+Chenauthor=Y.+Hanauthor=F.+Liauthor=Y.+Wangauthor=W.+Caoauthor=Y.+Shi&title=Spermidine+alleviates+experimental+autoimmune+encephalomyelitis+through+inducing+inhibitory+macrophages&doi=10.1038%2Fcdd.2016.71"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages</span></div><div class="casAuthors">Yang, Q.; Zheng, C.; Cao, J.; Cao, G.; Shou, P.; Lin, L.; Velletri, T.; Jiang, M.; Chen, Q.; Han, Y.; Li, F.; Wang, Y.; Cao, W.; Shi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1850-1861</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic and debilitating autoimmune disease, characterized by chronic inflammatory demyelination in the nervous tissue and subsequent neurol. dysfunction.  Spermidine, a natural polyamine, has been shown to affect inflammation in some exptl. models.  We show here that spermidine could alleviate exptl. autoimmune encephalomyelitis (EAE), a model for MS, through regulating the infiltration of CD4+ T cells and macrophages in central nervous system.  Unexpectedly, we found that spermidine treatment of MOG-specific T cells did not affect their pathogenic potency upon adaptive transfer; however, spermidine diminished the ability of macrophages in activating MOG-specific T cells ex vivo.  Depletion of macrophages in diseased mice completely abolished the therapeutic effect of spermidine, indicating a crit. role of spermidine-activated macrophages.  Mechanistically, spermidine was found to specifically suppress the expression of interleukin-1beta (IL-1β), IL-12 and CD80 while enhance the expression of arginase 1 in macrophages.  Interestingly, macrophages from spermidine-treated mice could also reverse EAE progression, while pretreatment of those macrophages with the arginase 1 inhibitor abrogated the therapeutic effect.  Therefore, our studies revealed a crit. role of macrophages in spermidine-mediated treatment on EAE and provided novel information for better management of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUE0So9URE07Vg90H21EOLACvtfcHk0lgbp2Kuzlq3Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSnsbnF&md5=87021a9aab4b10caacfe29460dbeb4be</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2016.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2016.71%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DG.%26aulast%3DShou%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DVelletri%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DW.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DSpermidine%2520alleviates%2520experimental%2520autoimmune%2520encephalomyelitis%2520through%2520inducing%2520inhibitory%2520macrophages%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D1850%26epage%3D1861%26doi%3D10.1038%2Fcdd.2016.71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i114"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01635">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_35544"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01635">10.1021/acs.jmedchem.8b01635</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Structures of 28 compounds from in-house library; expression level of Arg1/Ym1/Tnf-α protein; mice weight change and serum parameters during 14 days repeated dose toxicity study; flow cytometry analysis of dendritic cells and Treg cells; changes of gene expression in the KEGG pathway analysis; gene biomarker expression fold change of the in-house compounds; organ-to-body weight ratio during 14 days repeated dose toxicity study; organ-to-brain weight ratio during 14 days repeated dose toxicity study; primers used in qRT-PCR; compound information for the intermediates and target compounds; and NMR spectra and HPLC results for the target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_001.pdf">jm8b01635_si_001.pdf (5.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01635/suppl_file/jm8b01635_si_003.csv">jm8b01635_si_003.csv (5.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01635&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01635%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01635" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6679885baa8e227f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
